Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,A1BG,Alpha-1B-glycoprotein,24647,118,0.86 [0.31-2.37],0.7728542903137087
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AAMDC,Mth938 domain-containing protein,23928,116,0.92 [0.66-1.29],0.6352571750628234
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AARSD1,Alanyl-tRNA editing protein Aarsd1,28200,126,1.01 [0.76-1.34],0.9575649424183929
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABCA2,ATP-binding cassette sub-family A member 2,23828,115,1.12 [0.69-1.82],0.6510324311938791
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABHD14B,Protein ABHD14B,28033,127,1.07 [0.81-1.40],0.6468185499781105
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABL1,Tyrosine-protein kinase ABL1,28200,126,1.10 [0.88-1.37],0.3983224145960485
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABO,Histo-blood group ABO system transferase,24634,116,0.96 [0.85-1.08],0.4953375291484917
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABRAXAS2,BRISC complex subunit Abraxas 2,23828,115,1.05 [0.80-1.37],0.7279956084188703
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",27634,122,1.03 [0.85-1.25],0.7575613020859983
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24157,114,1.20 [0.98-1.47],0.0761580255908105
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24611,115,1.01 [0.83-1.23],0.926898108828694
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACAN,Aggrecan core protein,28068,123,0.77 [0.44-1.35],0.3595569177516275
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACE,Angiotensin-converting enzyme,24634,116,1.40 [0.71-2.76],0.3382135030104936
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACE2,Angiotensin-converting enzyme 2,27821,121,0.90 [0.65-1.24],0.5121167006867824
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACHE,Acetylcholinesterase,24061,114,1.03 [0.61-1.75],0.9053273838664532
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACOT13,Acyl-coenzyme A thioesterase 13,24515,118,1.08 [0.93-1.26],0.3225381171718849
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,28326,123,1.24 [0.92-1.66],0.1559003120202258
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACP1,Low molecular weight phosphotyrosine protein phosphatase,23910,115,0.73 [0.47-1.11],0.1391257821188773
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACP5,Tartrate-resistant acid phosphatase type 5,28428,126,0.71 [0.44-1.14],0.160038422324973
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACP6,Lysophosphatidic acid phosphatase type 6,28542,126,1.00 [0.79-1.26],0.9697025971483552
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACRBP,Acrosin-binding protein,24494,116,1.24 [0.81-1.90],0.3192395796630289
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACRV1,Acrosomal protein SP-10,23910,115,1.16 [0.94-1.42],0.1693901508136819
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACSL1,Long-chain-fatty-acid--CoA ligase 1,23828,115,1.08 [0.67-1.73],0.7548803312292257
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACTA2,"Actin, aortic smooth muscle",27821,121,1.15 [0.83-1.61],0.4014013425118713
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACTN2,Alpha-actinin-2,23828,115,1.37 [1.08-1.75],0.0096390099123244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACTN4,Alpha-actinin-4,27801,122,1.38 [0.93-2.05],0.1073877183119817
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACVRL1,Serine/threonine-protein kinase receptor R3,28083,127,1.09 [0.56-2.10],0.8065237337426931
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACY1,Aminoacylase-1,28326,123,0.81 [0.62-1.05],0.1033832676101562
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,23828,115,0.76 [0.55-1.07],0.112640654442906
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACYP1,Acylphosphatase-1,23970,114,1.10 [0.84-1.43],0.5067239133239805
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADA,Adenosine deaminase,28663,125,1.64 [1.11-2.42],0.0130919858129693
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADA2,Adenosine deaminase 2,28140,126,1.05 [0.72-1.53],0.7988063645420875
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,23910,115,0.87 [0.50-1.51],0.6237504063190912
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,27821,121,1.09 [0.65-1.84],0.7363966219883065
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,28132,127,1.01 [0.65-1.58],0.958946533307308
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,28663,125,1.38 [0.86-2.21],0.1847033792993157
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,28551,125,0.88 [0.51-1.52],0.6383876337712858
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24515,118,0.78 [0.43-1.42],0.4203441987618381
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,23910,115,1.20 [0.71-2.02],0.4936585755798333
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,28675,127,0.99 [0.51-1.94],0.9779239178291634
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,28200,126,0.85 [0.61-1.20],0.3586596447204839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,27821,121,1.23 [0.82-1.85],0.3126886941900665
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,23910,115,0.61 [0.36-1.02],0.0601892331247648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,28391,125,0.67 [0.48-0.93],0.0180355882251689
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTSL2,ADAMTS-like protein 2,24601,117,1.36 [0.82-2.26],0.2347083366453219
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTSL4,ADAMTS-like protein 4,23928,116,0.84 [0.40-1.76],0.6489287157562407
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTSL5,ADAMTS-like protein 5,24611,115,0.97 [0.62-1.52],0.8841149915346259
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,27634,122,0.86 [0.50-1.47],0.5847947630388165
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADD1,Alpha-adducin,24061,114,0.97 [0.75-1.25],0.8135217115369169
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRB3,Adhesion G protein-coupled receptor B3,28083,127,0.87 [0.54-1.40],0.5607225439347876
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRD1,Adhesion G-protein coupled receptor D1,24061,114,1.22 [0.79-1.90],0.371583263318055
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRE1,Adhesion G protein-coupled receptor E1,24515,118,1.05 [0.76-1.45],0.7673277872958562
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRE2,Adhesion G protein-coupled receptor E2,28450,126,0.86 [0.49-1.50],0.5908255027943103
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRE5,Adhesion G protein-coupled receptor E5,28519,126,0.77 [0.45-1.31],0.3357073598314535
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRF5,Adhesion G protein-coupled receptor F5,24611,115,0.60 [0.33-1.12],0.107227977741055
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRG1,Adhesion G-protein coupled receptor G1,28200,126,1.09 [0.86-1.40],0.4648224484479766
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRG2,Adhesion G-protein coupled receptor G2,28326,123,0.92 [0.51-1.65],0.7776337451567377
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRV1,Adhesion G-protein coupled receptor V1,23828,117,0.92 [0.70-1.20],0.5294377278984483
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADH1B,All-trans-retinol dehydrogenase,24061,114,0.97 [0.76-1.22],0.7742070904857389
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,27821,121,0.93 [0.76-1.12],0.4285288844924945
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADIPOQ,Adiponectin,24647,118,1.07 [0.82-1.39],0.6118254229392974
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADM,Pro-adrenomedullin,28579,126,0.90 [0.50-1.62],0.7222316199418957
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADRA2A,Alpha-2A adrenergic receptor,23828,115,1.12 [0.90-1.39],0.3028635040714232
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AFAP1,Actin filament-associated protein 1,24061,114,1.19 [0.98-1.45],0.0785458020108464
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AFM,Afamin,24647,118,0.54 [0.22-1.32],0.1763423477040088
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AFP,Alpha-fetoprotein,28043,127,0.85 [0.67-1.08],0.1810621596679154
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGBL2,Cytosolic carboxypeptidase 2,23828,117,0.92 [0.77-1.11],0.3915386841318241
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGER,Advanced glycosylation end product-specific receptor,28255,126,0.68 [0.46-1.00],0.0508096698225262
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGR2,Anterior gradient protein 2 homolog,27431,122,1.06 [0.90-1.24],0.5022968756297297
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGR3,Anterior gradient protein 3,27597,122,1.00 [0.76-1.32],0.9807509920907528
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGRN,Agrin,28450,126,0.94 [0.58-1.51],0.782883367741098
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGRP,Agouti-related protein,28663,125,1.13 [0.84-1.52],0.4269075334132264
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGT,Angiotensinogen,24634,116,2.34 [1.30-4.22],0.0047078547762774
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGXT,Serine--pyruvate aminotransferase,28326,123,1.00 [0.82-1.22],0.9880708219325685
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHCY,Adenosylhomocysteinase,28326,123,1.06 [0.84-1.33],0.6426081351093244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHNAK,Neuroblast differentiation-associated protein AHNAK,23928,116,0.54 [0.30-0.97],0.04062291637201
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHNAK2,Protein AHNAK2,23928,116,0.98 [0.53-1.80],0.9396482734113408
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24494,116,0.95 [0.72-1.24],0.693161318963473
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHSG,Alpha-2-HS-glycoprotein,24634,116,0.83 [0.43-1.59],0.5686337381050368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHSP,Alpha-hemoglobin-stabilizing protein,28272,126,0.94 [0.78-1.12],0.4728719636246347
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AIDA,"Axin interactor, dorsalization-associated protein",23924,115,0.83 [0.65-1.07],0.1527461307707377
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AIF1,Allograft inflammatory factor 1,27634,122,1.20 [0.89-1.61],0.2348360559399477
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AIF1L,Allograft inflammatory factor 1-like,23928,116,0.74 [0.50-1.09],0.1275721551247711
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",28149,126,1.01 [0.87-1.17],0.8726850612337798
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AK1,Adenylate kinase isoenzyme 1,28326,123,1.12 [0.88-1.43],0.3634292353864324
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AK2,"Adenylate kinase 2, mitochondrial",24539,118,1.05 [0.89-1.24],0.5357865788415801
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKAP12,A-kinase anchor protein 12,24061,114,0.94 [0.41-2.17],0.8840907292605642
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKR1B1,Aldo-keto reductase family 1 member B1,27634,122,1.10 [0.89-1.35],0.3788904568797048
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKR1B10,Aldo-keto reductase family 1 member B10,23924,115,0.74 [0.54-1.03],0.0745613474432656
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKR1C4,Aldo-keto reductase family 1 member C4,27821,121,0.74 [0.52-1.07],0.1087437643526122
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKR7L,Aflatoxin B1 aldehyde reductase member 4,23910,115,1.03 [0.80-1.32],0.8279138427584773
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKT1S1,Proline-rich AKT1 substrate 1,27654,122,1.05 [0.82-1.33],0.7054653265860662
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKT2,RAC-beta serine/threonine-protein kinase,24574,116,1.02 [0.89-1.18],0.7402309580714185
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKT3,RAC-gamma serine/threonine-protein kinase,27490,121,1.12 [0.85-1.47],0.4349461891594011
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALCAM,CD166 antigen,28675,127,0.93 [0.42-2.07],0.8608109238631274
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALDH1A1,Retinal dehydrogenase 1,28313,126,0.83 [0.61-1.12],0.2174842937724049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24494,116,0.91 [0.62-1.33],0.6204263573255643
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",28270,124,1.04 [0.82-1.31],0.7562654161909053
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24574,116,1.36 [0.98-1.89],0.0687927626371374
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALMS1,Alstrom syndrome protein 1,24157,114,0.82 [0.52-1.28],0.3770276102464889
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALPI,Intestinal-type alkaline phosphatase,23910,115,0.97 [0.84-1.12],0.6808222092595431
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALPP,"Alkaline phosphatase, placental type",28200,126,0.93 [0.81-1.07],0.2924333876218847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMBN,Ameloblastin,27801,122,0.56 [0.28-1.10],0.0935727245339942
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMBP,Protein AMBP,28542,126,1.61 [0.72-3.59],0.2438033906219774
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24601,117,1.17 [0.59-2.29],0.6533451241609785
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMFR,E3 ubiquitin-protein ligase AMFR,27654,122,0.99 [0.77-1.27],0.9414261873083316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMIGO1,Amphoterin-induced protein 1,23924,115,0.71 [0.46-1.08],0.1127680473336416
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMIGO2,Amphoterin-induced protein 2,28200,126,1.29 [0.65-2.56],0.4629884596901502
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMN,Protein amnionless,27801,122,0.99 [0.71-1.38],0.9414802072236892
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMOT,Angiomotin,24061,114,0.66 [0.42-1.04],0.0758232749688558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMOTL2,Angiomotin-like protein 2,24413,116,1.20 [0.87-1.66],0.27413099001938
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMPD3,AMP deaminase 3,24539,118,0.97 [0.76-1.23],0.7888333435028492
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23092,107,1.01 [0.70-1.47],0.9484442364609352
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMY2A,Pancreatic alpha-amylase,27258,119,0.90 [0.63-1.27],0.5366865601337012
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMY2B,Alpha-amylase 2B,26408,118,0.88 [0.62-1.24],0.4686039011402072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANG,Angiogenin,28225,126,0.89 [0.56-1.42],0.6231334249563901
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPT1,Angiopoietin-1,28239,126,0.97 [0.81-1.17],0.7729388267877118
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPT2,Angiopoietin-2,28579,126,1.07 [0.71-1.62],0.7322281873762062
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL1,Angiopoietin-related protein 1,27901,121,1.55 [0.90-2.65],0.1142865933842113
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL2,Angiopoietin-related protein 2,28356,126,0.89 [0.60-1.32],0.5579457403539154
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL3,Angiopoietin-related protein 3,28326,127,1.20 [0.77-1.87],0.4257429815745865
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL4,Angiopoietin-related protein 4,28407,126,0.97 [0.69-1.37],0.8739025171448165
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL7,Angiopoietin-related protein 7,28579,126,0.81 [0.53-1.23],0.3185921254042712
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANK2,Ankyrin-2,23828,115,1.09 [0.86-1.37],0.4712752190326275
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,23910,115,1.05 [0.84-1.31],0.6465308363457546
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANKRA2,Ankyrin repeat family A protein 2,23740,114,0.90 [0.64-1.26],0.5485089043712994
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANKRD54,Ankyrin repeat domain-containing protein 54,27634,122,0.97 [0.73-1.29],0.8364716482394248
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,23928,116,1.14 [0.77-1.69],0.5122212613355301
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANPEP,Aminopeptidase N,28357,127,1.31 [0.76-2.26],0.3232996427998134
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA1,Annexin A1,23923,111,1.13 [0.79-1.63],0.4969413164101526
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA10,Annexin A10,27654,122,0.91 [0.74-1.13],0.3970191910284081
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA11,Annexin A11,28258,124,1.11 [0.87-1.41],0.4186324087041339
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA2,Annexin A2,23580,115,1.00 [0.77-1.29],0.9865654812350706
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA3,Annexin A3,28551,125,1.09 [0.88-1.36],0.4237731163775686
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA4,Annexin A4,28181,123,1.16 [0.94-1.43],0.1620875471032768
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA5,Annexin A5,27558,122,1.59 [0.98-2.57],0.0613277051334966
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AOC1,Amiloride-sensitive amine oxidase [copper-containing],27801,122,1.05 [0.80-1.38],0.7170973454412845
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AOC3,Membrane primary amine oxidase,28407,127,1.14 [0.68-1.92],0.6101797761332323
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AP1G2,AP-1 complex subunit gamma-like 2,24494,116,0.97 [0.78-1.21],0.7951363200955789
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AP2B1,AP-2 complex subunit beta,23924,115,0.97 [0.67-1.39],0.853338457271787
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AP3B1,AP-3 complex subunit beta-1,24515,118,1.03 [0.82-1.29],0.8208792271089715
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AP3S2,AP-3 complex subunit sigma-2,24539,118,1.09 [0.76-1.56],0.6305655566324176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,28200,126,1.07 [0.77-1.48],0.6946551830046667
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APCS,Serum amyloid P-component,24442,118,0.84 [0.51-1.38],0.4869972789915927
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,28502,125,1.03 [0.79-1.34],0.8522464531946435
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APLP1,Amyloid-like protein 1,28326,123,0.69 [0.50-0.94],0.0204266683432128
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOA1,Apolipoprotein A-I,24647,118,0.95 [0.49-1.84],0.8862595593799899
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOA2,Apolipoprotein A-II,24634,116,0.81 [0.56-1.16],0.2465833444164976
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOA4,Apolipoprotein A-IV,24647,118,1.00 [0.61-1.64],0.9858683335255723
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOB,Apolipoprotein B-100,24634,116,1.24 [0.56-2.72],0.5977558778644292
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOBR,Apolipoprotein B receptor,23928,116,1.27 [0.83-1.95],0.2745983977646304
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOC1,Apolipoprotein C-I,24596,118,0.80 [0.49-1.30],0.3634914854077533
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOD,Apolipoprotein D,23499,111,0.96 [0.62-1.51],0.8736730779222707
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOE,Apolipoprotein E,24647,118,0.91 [0.69-1.21],0.5161692513245263
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOF,Apolipoprotein F,24634,116,1.77 [0.85-3.68],0.1275514990579142
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOH,Beta-2-glycoprotein 1,28313,126,1.17 [0.76-1.79],0.4692035903739288
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOL1,Apolipoprotein L1,24634,116,0.73 [0.52-1.01],0.0601218164152304
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOM,Apolipoprotein M,28372,127,0.70 [0.40-1.24],0.2254306876991604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APP,Amyloid-beta precursor protein,28262,126,0.90 [0.71-1.14],0.3955763789650842
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APPL2,DCC-interacting protein 13-beta,24061,114,1.03 [0.88-1.21],0.6992606796061461
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APRT,Adenine phosphoribosyltransferase,28099,126,1.30 [0.93-1.83],0.1254045664644918
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARAF,Serine/threonine-protein kinase A-Raf,24157,114,1.09 [0.85-1.41],0.5016873377771478
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AREG,Amphiregulin,28200,126,1.34 [0.98-1.84],0.0667785421588513
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARF6,ADP-ribosylation factor 6,24515,118,1.02 [0.87-1.20],0.8183963224008417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARFIP1,Arfaptin-1,24574,116,1.07 [0.84-1.38],0.5726343847879898
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARG1,Arginase-1,28181,122,0.85 [0.63-1.14],0.2780175102044964
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARG2,"Arginase-2, mitochondrial",24494,116,0.74 [0.46-1.18],0.2072505692449101
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP1,Rho GTPase-activating protein 1,27634,122,1.18 [0.84-1.65],0.3481814766530199
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP25,Rho GTPase-activating protein 25,27634,122,1.19 [0.93-1.52],0.1605173613539298
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP30,Rho GTPase-activating protein 30,24157,114,1.00 [0.63-1.57],0.983424652221124
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP45,Rho GTPase-activating protein 45,24061,114,0.99 [0.80-1.24],0.9596905451342878
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP5,Rho GTPase-activating protein 5,23740,114,1.26 [1.03-1.54],0.0251876040872428
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGEF1,Rho guanine nucleotide exchange factor 1,24539,118,1.06 [0.87-1.29],0.5597428798627302
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGEF10,Rho guanine nucleotide exchange factor 10,24574,116,0.96 [0.79-1.15],0.6427534198571824
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGEF12,Rho guanine nucleotide exchange factor 12,28308,124,1.05 [0.90-1.22],0.5643584813487601
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGEF5,Rho guanine nucleotide exchange factor 5,23828,117,1.07 [0.85-1.34],0.5753723978225254
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARID3A,AT-rich interactive domain-containing protein 3A,23828,117,1.04 [0.67-1.61],0.8548256312145995
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARID4B,AT-rich interactive domain-containing protein 4B,27654,122,0.99 [0.68-1.46],0.976032043122007
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARL13B,ADP-ribosylation factor-like protein 13B,23828,115,0.93 [0.72-1.21],0.6126762573470549
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,23828,115,1.24 [0.81-1.90],0.3215134013410236
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARMCX2,Armadillo repeat-containing X-linked protein 2,23828,117,0.96 [0.71-1.30],0.7936681432022475
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARNT,Aryl hydrocarbon receptor nuclear translocator,27801,122,0.73 [0.45-1.17],0.1850912031134072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,23828,115,1.14 [0.84-1.55],0.4041880907067046
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARSA,Arylsulfatase A,28313,126,1.09 [0.78-1.54],0.6089987995371586
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARSB,Arylsulfatase B,28200,126,0.93 [0.70-1.24],0.6257689376256119
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ART3,Ecto-ADP-ribosyltransferase 3,28407,127,0.45 [0.28-0.72],0.0008057598463047
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ART5,Ecto-ADP-ribosyltransferase 5,23828,117,1.17 [0.92-1.48],0.1959342851190713
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARTN,Artemin,27801,122,1.09 [0.80-1.50],0.5892830898076926
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASAH1,Acid ceramidase,24396,117,1.06 [0.73-1.53],0.7648311813827384
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASAH2,Neutral ceramidase,28132,127,1.09 [0.81-1.48],0.5723810449179971
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASGR1,Asialoglycoprotein receptor 1,28132,127,1.39 [0.83-2.33],0.2082380327688202
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASGR2,Asialoglycoprotein receptor 2,24634,116,1.32 [0.67-2.60],0.4169613646726172
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASPN,Asporin,24611,115,0.98 [0.52-1.87],0.9618528954395372
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASPSCR1,Tether containing UBX domain for GLUT4,24574,116,1.06 [0.82-1.37],0.6673328640760188
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASRGL1,Isoaspartyl peptidase/L-asparaginase,23928,116,0.97 [0.81-1.15],0.6927496624191745
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASS1,Argininosuccinate synthase,23828,115,0.79 [0.63-0.99],0.0433598197128241
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATF2,Cyclic AMP-dependent transcription factor ATF-2,27654,122,0.93 [0.72-1.21],0.6008674956389997
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATF4,Cyclic AMP-dependent transcription factor ATF-4,23740,114,1.05 [0.62-1.78],0.8510274861739588
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATG16L1,Autophagy-related protein 16-1,24515,118,0.97 [0.80-1.19],0.8043689710901015
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATG4A,Cysteine protease ATG4A,27634,122,1.10 [0.85-1.43],0.4654795736838085
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATOX1,Copper transport protein ATOX1,28391,125,1.14 [0.91-1.42],0.2493864400514794
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,23828,115,0.65 [0.40-1.05],0.0756838515932532
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,23828,115,0.91 [0.51-1.64],0.7624052567707646
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,23828,115,0.85 [0.52-1.38],0.5094399886055601
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP1B4,Protein ATP1B4,23740,114,1.03 [0.67-1.58],0.8861837547385104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP2B4,Plasma membrane calcium-transporting ATPase 4,23828,115,0.98 [0.73-1.30],0.865940117690151
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP5F1D,"ATP synthase subunit delta, mitochondrial",23828,115,0.94 [0.64-1.36],0.7270891681065559
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP5IF1,"ATPase inhibitor, mitochondrial",28450,126,1.05 [0.91-1.21],0.4862204464474674
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP5PO,"ATP synthase subunit O, mitochondrial",27654,122,1.27 [0.93-1.74],0.1250819960734766
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6AP2,Renin receptor,27634,122,1.00 [0.67-1.48],0.9817411937309384
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6V1D,V-type proton ATPase subunit D,28200,126,1.10 [0.62-1.97],0.7430653328997222
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6V1F,V-type proton ATPase subunit F,27604,122,1.01 [0.80-1.28],0.9212388559797776
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6V1G1,V-type proton ATPase subunit G 1,23928,116,1.12 [0.88-1.42],0.3437530830776649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6V1G2,V-type proton ATPase subunit G 2,23828,115,1.04 [0.87-1.25],0.6665607182138419
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATRAID,All-trans retinoic acid-induced differentiation factor,24515,118,1.18 [0.74-1.91],0.4855060200613759
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATRN,"Attractin, Isoform 2",24647,118,0.47 [0.17-1.35],0.1622577906829571
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATXN10,Ataxin-10,27654,122,1.11 [0.89-1.39],0.3451183770907226
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATXN2,Ataxin-2,23828,117,0.95 [0.80-1.13],0.5487997041400586
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATXN2L,Ataxin-2-like protein,24574,116,1.16 [0.83-1.63],0.3757496175272986
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATXN3,Ataxin-3,24539,118,1.00 [0.75-1.32],0.9798244536355172
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AXIN1,Axin-1,28308,124,1.04 [0.89-1.23],0.6082849893115267
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AXL,Tyrosine-protein kinase receptor UFO,28407,127,0.99 [0.56-1.75],0.974798382371028
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AZI2,5-azacytidine-induced protein 2,24574,116,0.98 [0.72-1.34],0.9023519985666394
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AZU1,Azurocidin,27472,121,1.10 [0.90-1.33],0.3529872666553439
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B2M,Beta-2-microglobulin,24647,118,1.08 [0.66-1.77],0.7451144101228317
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,23828,115,1.35 [0.59-3.09],0.4799723972556486
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",23928,116,1.11 [0.69-1.80],0.6663605520786293
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B4GALT1,"Beta-1,4-galactosyltransferase 1",28450,126,1.20 [0.67-2.12],0.5384201535634416
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B4GAT1,"Beta-1,4-glucuronyltransferase 1",28313,126,0.58 [0.30-1.10],0.0938296101978664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BABAM1,BRISC and BRCA1-A complex member 1,23910,115,1.07 [0.59-1.93],0.8329244891148845
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BACH1,Transcription regulator protein BACH1,28308,124,0.96 [0.77-1.19],0.687264098257939
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAG3,BAG family molecular chaperone regulator 3,28083,127,0.98 [0.66-1.44],0.904172147047794
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAG4,BAG family molecular chaperone regulator 4,23910,115,0.95 [0.66-1.36],0.7698326193982531
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAG6,Large proline-rich protein BAG6,27821,121,1.00 [0.64-1.54],0.9902251732524942
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,27634,122,0.95 [0.74-1.23],0.7064247528231353
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAMBI,BMP and activin membrane-bound inhibitor homolog,27634,122,1.29 [0.77-2.16],0.3333473085051472
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BANK1,B-cell scaffold protein with ankyrin repeats,28308,124,0.99 [0.85-1.15],0.8808190063660856
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAP18,Chromatin complexes subunit BAP18,24539,118,0.90 [0.68-1.17],0.4218506514651193
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BATF,Basic leucine zipper transcriptional factor ATF-like,23924,115,0.89 [0.69-1.13],0.3327739878766614
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAX,Apoptosis regulator BAX,27603,122,1.07 [0.90-1.28],0.4205797582240421
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCAM,Basal cell adhesion molecule,28313,126,1.26 [0.66-2.43],0.4852123733834272
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCAN,Brevican core protein,28132,127,0.59 [0.37-0.92],0.0206430768982215
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24611,115,0.94 [0.53-1.69],0.8434193152564236
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",23828,117,1.21 [0.92-1.59],0.1816862499619138
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCHE,Cholinesterase,24172,113,1.40 [0.72-2.71],0.3167250745059953
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL2,Apoptosis regulator Bcl-2,24515,118,1.08 [0.79-1.47],0.6464819139826934
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL2L1,Bcl-2-like protein 1,24539,118,1.05 [0.89-1.26],0.5524456261063388
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",28308,124,1.05 [0.73-1.52],0.7769458616877509
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL2L15,Bcl-2-like protein 15,23910,115,0.86 [0.62-1.20],0.3801160664232862
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL7A,B-cell CLL/lymphoma 7 protein family member A,23740,114,1.00 [0.76-1.32],0.990657897717578
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24494,116,1.28 [0.92-1.77],0.1368203570054607
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCR,Breakpoint cluster region protein,28308,124,1.01 [0.85-1.20],0.8709607911755581
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BDNF,Brain-derived neurotrophic factor,24601,117,1.02 [0.82-1.25],0.8896582545566789
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BECN1,Beclin-1,23928,116,1.02 [0.76-1.36],0.9080375386721664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BEX3,Protein BEX3,23740,114,0.96 [0.65-1.43],0.8470087667165089
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BGLAP,Osteocalcin,24601,117,0.97 [0.79-1.18],0.7572698396214828
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BGN,Biglycan,27595,122,0.93 [0.81-1.07],0.3182532446568942
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BHLHE40,Class E basic helix-loop-helix protein 40,23828,117,1.08 [0.85-1.37],0.5181866025205288
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,23828,115,1.06 [0.53-2.13],0.8589766566525008
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BID,BH3-interacting domain death agonist,28308,124,1.09 [0.87-1.36],0.4653767757388753
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BIN2,Bridging integrator 2,28313,126,0.97 [0.82-1.16],0.7534958468038366
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BIRC2,Baculoviral IAP repeat-containing protein 2,27634,122,1.06 [0.83-1.36],0.6362727428431331
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLMH,Bleomycin hydrolase,28675,127,1.05 [0.65-1.70],0.8502478392484714
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLNK,B-cell linker protein,23910,115,1.25 [0.84-1.86],0.281408601313325
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,23828,117,1.06 [0.85-1.33],0.5977345380109595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24539,118,0.93 [0.61-1.43],0.746739519345956
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLVRB,Flavin reductase,28313,126,1.02 [0.80-1.28],0.8973105638054194
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BMP10,Bone morphogenetic protein 10,24061,114,0.75 [0.40-1.40],0.3665331986524044
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BMP4,Bone morphogenetic protein 4,28083,127,0.84 [0.59-1.20],0.3334539425169479
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BMP6,Bone morphogenetic protein 6,27769,121,0.68 [0.47-0.97],0.031469850452206
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BMPER,BMP-binding endothelial regulator protein,24061,114,1.30 [0.61-2.77],0.491426052609938
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24611,115,1.09 [0.66-1.80],0.7358976090668905
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,23910,115,1.02 [0.69-1.52],0.9241079345277916
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BOC,Brother of CDO,27821,121,1.72 [0.87-3.39],0.1188294714534009
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BOLA1,BolA-like protein 1,23828,117,1.17 [0.87-1.57],0.2952521457076466
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BOLA2_BOLA2B,BolA-like protein 2,23928,116,0.97 [0.70-1.34],0.8444050494432086
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BPIFA2,BPI fold-containing family A member 2,23072,110,1.05 [0.89-1.24],0.5835889843193738
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BPIFB1,BPI fold-containing family B member 1,28273,126,0.93 [0.73-1.19],0.5760931545147802
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BPIFB2,BPI fold-containing family B member 2,24571,114,1.07 [0.81-1.41],0.6347255718108223
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRAP,BRCA1-associated protein,24282,118,1.02 [0.87-1.20],0.7928569320152982
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRD1,Bromodomain-containing protein 1,24157,114,1.38 [0.83-2.28],0.2148978472867336
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRD2,Bromodomain-containing protein 2,23828,117,0.93 [0.54-1.59],0.7782962064045984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRD3,Bromodomain-containing protein 3,23828,115,1.07 [0.75-1.51],0.7090248396780028
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRDT,Bromodomain testis-specific protein,23828,115,1.30 [0.81-2.08],0.2691129335386135
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRK1,Protein BRICK1,27654,122,1.17 [0.82-1.67],0.3734422999117667
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRME1,Break repair meiotic recombinase recruitment factor 1,23828,117,1.18 [0.83-1.68],0.3451950917993215
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRSK2,Serine/threonine-protein kinase BRSK2,24574,116,1.05 [0.67-1.64],0.8403140571974422
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BSG,Basigin,28612,123,1.16 [0.51-2.61],0.7229542471276063
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BSND,Barttin,23740,114,1.21 [0.76-1.90],0.4217634783355724
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,28593,126,1.01 [0.72-1.40],0.9753157567001624
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BST2,Bone marrow stromal antigen 2,28593,126,0.94 [0.70-1.27],0.6821222381223087
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTC,Probetacellulin,27634,122,1.14 [0.93-1.39],0.2151095988619043
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTD,Biotinidase,24647,118,0.39 [0.18-0.86],0.0196124993702584
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTLA,B- and T-lymphocyte attenuator,23740,114,0.97 [0.78-1.20],0.7965461872193533
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTN1A1,Butyrophilin subfamily 1 member A1,24450,116,1.03 [0.66-1.59],0.9106252888179878
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTN2A1,Butyrophilin subfamily 2 member A1,28450,126,1.15 [0.62-2.13],0.6587757380542498
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTN3A2,Butyrophilin subfamily 3 member A2,28308,124,0.98 [0.64-1.50],0.9210391608982016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTNL10,Butyrophilin-like protein 10,23740,114,0.85 [0.51-1.42],0.5275310115924878
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C19orf12,Protein C19orf12,27654,122,0.90 [0.69-1.17],0.4163442307037451
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1GALT1C1,C1GALT1-specific chaperone 1,23828,115,0.60 [0.32-1.10],0.0988059742590814
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QA,Complement C1q subcomponent subunit A,28515,122,1.97 [1.01-3.86],0.0467225813140317
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24574,116,0.88 [0.65-1.21],0.4423527682305721
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QL2,Complement C1q-like protein 2,23910,115,1.13 [0.76-1.68],0.5502267805071953
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,28407,127,0.87 [0.60-1.26],0.4574963631913722
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24061,114,0.76 [0.48-1.20],0.2404115760783768
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24574,116,0.89 [0.50-1.59],0.7037053860748453
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24018,114,0.88 [0.61-1.25],0.4653181261850341
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1R,Complement C1r subcomponent,24647,118,1.19 [0.52-2.75],0.6793412964121024
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1RL,Complement C1r subcomponent-like protein,24608,118,2.50 [1.00-6.27],0.0506491136133365
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1S,Complement C1s subcomponent,24647,118,0.92 [0.40-2.11],0.837834578728054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C2,Complement C2,28372,127,0.74 [0.46-1.19],0.211560910126608
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C2CD2L,Phospholipid transfer protein C2CD2L,27604,122,1.31 [0.95-1.79],0.0958534962874446
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C2orf69,UPF0565 protein C2orf69,23924,115,0.88 [0.62-1.24],0.4611511652153178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C3,Complement C3,23399,111,0.83 [0.53-1.31],0.4306240940857133
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C4BPB,C4b-binding protein beta chain,28391,125,1.18 [0.80-1.73],0.4110290761174385
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C5,Complement C5,24647,118,1.99 [0.73-5.39],0.1779223317666358
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C7,Complement component C7,24071,117,1.22 [0.70-2.12],0.4809975415240356
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C7orf50,Uncharacterized protein C7orf50,24539,118,1.03 [0.51-2.06],0.9366831023818724
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C8B,Complement component C8 beta chain,24647,118,1.01 [0.57-1.81],0.9601878128933676
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C9,Complement component C9,24634,116,1.38 [0.98-1.93],0.0622203553556827
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C9orf40,Uncharacterized protein C9orf40,24515,118,1.02 [0.82-1.26],0.8654624336586131
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA1,Carbonic anhydrase 1,27675,123,0.93 [0.71-1.21],0.5926614660104907
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA11,Carbonic anhydrase-related protein 11,27634,122,1.21 [0.77-1.89],0.4051859326450296
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA12,Carbonic anhydrase 12,28200,126,0.67 [0.40-1.12],0.1287774652027518
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA13,Carbonic anhydrase 13,27993,123,1.08 [0.93-1.26],0.3297652532337134
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA14,Carbonic anhydrase 14,28579,126,0.69 [0.44-1.08],0.1010810868846767
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA2,Carbonic anhydrase 2,28233,126,0.94 [0.75-1.18],0.6109374823394641
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA3,Carbonic anhydrase 3,28628,126,1.43 [1.14-1.80],0.0021435448587616
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA4,Carbonic anhydrase 4,28675,127,0.87 [0.45-1.69],0.6880037312120153
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA5A,"Carbonic anhydrase 5A, mitochondrial",27821,121,0.89 [0.74-1.07],0.1996401458696899
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA6,Carbonic anhydrase 6,28221,126,0.96 [0.75-1.23],0.7482521174827923
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA7,Carbonic anhydrase 7,24157,114,0.98 [0.58-1.66],0.9358782491302376
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA8,Carbonic anhydrase-related protein,23910,115,1.40 [0.83-2.36],0.201015983746199
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA9,Carbonic anhydrase 9,28579,126,0.85 [0.59-1.23],0.3831438573041189
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CABP2,Calcium-binding protein 2,23924,115,0.87 [0.65-1.17],0.3552342171597822
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,23828,117,1.61 [1.08-2.39],0.0183198315254166
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,23828,115,0.72 [0.48-1.10],0.1267420101477097
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,23828,117,0.94 [0.69-1.28],0.6815765108309151
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24574,116,1.06 [0.86-1.30],0.5748740260951744
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACYBP,Calcyclin-binding protein,24009,114,1.05 [0.89-1.25],0.5551244045480399
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CADPS,Calcium-dependent secretion activator 1,23924,115,1.02 [0.68-1.53],0.935088899257084
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALB1,Calbindin,28200,126,1.08 [0.74-1.58],0.6843674384851374
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALB2,Calretinin,27654,122,1.50 [0.94-2.40],0.0898545379303104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALCA,Calcitonin,28082,127,1.02 [0.80-1.31],0.8666575942153024
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALCB,Calcitonin gene-related peptide 2,24539,118,1.75 [1.32-2.33],0.0001179614073106
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,28497,125,0.96 [0.82-1.12],0.6045538908896038
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,23928,116,1.02 [0.81-1.28],0.8721741959466534
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALY,Neuron-specific vesicular protein calcyon,23828,115,1.18 [0.78-1.79],0.4222647961715953
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,27634,122,1.29 [0.94-1.79],0.1190511294436715
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,23924,115,0.94 [0.67-1.31],0.7149019838183209
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24574,116,1.00 [0.85-1.18],0.9882863320663188
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CANT1,Soluble calcium-activated nucleotidase 1,28251,123,0.75 [0.34-1.66],0.4772747457399436
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAPG,Macrophage-capping protein,28146,124,0.97 [0.74-1.26],0.8081119665058775
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAPN3,Calpain-3,24494,116,1.68 [1.26-2.23],0.0004243172463582
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAPS,Calcyphosin,24539,118,1.09 [0.93-1.28],0.3073539019518193
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CARHSP1,Calcium-regulated heat-stable protein 1,27654,122,1.03 [0.75-1.40],0.8635608612865583
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASC3,Protein CASC3,23924,115,1.14 [0.77-1.71],0.5091954017181259
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP1,Caspase-1,27654,122,1.00 [0.80-1.26],0.9718742883111228
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP10,Caspase-10,27654,122,1.07 [0.86-1.34],0.5402044504086081
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP2,Caspase-2,28308,124,1.01 [0.81-1.27],0.9132855078512708
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP3,Caspase-3,28675,127,1.07 [0.89-1.27],0.4726429225225887
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP4,Caspase-4,24157,114,0.97 [0.87-1.09],0.6077151523609197
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP7,Caspase-7,24539,118,1.10 [0.89-1.35],0.3758113211346647
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP8,Caspase-8,28505,126,1.04 [0.81-1.32],0.7793575949845766
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP9,Caspase-9,23910,115,1.19 [0.92-1.53],0.184959223165591
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASQ2,Calsequestrin-2,23828,115,0.93 [0.63-1.38],0.7153870707539995
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAT,Catalase,24258,115,0.89 [0.64-1.25],0.4991413582773844
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBLIF,Cobalamin binding intrinsic factor,28293,123,1.03 [0.82-1.29],0.8088791433141946
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBLN1,Cerebellin-1,23828,117,0.98 [0.81-1.19],0.8468996300491276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBLN4,Cerebellin-4,28579,126,0.81 [0.49-1.34],0.4136450912522912
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBS,Cystathionine beta-synthase,23928,116,0.86 [0.59-1.23],0.4040378650111752
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBX2,Chromobox protein homolog 2,23828,115,0.81 [0.49-1.37],0.437650650656682
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,28132,127,0.98 [0.79-1.21],0.8588229936241073
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCAR2,Cell cycle and apoptosis regulator protein 2,24539,118,0.95 [0.68-1.32],0.7554603468616657
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCDC134,Coiled-coil domain-containing protein 134,24494,116,1.06 [0.74-1.50],0.7651344377630611
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCDC28A,Coiled-coil domain-containing protein 28A,23924,115,0.84 [0.46-1.54],0.5708626595900459
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCDC50,Coiled-coil domain-containing protein 50,24574,116,1.10 [0.89-1.35],0.3649312485348155
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCDC80,Coiled-coil domain-containing protein 80,28326,123,1.27 [0.79-2.04],0.3226265038243961
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,23928,116,0.89 [0.67-1.20],0.4521374719936689
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL11,Eotaxin,28663,125,0.77 [0.51-1.16],0.2128766253422594
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL13,C-C motif chemokine 13,28614,125,0.97 [0.77-1.22],0.8130203200199613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL14,C-C motif chemokine 14,28225,126,1.09 [0.74-1.60],0.6712372040069674
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL15,C-C motif chemokine 15,28675,127,0.97 [0.67-1.39],0.8555433471696952
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL16,C-C motif chemokine 16,28675,127,1.03 [0.76-1.40],0.8335451980001324
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL17,C-C motif chemokine 17,28255,125,0.96 [0.81-1.14],0.6344529995471149
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL18,C-C motif chemokine 18,27924,125,0.96 [0.76-1.20],0.7023437528362392
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL19,C-C motif chemokine 19,28593,126,1.20 [1.09-1.33],0.0002578105771872
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL2,C-C motif chemokine 2,28083,127,0.87 [0.64-1.17],0.3526219347438908
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL20,C-C motif chemokine 20,28663,125,0.88 [0.72-1.08],0.2172364706549058
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL21,C-C motif chemokine 21,28450,126,1.11 [0.77-1.62],0.5684331187911977
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL22,C-C motif chemokine 22,28005,125,0.85 [0.62-1.16],0.3044768411626017
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL23,C-C motif chemokine 23,28450,126,1.12 [0.77-1.63],0.5424873724416073
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL24,C-C motif chemokine 24,28407,126,0.85 [0.70-1.03],0.093388088104959
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL25,C-C motif chemokine 25,28663,125,0.75 [0.55-1.03],0.0762548553737131
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL26,C-C motif chemokine 26,28308,124,1.07 [0.91-1.26],0.4097953939364473
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL27,C-C motif chemokine 27,28326,123,0.94 [0.73-1.21],0.6511444488752494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL28,C-C motif chemokine 28,28224,124,1.00 [0.77-1.31],0.9718496161540172
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL3,C-C motif chemokine 3,28308,124,1.08 [0.86-1.35],0.5314376065458195
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL4,C-C motif chemokine 4,28350,125,1.01 [0.79-1.29],0.9305387010344082
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL5,C-C motif chemokine 5,28407,127,0.96 [0.83-1.12],0.6440834949067193
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL7,C-C motif chemokine 7,28308,124,1.25 [1.00-1.57],0.0506565606776328
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL8,C-C motif chemokine 8,28542,126,0.90 [0.70-1.16],0.4335040576709601
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN1,CCN family member 1,28160,126,1.01 [0.82-1.24],0.9410603694150402
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN2,CCN family member 2,28329,126,1.00 [0.76-1.30],0.9797276806468193
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN3,CCN family member 3,28629,127,1.89 [1.25-2.86],0.0023977885270574
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN4,CCN family member 4,28579,126,0.98 [0.66-1.45],0.9147929357589816
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN5,CCN family member 5,28313,126,1.15 [0.77-1.72],0.4886474769329634
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCND2,G1/S-specific cyclin-D2,24157,114,0.64 [0.43-0.96],0.0323314923855332
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCNE1,G1/S-specific cyclin-E1,23910,115,0.86 [0.67-1.09],0.2091321208017973
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCS,Copper chaperone for superoxide dismutase,28132,127,0.91 [0.65-1.27],0.5850954913490218
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCT5,T-complex protein 1 subunit epsilon,27634,122,0.97 [0.67-1.39],0.8539796687665818
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD101,Immunoglobulin superfamily member 2,24515,118,0.95 [0.63-1.44],0.8227366143106744
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD109,CD109 antigen,28313,126,0.87 [0.55-1.39],0.5598054838343018
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD14,Monocyte differentiation antigen CD14,27701,124,1.16 [0.79-1.70],0.4514598131819267
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD160,CD160 antigen,28663,125,1.01 [0.72-1.42],0.957456219224057
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD163,Scavenger receptor cysteine-rich type 1 protein M130,28407,127,1.12 [0.78-1.60],0.5352304774259495
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD164,Sialomucin core protein 24,28313,126,1.31 [0.85-2.04],0.2213055028168269
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD164L2,CD164 sialomucin-like 2 protein,23924,115,0.79 [0.48-1.32],0.3695530459202193
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD177,CD177 antigen,28266,126,0.91 [0.81-1.02],0.1115659709266333
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD1C,T-cell surface glycoprotein CD1c,28391,125,0.78 [0.41-1.47],0.441561310860409
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD2,T-cell surface antigen CD2,23828,115,0.87 [0.53-1.45],0.6036588195180497
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD200,OX-2 membrane glycoprotein,28308,124,0.92 [0.50-1.70],0.7908256818192149
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD200R1,Cell surface glycoprotein CD200 receptor 1,28207,124,1.18 [0.75-1.84],0.4807416569367726
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD207,C-type lectin domain family 4 member K,27724,123,1.11 [0.73-1.68],0.6362232308244281
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD209,CD209 antigen,28385,126,0.96 [0.64-1.44],0.8473745347239917
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD22,B-cell receptor CD22,28663,125,1.14 [0.78-1.67],0.5012716899049114
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD226,CD226 antigen,23910,115,0.87 [0.57-1.34],0.5353131863954281
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD244,Natural killer cell receptor 2B4,28663,125,1.06 [0.59-1.90],0.8493096543640984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD248,Endosialin,24601,117,0.50 [0.33-0.75],0.0008576312811911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD27,CD27 antigen,28391,125,1.02 [0.69-1.52],0.9150462007802777
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD274,Programmed cell death 1 ligand 1,28132,127,0.83 [0.51-1.35],0.4565086996177396
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD276,CD276 antigen,28305,126,1.64 [1.04-2.58],0.0329065320908087
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD28,T-cell-specific surface glycoprotein CD28,27634,122,1.03 [0.66-1.62],0.8853471293736601
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD2AP,CD2-associated protein,28326,123,1.02 [0.80-1.31],0.871245521084808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300A,CMRF35-like molecule 8,24061,114,0.91 [0.49-1.67],0.75165800000502
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300C,CMRF35-like molecule 6,28593,126,1.10 [0.69-1.74],0.6881166485943759
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300E,CMRF35-like molecule 2,28489,126,0.91 [0.61-1.36],0.643512662140983
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300LF,CMRF35-like molecule 1,28579,126,1.12 [0.86-1.46],0.4103242806096582
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300LG,CMRF35-like molecule 9,28313,126,0.95 [0.62-1.46],0.8186911530089874
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD302,CD302 antigen,28200,126,1.08 [0.64-1.85],0.7694951596327955
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD33,Myeloid cell surface antigen CD33,28391,125,1.12 [0.91-1.37],0.2932862812106973
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD34,Hematopoietic progenitor cell antigen CD34,28494,126,0.83 [0.44-1.60],0.5835905768921815
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD36,Platelet glycoprotein 4,23910,115,0.94 [0.64-1.39],0.7538830983202088
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,28200,126,0.63 [0.37-1.06],0.082398231454501
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD3D,T-cell surface glycoprotein CD3 delta chain,23828,117,1.04 [0.63-1.71],0.8779341236963659
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24157,114,1.08 [0.68-1.73],0.7326064490924857
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD3G,T-cell surface glycoprotein CD3 gamma chain,23910,115,1.10 [0.93-1.30],0.2483072479565741
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD4,T-cell surface glycoprotein CD4,28262,124,1.01 [0.58-1.75],0.9728996047708502
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD40,Tumor necrosis factor receptor superfamily member 5,28307,125,1.03 [0.76-1.41],0.8409735957319071
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD40LG,CD40 ligand,28663,125,1.06 [0.87-1.29],0.5918825939175639
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD46,Membrane cofactor protein,28131,126,0.98 [0.56-1.72],0.954324539939821
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD48,CD48 antigen,28407,126,0.81 [0.47-1.39],0.4475789625264839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD5,T-cell surface glycoprotein CD5,28542,126,1.10 [0.69-1.75],0.6847513483501217
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD55,Complement decay-accelerating factor,27310,122,0.87 [0.46-1.67],0.6821030416957732
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD58,Lymphocyte function-associated antigen 3,28250,126,1.33 [0.54-3.27],0.531402945548474
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD59,CD59 glycoprotein,27266,122,0.89 [0.41-1.95],0.7741420631253343
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD5L,CD5 antigen-like,24515,118,1.35 [0.94-1.94],0.1069430015389806
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD6,T-cell differentiation antigen CD6,28612,123,0.93 [0.69-1.25],0.6112833562735026
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD63,CD63 antigen,28083,127,0.96 [0.71-1.30],0.7703603627505898
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD69,Early activation antigen CD69,28170,122,1.03 [0.86-1.23],0.7651581096683998
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD7,T-cell antigen CD7,23873,115,1.03 [0.68-1.56],0.907512425776396
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD70,CD70 antigen,28308,124,0.78 [0.54-1.14],0.1997015815156192
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD72,B-cell differentiation antigen CD72,24061,114,1.21 [0.79-1.84],0.3874272065217026
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD74,HLA class II histocompatibility antigen gamma chain,28593,126,1.17 [0.75-1.85],0.4898295469159931
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD79B,B-cell antigen receptor complex-associated protein beta chain,28663,125,1.22 [0.85-1.75],0.2718366184347375
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD80,T-lymphocyte activation antigen CD80,24611,115,1.49 [0.91-2.44],0.1104793054928724
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD82,CD82 antigen,24157,114,1.32 [0.95-1.83],0.0973418693263099
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD83,CD83 antigen,28308,124,1.23 [0.77-1.96],0.3792874946870255
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD84,SLAM family member 5,28308,124,1.24 [0.75-2.04],0.4074817180548447
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD86,T-lymphocyte activation antigen CD86,24515,118,0.85 [0.48-1.50],0.5757062690463168
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD8A,T-cell surface glycoprotein CD8 alpha chain,28593,126,0.99 [0.72-1.37],0.9538493496511388
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD93,Complement component C1q receptor,27223,124,0.98 [0.58-1.65],0.9416024129204325
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD99,CD99 antigen,28313,126,1.25 [0.55-2.81],0.5946560210173111
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD99L2,CD99 antigen-like protein 2,28313,126,1.34 [0.70-2.55],0.37558014090336
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDA,Cytidine deaminase,24571,115,0.91 [0.63-1.32],0.6287874683777912
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDAN1,Codanin-1,24539,118,0.81 [0.36-1.83],0.6059075074030686
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC123,Cell division cycle protein 123 homolog,23740,114,1.18 [0.94-1.50],0.1602745117961496
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC25A,M-phase inducer phosphatase 1,23740,114,0.84 [0.52-1.36],0.4867313888710797
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC26,Anaphase-promoting complex subunit CDC26,24475,118,1.04 [0.82-1.34],0.7326282499590238
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC27,Cell division cycle protein 27 homolog,27634,122,1.00 [0.77-1.30],0.978488285417528
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC37,Hsp90 co-chaperone Cdc37,28391,125,1.08 [0.90-1.30],0.4135874139490711
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24515,118,0.99 [0.83-1.17],0.8730954076757125
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDCP1,CUB domain-containing protein 1,28132,127,1.13 [0.84-1.52],0.4036131379099834
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH1,Cadherin-1,27353,122,0.76 [0.49-1.18],0.2206577315049039
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH15,Cadherin-15,28543,126,1.14 [0.89-1.48],0.3004445041305151
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH17,Cadherin-17,28326,123,0.86 [0.68-1.10],0.239846380602518
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH2,Cadherin-2,28326,123,1.10 [0.71-1.72],0.667123291887435
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH22,Cadherin-22,24157,114,0.74 [0.37-1.45],0.3760371268025247
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH23,Cadherin-23,24539,118,0.67 [0.33-1.34],0.2539449154881575
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH3,Cadherin-3,28593,126,1.00 [0.64-1.57],0.9853644272978128
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH4,Cadherin-4,23828,117,0.87 [0.58-1.31],0.5128769945265474
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH5,Cadherin-5,28675,127,0.82 [0.49-1.38],0.4554061125897135
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH6,Cadherin-6,28326,123,1.07 [0.71-1.61],0.7548983474100567
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDHR1,Cadherin-related family member 1,27654,122,1.18 [0.83-1.67],0.3556131017790173
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDHR2,Cadherin-related family member 2,28200,126,1.03 [0.83-1.28],0.8053829178678324
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDHR5,Cadherin-related family member 5,28326,123,1.17 [0.77-1.77],0.471477158104354
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDK1,Cyclin-dependent kinase 1,23740,114,0.83 [0.51-1.36],0.4549547601235955
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24574,116,0.97 [0.72-1.31],0.8578562761751862
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDKL5,Cyclin-dependent kinase-like 5,23828,117,0.98 [0.70-1.39],0.9162278665460066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDKN1A,Cyclin-dependent kinase inhibitor 1,28200,126,1.03 [0.89-1.19],0.7251846687299301
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,28200,126,1.04 [0.88-1.23],0.634119309845836
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDNF,Cerebral dopamine neurotrophic factor,28200,126,1.14 [0.71-1.84],0.5944526039863852
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,28355,126,0.71 [0.40-1.28],0.2551813197416536
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDSN,Corneodesmosin,28571,125,1.03 [0.71-1.49],0.8688782942984749
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,28350,125,1.01 [0.53-1.92],0.980875097798982
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24515,118,1.00 [0.81-1.23],0.970322398113755
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24157,114,0.97 [0.74-1.27],0.820268323507503
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24515,118,0.99 [0.63-1.55],0.9676648344226754
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24157,114,1.09 [0.75-1.61],0.6449968240524837
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,28308,124,1.17 [0.98-1.40],0.0816458635336657
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,27634,122,0.86 [0.61-1.23],0.415350686329604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,27256,122,0.96 [0.74-1.24],0.758571530776036
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24601,117,1.27 [0.85-1.88],0.2391174085984832
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,27821,121,1.47 [1.10-1.97],0.008697971668448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEBPA,CCAAT/enhancer-binding protein alpha,23910,115,0.82 [0.47-1.41],0.4674174420830554
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEBPB,CCAAT/enhancer-binding protein beta,27821,121,1.21 [0.81-1.80],0.3475467463398697
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CELA2A,Chymotrypsin-like elastase family member 2A,24601,117,0.92 [0.69-1.22],0.5474472645826223
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CELA3A,Chymotrypsin-like elastase family member 3A,28625,127,0.81 [0.61-1.06],0.1261709645215108
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24061,114,0.73 [0.38-1.39],0.3366275564033558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEMIP2,Cell surface hyaluronidase,23910,115,1.31 [0.85-2.03],0.2166740255218677
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEND1,Cell cycle exit and neuronal differentiation protein 1,23828,117,1.09 [0.83-1.43],0.544312985854625
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CENPF,Centromere protein F,24157,114,1.03 [0.75-1.42],0.8537682050635602
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CENPJ,Centromere protein J,24157,114,0.96 [0.74-1.25],0.7573752618059986
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP112,Centrosomal protein of 112 kDa,23828,115,0.95 [0.63-1.44],0.8130627886200781
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP152,Centrosomal protein of 152 kDa,23740,114,0.83 [0.53-1.30],0.4083184117716191
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP164,Centrosomal protein of 164 kDa,27801,122,1.10 [0.88-1.38],0.3917103141242328
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP170,Centrosomal protein of 170 kDa,23928,116,1.00 [0.79-1.25],0.9690268689337168
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP20,Centrosomal protein 20,27634,122,1.04 [0.84-1.29],0.6953878479582105
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP290,Centrosomal protein of 290 kDa,24157,114,0.86 [0.59-1.26],0.4433301609818543
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP350,Centrosome-associated protein 350,23740,114,0.89 [0.54-1.47],0.6434414662983612
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP43,Centrosomal protein 43,27600,120,1.06 [0.85-1.34],0.5933103959830954
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP85,Centrosomal protein of 85 kDa,27634,122,0.99 [0.77-1.27],0.9267654392143544
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CERT,Ceramide transfer protein,27654,122,1.10 [0.85-1.43],0.4689789037109007
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CES1,Liver carboxylesterase 1,28374,127,1.01 [0.84-1.22],0.9194939064746364
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CES2,Cocaine esterase,28200,126,0.85 [0.63-1.14],0.2758885243660177
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CES3,Carboxylesterase 3,28200,126,0.99 [0.79-1.24],0.946297616194432
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CETN2,Centrin-2,27654,122,1.01 [0.80-1.27],0.9492544483126444
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CETN3,Centrin-3,24515,118,0.98 [0.79-1.22],0.8474661061181912
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFB,Complement factor B,24191,117,1.03 [0.61-1.77],0.9004764050781306
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFC1,Cryptic protein,27634,122,0.80 [0.55-1.16],0.2337774252037157
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFD,Complement factor D,24647,118,0.84 [0.33-2.16],0.7178753987247443
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFH,Complement factor H,23222,112,0.71 [0.33-1.55],0.3953982753332167
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFHR2,Complement factor H-related protein 2,24471,118,0.98 [0.72-1.33],0.9092297775570862
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFHR4,Complement factor H-related protein 4,24599,118,1.28 [0.99-1.65],0.0603174509713258
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFHR5,Complement factor H-related protein 5,24319,113,0.85 [0.56-1.30],0.4495749168572868
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFI,Complement factor I,24647,118,1.32 [0.55-3.15],0.5333792755843556
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFP,Properdin,24647,118,1.18 [0.60-2.32],0.6234008988450399
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CGA,Glycoprotein hormones alpha chain,28313,126,1.06 [0.88-1.29],0.5278901713158256
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24634,116,0.89 [0.57-1.39],0.6051838686051608
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CGN,Cingulin,23924,115,1.44 [1.03-2.02],0.0341585846393044
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CGREF1,Cell growth regulator with EF hand domain protein 1,28326,123,0.82 [0.56-1.20],0.3157659647634255
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,27634,122,1.08 [0.83-1.40],0.5645434871500885
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHAD,Chondroadherin,24061,114,0.95 [0.66-1.35],0.7714601571920662
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24539,118,1.36 [0.91-2.02],0.1297785732846498
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHCHD6,MICOS complex subunit MIC25,24494,116,0.78 [0.40-1.52],0.4591435060071517
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHEK2,Serine/threonine-protein kinase Chk2,27821,121,1.29 [0.82-2.03],0.2662341137490028
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHGA,Chromogranin-A,24601,117,1.19 [0.98-1.44],0.0743604605905345
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHGB,Secretogranin-1,28493,126,0.80 [0.54-1.20],0.2819598778565562
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHI3L1,Chitinase-3-like protein 1,27656,125,1.01 [0.82-1.24],0.932723225637196
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHIT1,Chitotriosidase-1,28435,126,0.97 [0.88-1.07],0.5925954655625887
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHL1,Neural cell adhesion molecule L1-like protein,28362,127,1.04 [0.63-1.71],0.8906578831218148
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHM,Rab proteins geranylgeranyltransferase component A 1,23924,115,1.00 [0.74-1.34],0.9916597504895752
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHMP1A,Charged multivesicular body protein 1a,28132,127,1.08 [0.89-1.32],0.4402864457725194
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHMP6,Charged multivesicular body protein 6,24611,115,0.98 [0.72-1.33],0.8801361189323268
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHP1,Calcineurin B homologous protein 1,23828,117,0.85 [0.65-1.11],0.2275893468394077
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHRDL1,Chordin-like protein 1,28407,126,0.92 [0.55-1.52],0.7373719429891212
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHRDL2,Chordin-like protein 2,28326,123,0.88 [0.66-1.18],0.406496724810409
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHRM1,Muscarinic acetylcholine receptor M1,23924,115,0.68 [0.39-1.20],0.1867266585701255
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CIAPIN1,Anamorsin,28391,125,1.04 [0.81-1.33],0.7553600435769171
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CILP,Cartilage intermediate layer protein 1,24601,117,0.85 [0.62-1.17],0.3188055611884082
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CINP,Cyclin-dependent kinase 2-interacting protein,24157,114,0.74 [0.46-1.20],0.2217349578688914
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CIRBP,Cold-inducible RNA-binding protein,24515,118,1.01 [0.85-1.22],0.8727018266014317
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CIT,Citron Rho-interacting kinase,23924,115,0.81 [0.53-1.22],0.3097693990948725
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CKAP4,Cytoskeleton-associated protein 4,28512,122,1.36 [0.77-2.42],0.2922417565907091
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CKB,Creatine kinase B-type,24601,117,1.24 [0.92-1.67],0.1496333122546254
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",28202,125,0.81 [0.67-0.99],0.0369529279061451
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLASP1,CLIP-associating protein 1,23740,114,0.96 [0.74-1.23],0.7273169124260934
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLC,Galectin-10,28287,123,1.11 [0.89-1.39],0.3577853544194279
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC10A,C-type lectin domain family 10 member A,28132,127,0.83 [0.53-1.27],0.3854542418542245
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC11A,C-type lectin domain family 11 member A,28263,126,0.65 [0.47-0.90],0.0091951291993904
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC12A,C-type lectin domain family 12 member A,23910,115,1.09 [0.46-2.59],0.851762263476066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC14A,C-type lectin domain family 14 member A,28313,126,1.01 [0.61-1.69],0.9683430128508186
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC1A,C-type lectin domain family 1 member A,27821,121,0.84 [0.50-1.39],0.4918397005649672
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC1B,C-type lectin domain family 1 member B,28593,126,0.97 [0.82-1.13],0.6705158689975063
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC2L,C-type lectin domain family 2 member L,23924,115,1.09 [0.79-1.51],0.5817997050615134
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC3B,Tetranectin,24078,117,0.58 [0.32-1.03],0.0609157648988367
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4A,C-type lectin domain family 4 member A,28308,124,0.83 [0.53-1.29],0.4067755596344702
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4C,C-type lectin domain family 4 member C,28308,124,1.04 [0.74-1.47],0.7995460732998508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4D,C-type lectin domain family 4 member D,28308,124,1.19 [0.93-1.53],0.1746953745786898
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4G,C-type lectin domain family 4 member G,28308,124,1.40 [0.87-2.24],0.1605065646094092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4M,C-type lectin domain family 4 member M,24560,117,0.81 [0.57-1.17],0.2600359182357876
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC5A,C-type lectin domain family 5 member A,28224,122,1.22 [0.71-2.08],0.4716951733579207
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC6A,C-type lectin domain family 6 member A,27634,122,1.27 [0.91-1.76],0.1608880674279585
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC7A,C-type lectin domain family 7 member A,28663,125,1.47 [1.05-2.06],0.0267133758319456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLGN,Calmegin,23924,115,0.89 [0.58-1.35],0.5745958384692577
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLIC5,Chloride intracellular channel protein 5,23924,115,0.62 [0.32-1.19],0.1483642339815873
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLINT1,Clathrin interactor 1,23740,114,1.03 [0.72-1.48],0.878771696099742
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLIP2,CAP-Gly domain-containing linker protein 2,28308,124,1.06 [0.92-1.22],0.3986506680569485
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLMP,CXADR-like membrane protein,28579,126,1.17 [0.55-2.49],0.6820125063682316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLNS1A,Methylosome subunit pICln,23924,115,1.24 [0.76-2.02],0.3812738661111526
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",28082,127,1.06 [0.90-1.25],0.4686529053187447
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLPS,Colipase,28272,126,0.93 [0.74-1.16],0.5170323279692091
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLSPN,Claspin,27604,122,0.73 [0.42-1.26],0.2600116858631525
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLSTN1,Calsyntenin-1,27654,122,1.20 [0.91-1.58],0.1954215449896143
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLSTN2,Calsyntenin-2,28663,125,0.97 [0.65-1.45],0.8786607911864057
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLSTN3,Calsyntenin-3,24539,118,0.82 [0.46-1.46],0.4956303532889127
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLTA,Clathrin light chain A,27821,121,1.13 [0.82-1.57],0.4516042395753814
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLU,Clusterin,24647,118,1.15 [0.71-1.85],0.5764086638048149
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLUL1,Clusterin-like protein 1,28279,123,0.87 [0.61-1.23],0.4271850718922091
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CMC1,COX assembly mitochondrial protein homolog,24611,115,1.05 [0.86-1.27],0.6366158961241406
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CMIP,C-Maf-inducing protein,24494,116,1.01 [0.82-1.25],0.9144199793665588
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNDP1,Beta-Ala-His dipeptidase,28407,127,0.87 [0.63-1.22],0.424988161902874
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNGB3,Cyclic nucleotide-gated cation channel beta-3,23828,117,1.22 [0.95-1.56],0.1203807837936132
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",23884,116,1.00 [0.80-1.25],0.9705123440804762
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNPY2,Protein canopy homolog 2,27821,121,1.16 [0.93-1.46],0.196365217980764
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNPY4,Protein canopy homolog 4,28200,126,1.11 [0.91-1.37],0.3008018448205524
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNST,Consortin,28326,123,1.02 [0.88-1.18],0.769686367452644
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTF,Ciliary neurotrophic factor,23828,117,1.06 [0.63-1.78],0.8326477019755586
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN1,Contactin-1,28675,127,0.87 [0.48-1.55],0.6255317072352274
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN2,Contactin-2,28579,126,1.11 [0.78-1.57],0.5618439501143448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN3,Contactin-3,28313,126,0.69 [0.43-1.11],0.1232272264754214
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN4,Contactin-4,28313,126,1.97 [1.02-3.82],0.0436375811198069
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN5,Contactin-5,28408,126,0.78 [0.50-1.21],0.264901549157863
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTNAP2,Contactin-associated protein-like 2,28308,124,0.89 [0.61-1.31],0.5546779835343761
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTNAP4,Contactin-associated protein-like 4,23924,115,0.97 [0.81-1.16],0.7320016765843342
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COCH,Cochlin,24611,115,0.76 [0.51-1.13],0.1770911126011797
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL15A1,Collagen alpha-1(XV) chain,24601,117,1.33 [0.68-2.60],0.4082050380833733
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL18A1,Collagen alpha-1(XVIII) chain,28422,126,1.08 [0.54-2.14],0.8323966785808155
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL1A1,Collagen alpha-1(I) chain,28675,127,0.76 [0.40-1.43],0.3939878138818593
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL24A1,Collagen alpha-1(XXIV) chain,24515,118,1.02 [0.74-1.39],0.9194742194191716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL28A1,Collagen alpha-1(XXVIII) chain,23924,115,0.99 [0.78-1.24],0.9115347540752102
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL2A1,Collagen alpha-1(II) chain,23928,116,1.04 [0.84-1.30],0.704403527380172
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL3A1,Collagen alpha-1(III) chain,24601,117,0.97 [0.46-2.06],0.9313740996001836
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL4A1,Collagen alpha-1(IV) chain,28326,123,1.20 [0.81-1.79],0.3571510584846206
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL4A4,Collagen alpha-4(IV) chain,24116,114,1.00 [0.71-1.41],0.995551423957986
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL5A1,Collagen alpha-1(V) chain,24061,114,0.99 [0.63-1.56],0.955981751595576
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL6A3,Collagen alpha-3(VI) chain,28675,127,1.46 [0.93-2.29],0.1006410961529188
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL9A1,Collagen alpha-1(IX) chain,28308,124,0.90 [0.62-1.30],0.5677275780233719
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL9A2,Collagen alpha-2(IX) chain,24157,114,1.08 [0.75-1.56],0.6860405660306688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COLEC12,Collectin-12,28305,126,1.39 [0.75-2.56],0.2973809180874145
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COMMD1,COMM domain-containing protein 1,23928,116,0.93 [0.70-1.25],0.6367577514026741
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COMMD9,COMM domain-containing protein 9,24494,116,1.19 [0.79-1.78],0.4097514788989588
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COMP,Cartilage oligomeric matrix protein,28009,126,1.03 [0.64-1.64],0.9058427409192312
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COMT,Catechol O-methyltransferase,27512,120,1.10 [0.91-1.33],0.3470514217106442
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COPB2,Coatomer subunit beta',23828,115,1.12 [0.75-1.70],0.5771862967817358
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COPE,Coatomer subunit epsilon,27654,122,0.84 [0.57-1.23],0.3693298367911725
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",23928,116,1.03 [0.70-1.53],0.8727532809001973
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CORO1A,Coronin-1A,27762,123,1.03 [0.86-1.22],0.7466059583310898
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CORO6,Coronin-6,23828,117,1.55 [1.11-2.17],0.0096555943010447
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",28200,126,1.13 [0.91-1.40],0.2802633755804301
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COX6B1,Cytochrome c oxidase subunit 6B1,24611,115,1.53 [0.92-2.54],0.1003247309521098
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPA1,Carboxypeptidase A1,28675,127,0.72 [0.55-0.93],0.0115341584876607
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPA2,Carboxypeptidase A2,28490,126,0.83 [0.65-1.07],0.1485447390324708
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPA4,Carboxypeptidase A4,23579,111,0.90 [0.59-1.37],0.6227896887696808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPB1,Carboxypeptidase B,28675,127,0.69 [0.52-0.90],0.0071376465770524
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPB2,Carboxypeptidase B2,24596,118,0.73 [0.34-1.56],0.4153679283756589
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPE,Carboxypeptidase E,28377,126,0.83 [0.57-1.21],0.3371326924065318
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPLX2,Complexin-2,23740,114,1.06 [0.60-1.87],0.847549741306318
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPM,Carboxypeptidase M,28466,125,0.77 [0.49-1.20],0.2442854048212382
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",23910,115,1.22 [0.65-2.27],0.5310419308864176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPPED1,Serine/threonine-protein phosphatase CPPED1,28593,126,1.01 [0.80-1.27],0.9344934006826614
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPQ,Carboxypeptidase Q,24560,117,1.06 [0.66-1.72],0.8064676164415178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPTP,Ceramide-1-phosphate transfer protein,23828,115,1.00 [0.64-1.55],0.9849362246938016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPVL,Probable serine carboxypeptidase CPVL,28526,125,1.23 [0.83-1.82],0.3043765755598976
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPXM1,Probable carboxypeptidase X1,28391,125,0.93 [0.74-1.17],0.5175547652731919
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPXM2,Inactive carboxypeptidase-like protein X2,24611,115,1.18 [0.58-2.39],0.64224217729192
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CR1,Complement receptor type 1,24540,115,1.06 [0.64-1.75],0.8240017933304677
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CR2,Complement receptor type 2,28407,127,1.37 [0.98-1.92],0.0638539723872248
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,27634,122,0.98 [0.81-1.18],0.8174683500800493
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRADD,Death domain-containing protein CRADD,28082,127,1.06 [0.86-1.30],0.5858005687839942
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CREB3,Cyclic AMP-responsive element-binding protein 3,23740,114,1.04 [0.76-1.42],0.8149681533629385
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CREBZF,CREB/ATF bZIP transcription factor,23740,114,0.75 [0.36-1.54],0.4324875237415814
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CREG1,Protein CREG1,27932,125,1.04 [0.69-1.56],0.8525987917900526
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRELD1,Protein disulfide isomerase CRELD1,24061,114,0.82 [0.51-1.33],0.415158253260828
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRELD2,Protein disulfide isomerase CRELD2,28407,126,1.06 [0.79-1.42],0.7057315631343397
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRH,Corticoliberin,27589,122,1.00 [0.83-1.20],0.9618346034364396
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRHBP,Corticotropin-releasing factor-binding protein,28305,126,0.80 [0.46-1.40],0.4348682472397683
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRHR1,Corticotropin-releasing factor receptor 1,27821,121,1.15 [0.91-1.45],0.2412412867861292
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRIM1,Cysteine-rich motor neuron 1 protein,28450,126,0.73 [0.33-1.63],0.4412295517776644
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRIP2,Cysteine-rich protein 2,28132,127,0.85 [0.54-1.32],0.4597651059802461
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRISP2,Cysteine-rich secretory protein 2,28579,126,0.88 [0.68-1.15],0.3609122288518516
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRISP3,Cysteine-rich secretory protein 3,24393,116,1.25 [0.65-2.42],0.5012695556365168
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRKL,Crk-like protein,28352,126,1.05 [0.91-1.22],0.4800584968889556
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRLF1,Cytokine receptor-like factor 1,28450,126,1.01 [0.55-1.84],0.9854111296508252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRNN,Cornulin,27488,123,1.24 [0.97-1.58],0.0800867418478092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRTAC1,Cartilage acidic protein 1,28675,127,1.06 [0.63-1.77],0.8296597810679387
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRTAM,Cytotoxic and regulatory T-cell molecule,28132,127,1.22 [0.90-1.67],0.2046105706905
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRTAP,Cartilage-associated protein,23924,115,0.99 [0.69-1.42],0.9509748859299908
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRX,Cone-rod homeobox protein,27821,121,1.01 [0.87-1.18],0.8656309226786638
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYBB1,Beta-crystallin B1,24611,115,1.07 [0.82-1.39],0.6227689056937491
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYBB2,Beta-crystallin B2,24539,118,1.09 [0.84-1.41],0.5341716282708933
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYGD,Gamma-crystallin D,24539,118,0.96 [0.80-1.14],0.6255881464039108
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYM,Ketimine reductase mu-crystallin,23828,117,1.07 [0.86-1.33],0.5459842876475969
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYZL1,Quinone oxidoreductase-like protein 1,23928,116,1.06 [0.87-1.29],0.549440564834765
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSDE1,Cold shock domain-containing protein E1,23828,115,0.98 [0.84-1.14],0.8132876994115964
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF1,Macrophage colony-stimulating factor 1,28450,126,1.52 [0.86-2.68],0.150196807566617
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF1R,Macrophage colony-stimulating factor 1 receptor,24634,116,1.25 [0.82-1.93],0.3003656702844433
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF2,Granulocyte-macrophage colony-stimulating factor,23828,115,0.55 [0.32-0.94],0.0286585585401397
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,28132,127,1.12 [0.87-1.43],0.3736649764816546
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF2RB,Cytokine receptor common subunit beta,23910,115,0.78 [0.52-1.18],0.2409844426476479
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF3,Granulocyte colony-stimulating factor,27801,122,0.75 [0.54-1.06],0.1059669630042672
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF3R,Granulocyte colony-stimulating factor receptor,23910,115,0.98 [0.55-1.75],0.944892478699082
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSH1,Chorionic somatomammotropin hormone 1,24634,116,0.64 [0.35-1.18],0.1516638422291179
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSNK1D,Casein kinase I isoform delta,23910,115,0.96 [0.73-1.28],0.8020669345435298
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSNK2A1,Casein kinase II subunit alpha,24574,116,1.20 [0.82-1.75],0.359323643582861
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSPG4,Chondroitin sulfate proteoglycan 4,24601,117,0.84 [0.50-1.43],0.5294273214375514
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSPG5,Chondroitin sulfate proteoglycan 5,23828,117,1.05 [0.74-1.50],0.7788972659543107
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSRP3,Cysteine and glycine-rich protein 3,23828,115,1.29 [1.12-1.48],0.000318540748149
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST1,Cystatin-SN,21326,102,1.11 [0.92-1.35],0.2801961270274353
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST3,Cystatin-C,28359,127,1.31 [0.74-2.29],0.3508480259545181
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST5,Cystatin-D,27804,127,0.97 [0.72-1.29],0.81122620124328
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST6,Cystatin-M,27597,123,1.18 [0.84-1.65],0.3351795600791681
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST7,Cystatin-F,28350,125,1.10 [0.94-1.28],0.2305198318162301
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSTB,Cystatin-B,27932,126,1.30 [0.91-1.84],0.1435529863345792
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTAG1A_CTAG1B,Cancer/testis antigen 1,24105,114,1.01 [0.71-1.44],0.9507813065586056
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTBS,Di-N-acetylchitobiase,24294,114,1.32 [0.68-2.56],0.4088233689531307
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTF1,Cardiotrophin-1,27821,121,0.96 [0.79-1.16],0.6899897454386641
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTHRC1,Collagen triple helix repeat-containing protein 1,24601,117,1.17 [0.62-2.21],0.6371993748569329
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTLA4,Cytotoxic T-lymphocyte protein 4,24601,117,1.37 [0.85-2.21],0.20007079573731
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTNNA1,Catenin alpha-1,23828,117,1.21 [0.79-1.84],0.3805170918375876
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTRB1,Chymotrypsinogen B,28313,126,0.84 [0.63-1.13],0.2523177434370321
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTRC,Chymotrypsin-C,28306,126,0.74 [0.58-0.95],0.0166495331671202
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTRL,Chymotrypsin-like protease CTRL-1,24539,118,0.83 [0.65-1.08],0.167634269637951
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSB,Cathepsin B,28326,126,1.00 [0.74-1.36],0.9924991693446584
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSC,Dipeptidyl peptidase 1,28259,126,0.90 [0.63-1.30],0.584323686284119
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSD,Cathepsin D,26417,113,1.13 [0.76-1.70],0.5384116161221001
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSE,Cathepsin E,24061,114,1.33 [0.96-1.86],0.0896079747932245
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSF,Cathepsin F,28391,125,0.92 [0.63-1.35],0.6728994328795492
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSH,Pro-cathepsin H,27736,120,0.98 [0.79-1.23],0.8834192373294475
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSL,Cathepsin L1,28326,123,1.49 [0.78-2.84],0.2236971530530248
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSO,Cathepsin O,28663,125,1.16 [0.70-1.93],0.5628474661109797
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSS,Cathepsin S,22353,98,1.49 [0.67-3.32],0.3332466081576349
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSV,Cathepsin L2,28486,125,0.92 [0.63-1.35],0.678928219259597
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSZ,Cathepsin Z,28302,127,0.97 [0.59-1.60],0.9186627405425728
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CUZD1,CUB and zona pellucida-like domain-containing protein 1,23924,115,0.92 [0.56-1.51],0.7352845075066847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CWC15,Spliceosome-associated protein CWC15 homolog,24386,118,0.96 [0.72-1.28],0.7640532774777653
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CX3CL1,Fractalkine,28132,127,1.20 [0.76-1.92],0.4314023965137316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXADR,Coxsackievirus and adenovirus receptor,28308,124,0.94 [0.68-1.29],0.6880315877700741
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL1,Growth-regulated alpha protein,28261,125,0.88 [0.74-1.05],0.1678030311974648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL10,C-X-C motif chemokine 10,28450,126,0.89 [0.69-1.14],0.3585389074194343
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL11,C-X-C motif chemokine 11,28593,126,0.93 [0.75-1.14],0.462605046194789
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL12,Stromal cell-derived factor 1,27801,122,1.35 [0.93-1.97],0.1189353529730493
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL13,C-X-C motif chemokine 13,28593,126,0.95 [0.72-1.25],0.7000508451787373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL14,C-X-C motif chemokine 14,27801,122,0.79 [0.57-1.08],0.1418695854456298
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL16,C-X-C motif chemokine 16,28620,127,1.06 [0.54-2.08],0.8667298567349211
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL17,C-X-C motif chemokine 17,28663,125,0.90 [0.64-1.28],0.5590316819502041
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL3,C-X-C motif chemokine 3,28307,125,0.97 [0.82-1.14],0.6911403408182493
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL5,C-X-C motif chemokine 5,28229,123,0.96 [0.84-1.10],0.5772319266821272
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL6,C-X-C motif chemokine 6,28663,125,0.97 [0.79-1.19],0.7650650805220333
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL8,Interleukin-8,28100,124,0.80 [0.62-1.04],0.0912937398605777
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL9,C-X-C motif chemokine 9,28450,126,1.00 [0.79-1.27],0.9913610577931083
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYB5A,Cytochrome b5,23740,114,0.82 [0.61-1.09],0.1735051148384825
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYB5R2,NADH-cytochrome b5 reductase 2,24222,118,1.13 [0.84-1.53],0.4297588851192764
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",23828,115,1.23 [1.06-1.44],0.0080670627453976
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYTH3,Cytohesin-3,23740,114,0.88 [0.67-1.14],0.3314757646036402
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYTL1,Cytokine-like protein 1,24601,117,0.76 [0.36-1.61],0.4786323826376224
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAAM1,Disheveled-associated activator of morphogenesis 1,24061,114,1.06 [0.85-1.31],0.6053358039977015
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAB2,Disabled homolog 2,28579,126,1.07 [0.93-1.23],0.3423371220257693
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAG1,Dystroglycan,28450,126,1.03 [0.75-1.42],0.8600767556620778
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAND5,DAN domain family member 5,23910,115,0.87 [0.63-1.20],0.3896119019868315
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAPK2,Death-associated protein kinase 2,23910,115,1.10 [0.82-1.47],0.5294773398622565
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,28308,124,1.08 [0.94-1.24],0.2586777654365947
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DARS1,"Aspartate--tRNA ligase, cytoplasmic",28082,127,1.04 [0.84-1.30],0.6929379101676181
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DBH,Dopamine beta-hydroxylase,24594,116,0.86 [0.75-0.99],0.0301424205785295
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DBI,Acyl-CoA-binding protein,28171,124,1.16 [0.95-1.40],0.1466413107889964
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DBN1,Drebrin,23910,115,0.98 [0.70-1.39],0.9277042067837556
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DBNL,Drebrin-like protein,28450,126,1.04 [0.88-1.23],0.6511357097516435
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",28391,125,0.78 [0.50-1.20],0.2583944354509645
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCC,Netrin receptor DCC,23924,115,0.40 [0.15-1.07],0.0672151404164643
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCDC2C,Doublecortin domain-containing protein 2C,23740,114,1.07 [0.82-1.41],0.6147411520781481
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCLRE1C,Protein artemis,23740,114,1.10 [0.63-1.91],0.7456952776661285
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCN,Decorin,27821,121,0.73 [0.34-1.55],0.4115603296038804
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTD,Deoxycytidylate deaminase,24061,114,1.09 [0.90-1.32],0.3751160814086041
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTN1,Dynactin subunit 1,28579,126,0.99 [0.78-1.25],0.914021743779006
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTN2,Dynactin subunit 2,28200,126,0.97 [0.82-1.14],0.6906794146967179
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTN6,Dynactin subunit 6,27654,122,1.04 [0.84-1.30],0.7110783866627592
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTPP1,dCTP pyrophosphatase 1,28326,123,0.74 [0.45-1.22],0.2420739369740342
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCUN1D1,DCN1-like protein 1,23828,117,1.07 [0.86-1.34],0.5371530866857963
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCUN1D2,DCN1-like protein 2,23740,114,0.99 [0.79-1.24],0.9360919704857212
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCXR,L-xylulose reductase,28391,125,0.92 [0.69-1.24],0.5939771711527785
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDA1,DET1- and DDB1-associated protein 1,23828,115,1.22 [0.82-1.82],0.3290209359326628
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",28200,126,1.05 [0.74-1.48],0.7921734682643723
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDC,Aromatic-L-amino-acid decarboxylase,28293,123,0.91 [0.66-1.26],0.5701695724901643
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDHD2,Phospholipase DDHD2,24574,116,0.97 [0.74-1.26],0.8013849607610566
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDI2,Protein DDI1 homolog 2,24061,114,0.90 [0.71-1.14],0.3867011130969248
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDR1,Epithelial discoidin domain-containing receptor 1,28593,126,1.43 [0.74-2.74],0.2850102158099108
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDT,D-dopachrome decarboxylase,24601,117,0.74 [0.48-1.16],0.1924892173690596
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX1,ATP-dependent RNA helicase DDX1,24515,118,1.07 [0.78-1.48],0.6721110308794203
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX25,ATP-dependent RNA helicase DDX25,23924,115,1.13 [0.74-1.73],0.5723361022999569
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX39A,ATP-dependent RNA helicase DDX39A,23910,115,1.02 [0.46-2.24],0.9621324175187278
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX4,Probable ATP-dependent RNA helicase DDX4,23910,115,1.34 [1.07-1.68],0.0099052863150329
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX53,Probable ATP-dependent RNA helicase DDX53,23924,115,1.13 [0.70-1.83],0.616524899175809
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX58,Antiviral innate immune response receptor RIG-I,27634,122,0.99 [0.75-1.29],0.9284481445394052
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",28308,124,1.09 [0.93-1.28],0.2989671878048801
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFA1_DEFA1B,Neutrophil defensin 1,27728,126,1.11 [0.83-1.48],0.4832139367693372
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB103A_DEFB103B,Beta-defensin 103,23743,114,1.22 [0.84-1.77],0.2985915282421683
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB104A_DEFB104B,Beta-defensin 104,23828,117,1.28 [0.99-1.64],0.0557504152362012
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB116,Beta-defensin 116,23828,117,1.18 [0.97-1.43],0.0925494367264054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB118,Beta-defensin 118,23828,117,0.92 [0.66-1.28],0.6103681790073854
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB4A_DEFB4B,Beta-defensin 4A,27905,125,1.00 [0.90-1.11],0.974243140617665
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DENND2B,DENN domain-containing protein 2B,23828,115,1.04 [0.73-1.47],0.8476581836122916
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DENR,Density-regulated protein,23910,115,0.93 [0.67-1.27],0.6328677628974313
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DFFA,DNA fragmentation factor subunit alpha,28663,125,1.05 [0.83-1.31],0.7037886073486151
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DGCR6,Protein DGCR6,23828,117,0.92 [0.61-1.41],0.7149968430050775
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DGKA,Diacylglycerol kinase alpha,23910,115,1.09 [0.79-1.51],0.5913747999459663
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DGKZ,Diacylglycerol kinase zeta,27801,122,1.06 [0.68-1.64],0.8018881284348471
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DHODH,Dihydroorotate dehydrogenase,23828,115,0.59 [0.37-0.94],0.0279265995996358
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DHPS,Deoxyhypusine synthase,24494,116,0.92 [0.58-1.44],0.7072171154154598
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24539,118,1.09 [0.77-1.55],0.6275623283945909
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DIABLO,"Diablo homolog, mitochondrial",28224,122,1.08 [0.94-1.25],0.2677901445285137
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DIPK1C,Divergent protein kinase domain 1C,23924,115,0.65 [0.40-1.07],0.0893587017517462
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DIPK2B,Divergent protein kinase domain 2B,24061,114,0.82 [0.43-1.57],0.5557668987581461
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DKK1,Dickkopf-related protein 1,28593,126,0.90 [0.70-1.17],0.4400982453457989
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DKK3,Dickkopf-related protein 3,28675,127,0.55 [0.32-0.94],0.0298725849276725
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DKK4,Dickkopf-related protein 4,28081,127,0.89 [0.63-1.26],0.5121622909530005
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DKKL1,Dickkopf-like protein 1,28200,126,1.16 [0.95-1.42],0.1443059121553454
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLG4,Disks large homolog 4,24539,118,0.99 [0.78-1.27],0.9531470989051984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLGAP5,Disks large-associated protein 5,24574,116,1.07 [0.78-1.46],0.6764984002265828
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLK1,Protein delta homolog 1,28675,127,0.91 [0.69-1.20],0.4980267867766136
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLL1,Delta-like protein 1,28391,125,1.24 [0.73-2.13],0.4283664178526774
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLL4,Delta-like protein 4,23928,116,0.82 [0.60-1.12],0.2083338720239876
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DMD,Dystrophin,23928,116,1.06 [0.76-1.49],0.7271115980850584
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DMP1,Dentin matrix acidic phosphoprotein 1,23928,116,0.87 [0.66-1.14],0.3036280641497051
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJA1,DnaJ homolog subfamily A member 1,23740,114,0.76 [0.49-1.20],0.241312434218354
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJA2,DnaJ homolog subfamily A member 2,28563,124,1.07 [0.88-1.29],0.4997380762676466
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJA4,DnaJ homolog subfamily A member 4,24539,118,1.05 [0.82-1.33],0.7053338284173496
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB1,DnaJ homolog subfamily B member 1,28200,126,1.02 [0.86-1.23],0.7911098700586982
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB14,DnaJ homolog subfamily B member 14,24515,118,1.00 [0.76-1.30],0.9716563167030844
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB2,DnaJ homolog subfamily B member 2,24061,114,1.10 [0.79-1.52],0.5791226563429543
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB6,DnaJ homolog subfamily B member 6,23837,112,1.10 [0.89-1.35],0.3888518342746877
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB8,DnaJ homolog subfamily B member 8,27821,121,1.15 [0.89-1.48],0.2934577818473928
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJC21,DnaJ homolog subfamily C member 21,24539,118,1.12 [0.73-1.73],0.6027636200439508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJC6,Putative tyrosine-protein phosphatase auxilin,23928,116,1.08 [0.88-1.33],0.4411559263737094
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJC9,DnaJ homolog subfamily C member 9,24515,118,1.02 [0.81-1.28],0.8785431202930506
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNER,Delta and Notch-like epidermal growth factor-related receptor,28264,126,0.46 [0.25-0.85],0.0126495081098445
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNLZ,DNL-type zinc finger protein,23828,117,0.92 [0.74-1.15],0.4650572140018434
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNM1,Dynamin-1,24515,118,1.06 [0.91-1.24],0.432784445413535
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNM3,Dynamin-3,24574,116,0.95 [0.68-1.31],0.7485071574370984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNMBP,Dynamin-binding protein,28132,127,0.92 [0.71-1.19],0.5368414680374655
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNPEP,Aspartyl aminopeptidase,24539,118,0.94 [0.71-1.26],0.6981566299692115
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,28395,126,0.92 [0.68-1.24],0.5677293965095358
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DOC2B,Double C2-like domain-containing protein beta,23924,115,0.86 [0.50-1.48],0.5931555728194969
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DOCK9,Dedicator of cytokinesis protein 9,23828,117,0.89 [0.75-1.06],0.2016929192518899
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DOK1,Docking protein 1,24539,118,1.02 [0.89-1.16],0.800729151725063
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DOK2,Docking protein 2,28326,123,1.06 [0.93-1.21],0.3553121331800556
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPEP1,Dipeptidase 1,28082,127,1.01 [0.73-1.40],0.9606506635241032
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPEP2,Dipeptidase 2,28200,126,1.71 [1.03-2.86],0.0389858226434933
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPP10,Inactive dipeptidyl peptidase 10,28308,124,0.99 [0.63-1.55],0.9648223927978804
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPP4,Dipeptidyl peptidase 4,27757,126,0.94 [0.55-1.59],0.8097536518521455
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPP6,Dipeptidyl aminopeptidase-like protein 6,28200,126,0.83 [0.52-1.32],0.4230871472263223
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPP7,Dipeptidyl peptidase 2,28084,122,1.00 [0.77-1.30],0.9890916671945104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPT,Dermatopontin,28675,127,0.85 [0.48-1.52],0.5871084101048322
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPY30,Protein dpy-30 homolog,28502,125,0.94 [0.72-1.23],0.6497300970924573
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DRAXIN,Draxin,28132,127,1.03 [0.71-1.49],0.8806353205085118
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DRG2,Developmentally-regulated GTP-binding protein 2,28200,126,1.09 [0.83-1.42],0.55545466958166
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSC2,Desmocollin-2,27973,126,1.06 [0.67-1.70],0.7962213135050413
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSCAM,Down syndrome cell adhesion molecule,24574,116,1.10 [0.67-1.79],0.7129091493040223
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSG2,Desmoglein-2,28313,126,1.09 [0.61-1.96],0.7654542445178731
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSG3,Desmoglein-3,28494,124,1.01 [0.63-1.60],0.9819845576340016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSG4,Desmoglein-4,28104,125,1.03 [0.75-1.41],0.8614334120704159
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTD1,D-aminoacyl-tRNA deacylase 1,24061,114,1.15 [0.94-1.41],0.1658071331203107
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTNB,Dystrobrevin beta,24454,116,1.35 [0.95-1.91],0.0989752184957189
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTX2,Probable E3 ubiquitin-protein ligase DTX2,23924,115,1.27 [1.03-1.57],0.0244548309970523
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTX3,Probable E3 ubiquitin-protein ligase DTX3,28200,126,1.18 [0.62-2.27],0.6100147323464369
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTYMK,Thymidylate kinase,24611,115,1.02 [0.79-1.32],0.8816922048066641
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUOX2,Dual oxidase 2,27821,121,1.02 [0.82-1.27],0.8766254084236242
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUSP13,Dual specificity protein phosphatase 13 isoform A,24494,116,0.76 [0.49-1.18],0.2179692110668709
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUSP29,Dual specificity phosphatase 29,23924,115,1.01 [0.77-1.32],0.9438558755182016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUSP3,Dual specificity protein phosphatase 3,27654,122,0.84 [0.67-1.04],0.1059126937554945
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24515,118,1.03 [0.87-1.21],0.7606302925395717
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DXO,Decapping and exoribonuclease protein,24539,118,1.12 [0.77-1.64],0.5377893637999556
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24494,116,1.04 [0.73-1.49],0.8237772626230926
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DYNLT1,Dynein light chain Tctex-type 1,23924,115,1.04 [0.84-1.28],0.7275960213572571
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DYNLT3,Dynein light chain Tctex-type 3,24494,116,1.06 [0.71-1.57],0.7875261575902613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,28132,127,1.04 [0.88-1.23],0.6413431812655752
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EBI3_IL27,Interleukin-27,28542,126,1.55 [0.96-2.51],0.0714311393959458
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECE1,Endothelin-converting enzyme 1,27654,122,0.86 [0.54-1.36],0.5114199985637158
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24611,115,0.85 [0.67-1.09],0.207928603910727
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECHS1,"Enoyl-CoA hydratase, mitochondrial",23928,116,1.05 [0.87-1.25],0.6326188872704165
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECI2,Enoyl-CoA delta isomerase 2,23828,115,0.96 [0.71-1.28],0.770930135422783
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECM1,Extracellular matrix protein 1,23951,116,1.03 [0.64-1.68],0.8968864675754298
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECSCR,Endothelial cell-specific chemotaxis regulator,23828,117,0.99 [0.70-1.41],0.965688143558102
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDA2R,Tumor necrosis factor receptor superfamily member 27,28579,126,2.26 [1.56-3.29],1.976813290423276e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDAR,Tumor necrosis factor receptor superfamily member EDAR,28308,124,1.06 [0.89-1.26],0.5001199758717292
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDDM3B,Epididymal secretory protein E3-beta,24494,116,0.75 [0.53-1.08],0.1226239225317204
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,23828,115,0.84 [0.49-1.43],0.5156806878427742
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDF1,Endothelial differentiation-related factor 1,24574,116,1.09 [0.86-1.37],0.4919757241275074
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,27821,121,0.89 [0.57-1.39],0.6092561899981042
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDN1,Endothelin-1,23928,116,1.09 [0.58-2.03],0.7914179488743487
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDNRB,Endothelin receptor type B,23910,115,0.83 [0.53-1.30],0.4205442473202568
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EEF1D,Elongation factor 1-delta,24611,115,0.98 [0.81-1.19],0.8424940721703235
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24515,118,0.96 [0.49-1.87],0.902729499033998
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFCAB2,Dynein regulatory complex protein 8,24157,114,1.09 [0.66-1.78],0.7398152858329725
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,28353,127,0.90 [0.54-1.51],0.6985956128793256
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFHD1,EF-hand domain-containing protein D1,24574,116,1.31 [0.83-2.06],0.2538243161786163
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFNA1,Ephrin-A1,28262,124,1.61 [0.92-2.83],0.0959711278249966
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFNA4,Ephrin-A4,28083,127,1.08 [0.62-1.89],0.7855453667205265
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFNB2,Ephrin-B2,23924,115,0.94 [0.69-1.28],0.686390490994467
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGF,Pro-epidermal growth factor,28258,126,1.00 [0.86-1.16],0.9598613653775134
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGFL7,Epidermal growth factor-like protein 7,27634,122,0.93 [0.62-1.39],0.714908658280364
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGFLAM,Pikachurin,24515,118,0.67 [0.37-1.21],0.1816779462816151
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGFR,Epidermal growth factor receptor,28675,127,0.87 [0.33-2.27],0.7694852493304554
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGLN1,Egl nine homolog 1,28308,124,1.20 [0.95-1.50],0.1190319655433005
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EHBP1,EH domain-binding protein 1,24611,115,1.02 [0.81-1.29],0.8432447077407327
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EHD3,EH domain-containing protein 3,23928,116,1.05 [0.90-1.22],0.5696796795633208
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24539,118,0.89 [0.64-1.25],0.5122365533210114
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24438,118,1.02 [0.87-1.19],0.8111270517283266
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,23828,115,0.89 [0.67-1.18],0.4057202899384802
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,23928,116,1.06 [0.71-1.60],0.7614805807641903
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4B,Eukaryotic translation initiation factor 4B,28132,127,0.95 [0.72-1.24],0.6985392521790452
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4E,Eukaryotic translation initiation factor 4E,23910,115,1.03 [0.85-1.25],0.7607988299195247
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,28326,123,1.04 [0.82-1.32],0.7600763300344168
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,28663,125,1.08 [0.92-1.26],0.3631835787377852
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24574,116,0.90 [0.69-1.18],0.4579611912077815
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF5,Eukaryotic translation initiation factor 5,23828,115,1.22 [0.86-1.73],0.2630805322130933
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF5A,Eukaryotic translation initiation factor 5A-1,27801,122,1.25 [0.77-2.03],0.3680837702255654
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELAC1,Zinc phosphodiesterase ELAC protein 1,24574,116,1.08 [0.88-1.33],0.4567828499005968
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELAVL4,ELAV-like protein 4,23828,117,0.96 [0.77-1.19],0.6858875161789497
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELN,Elastin,24611,115,1.74 [1.06-2.87],0.0295130484946703
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELOA,Elongin-A,28200,126,0.92 [0.68-1.25],0.593086671369902
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELOB,Elongin-B,23828,115,1.21 [0.81-1.82],0.3519026039796133
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENAH,Protein enabled homolog,27801,122,1.28 [0.93-1.75],0.1281398526133882
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENDOU,Poly(U)-specific endoribonuclease,22730,106,1.07 [0.76-1.52],0.6952812916374791
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENG,Endoglin,28675,127,0.80 [0.32-2.01],0.6328228710034172
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENO1,Alpha-enolase,28294,126,1.06 [0.87-1.30],0.5442226752279615
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENO2,Gamma-enolase,28593,126,1.06 [0.84-1.34],0.6299286940797234
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENO3,Beta-enolase,23928,116,1.23 [0.94-1.60],0.1240811501370181
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENOPH1,Enolase-phosphatase E1,24494,116,0.99 [0.71-1.37],0.9494006468878236
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,23828,115,1.28 [0.70-2.31],0.4201124837354096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPEP,Glutamyl aminopeptidase,23828,115,0.91 [0.58-1.43],0.6747855007291594
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,28675,127,0.76 [0.42-1.39],0.3771514290533881
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,28450,126,0.90 [0.64-1.26],0.5299271349391257
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,23928,116,0.72 [0.44-1.17],0.1831417124942319
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,27508,123,1.08 [0.90-1.30],0.3960497805379557
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENSA,Alpha-endosulfine,24494,116,1.16 [0.85-1.58],0.3606513177264583
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,27634,122,1.04 [0.72-1.49],0.8458553747115836
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,27821,121,1.02 [0.48-2.17],0.9528834920592736
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,27821,121,1.09 [0.60-2.00],0.7694987867077585
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENTR1,Endosome-associated-trafficking regulator 1,23928,116,0.95 [0.71-1.28],0.7486342247379919
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EP300,Histone acetyltransferase p300,23910,115,0.85 [0.47-1.55],0.6007080464822512
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPB41L5,Band 4.1-like protein 5,23924,115,0.85 [0.62-1.16],0.3052044581556804
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPCAM,Epithelial cell adhesion molecule,28314,125,0.83 [0.70-0.99],0.0336991539021673
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPGN,Epigen,24494,116,1.26 [0.96-1.65],0.0998383826796148
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHA1,Ephrin type-A receptor 1,28395,126,0.57 [0.37-0.90],0.0152146584814027
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHA10,Ephrin type-A receptor 10,27654,122,0.99 [0.77-1.27],0.911181985021096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHA2,Ephrin type-A receptor 2,27309,126,1.14 [0.67-1.93],0.6357204913313816
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHA4,Ephrin type-A receptor 4,24061,114,0.96 [0.51-1.81],0.910807269049323
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHB4,Ephrin type-B receptor 4,28675,127,1.15 [0.60-2.19],0.6677110647721274
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHB6,Ephrin type-B receptor 6,28082,127,0.94 [0.56-1.58],0.8187757956641696
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHX2,Bifunctional epoxide hydrolase 2,27821,121,1.40 [1.16-1.69],0.0004372406796326
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPN1,Epsin-1,24157,114,0.89 [0.56-1.41],0.6213563614668871
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPO,Erythropoietin,28308,124,1.02 [0.83-1.25],0.8351274847929782
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPPK1,Epiplakin,23928,116,1.02 [0.81-1.29],0.8657610145070931
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,28539,125,0.68 [0.40-1.15],0.1498537257990287
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERBB2,Receptor tyrosine-protein kinase erbB-2,28391,125,0.66 [0.37-1.17],0.1530011805425436
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERBB3,Receptor tyrosine-protein kinase erbB-3,28200,125,0.70 [0.31-1.60],0.4017193814303526
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERBB4,Receptor tyrosine-protein kinase erbB-4,28391,125,1.16 [0.61-2.23],0.6514869843713647
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERBIN,Erbin,28200,126,1.05 [0.90-1.22],0.5332749637088513
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERC2,ERC protein 2,23924,115,0.87 [0.66-1.14],0.3114693874250173
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERCC1,DNA excision repair protein ERCC-1,23740,114,1.11 [0.66-1.85],0.697910431736526
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EREG,Proepiregulin,28082,127,1.08 [0.89-1.30],0.4493517482345928
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERI1,3'-5' exoribonuclease 1,24157,114,1.43 [0.91-2.24],0.1179171847626484
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERMAP,Erythroid membrane-associated protein,23910,115,1.18 [0.80-1.74],0.414919320002776
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24494,116,0.77 [0.48-1.24],0.2868235879507022
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERP29,Endoplasmic reticulum resident protein 29,24061,114,1.07 [0.92-1.24],0.3757815399957515
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERP44,Endoplasmic reticulum resident protein 44,28160,126,1.01 [0.55-1.83],0.9844061905928304
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,23828,115,0.87 [0.57-1.32],0.5022552699028509
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESAM,Endothelial cell-selective adhesion molecule,28675,127,0.92 [0.56-1.52],0.7550667004521839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESM1,Endothelial cell-specific molecule 1,28305,126,1.11 [0.70-1.74],0.6667952597564784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESPL1,Separin,23740,114,0.92 [0.65-1.32],0.661898116930009
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESR1,Estrogen receptor,23910,115,0.81 [0.56-1.16],0.2497111480326339
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESYT2,Extended synaptotagmin-2,24539,118,0.98 [0.79-1.21],0.8427468825953958
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EVI2B,Protein EVI2B,23740,114,0.82 [0.49-1.37],0.4430245694668449
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EVI5,Ecotropic viral integration site 5 protein homolog,23910,115,1.02 [0.84-1.23],0.8748026517842981
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EVPL,Envoplakin,24157,114,1.32 [0.81-2.14],0.2651664093105585
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EXOSC10,Exosome component 10,23828,115,1.07 [0.81-1.41],0.6340874471219307
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EXTL1,Exostosin-like 1,23828,115,0.68 [0.43-1.07],0.094991762346394
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EZR,Ezrin,28593,126,0.54 [0.28-1.05],0.0699179007600942
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F10,Coagulation factor X,24634,116,0.54 [0.28-1.07],0.0781112310393156
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F11,Coagulation factor XI,24284,117,1.19 [0.74-1.92],0.4719237380020343
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F11R,Junctional adhesion molecule A,28313,126,1.00 [0.76-1.32],0.9915975692281196
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F12,Coagulation factor XII,24647,118,0.80 [0.53-1.20],0.2800064504260554
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F13B,Coagulation factor XIII B chain,24515,118,0.63 [0.33-1.22],0.1687042769362169
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F2,Prothrombin,24647,118,1.12 [0.35-3.64],0.847248790937725
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F2R,Proteinase-activated receptor 1,28407,126,1.01 [0.77-1.32],0.95093827283255
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F3,Tissue factor,28401,125,0.74 [0.41-1.33],0.3083418950421407
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F7,Coagulation factor VII,28360,126,0.92 [0.55-1.56],0.7681477387212163
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F9,Coagulation factor IX,28372,127,0.92 [0.39-2.14],0.8394223921317319
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP1,"Fatty acid-binding protein, liver",28305,126,0.79 [0.67-0.95],0.0098923019116878
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP2,"Fatty acid-binding protein, intestinal",28326,123,0.80 [0.65-0.99],0.0433059382100677
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP3,"Fatty acid-binding protein, heart",24611,115,1.49 [1.11-1.99],0.0082087000229294
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP4,"Fatty acid-binding protein, adipocyte",28675,127,1.10 [0.81-1.51],0.5317260641201775
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP5,Fatty acid-binding protein 5,28513,124,1.07 [0.85-1.34],0.577011849898297
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP6,Gastrotropin,27784,121,0.72 [0.52-0.99],0.0427627986005293
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP9,Fatty acid-binding protein 9,28308,124,1.20 [0.91-1.57],0.2036011222028833
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FADD,FAS-associated death domain protein,28326,123,1.12 [0.92-1.37],0.2668348672972082
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM13A,Protein FAM13A,24515,118,0.89 [0.68-1.15],0.371870240351393
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM171A2,Protein FAM171A2,24574,116,1.03 [0.92-1.14],0.637486437424017
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM171B,Protein FAM171B,24494,116,1.52 [0.93-2.51],0.0976079752449198
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM172A,Cotranscriptional regulator FAM172A,23928,116,0.99 [0.75-1.32],0.9699676407834498
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM20A,Pseudokinase FAM20A,24611,115,0.87 [0.47-1.63],0.6714329050976617
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM3B,Protein FAM3B,28200,126,0.93 [0.60-1.43],0.7368149159455588
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM3C,Protein FAM3C,28293,123,0.76 [0.44-1.32],0.3337491968896051
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM3D,Protein FAM3D,24515,118,1.00 [0.81-1.23],0.9676554135175466
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAP,Prolyl endopeptidase FAP,28675,127,1.68 [0.95-2.97],0.0723725904972663
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FARSA,Phenylalanine--tRNA ligase alpha subunit,23924,115,1.10 [0.86-1.41],0.4356607556904617
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAS,Tumor necrosis factor receptor superfamily member 6,28573,126,1.20 [0.79-1.82],0.4018588393612506
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FASLG,Tumor necrosis factor ligand superfamily member 6,28663,125,1.09 [0.71-1.66],0.6951632313097643
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FBLN2,Fibulin-2,24601,117,0.82 [0.46-1.44],0.4823284932967822
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FBN2,Fibrillin-2,23924,115,1.13 [0.84-1.51],0.4219307437901521
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FBP1,"Fructose-1,6-bisphosphatase 1",28326,123,0.96 [0.77-1.19],0.7231478918301965
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24611,115,0.97 [0.76-1.24],0.796429054630518
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCAR,Immunoglobulin alpha Fc receptor,28308,124,1.02 [0.73-1.43],0.9032741993214002
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24574,116,0.99 [0.47-2.06],0.9698054705224092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCER2,Low affinity immunoglobulin epsilon Fc receptor,28313,126,0.90 [0.65-1.24],0.5095639818099038
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,28183,125,0.84 [0.67-1.05],0.1233903941326633
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,27634,122,1.08 [0.83-1.42],0.5541859733485119
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,28317,126,0.93 [0.68-1.27],0.6375929862187263
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCN1,Ficolin-1,24594,116,0.97 [0.71-1.32],0.845035710332898
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCN2,Ficolin-2,28184,126,1.47 [0.97-2.23],0.0669062635939079
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL1,Fc receptor-like protein 1,28326,123,1.05 [0.73-1.50],0.7941145917432509
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL2,Fc receptor-like protein 2,28537,125,1.10 [0.79-1.53],0.5769865443085627
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL3,Fc receptor-like protein 3,27801,122,0.85 [0.63-1.16],0.3054509053289536
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL5,Fc receptor-like protein 5,28313,126,0.88 [0.67-1.17],0.3805536617787788
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL6,Fc receptor-like protein 6,28308,124,1.07 [0.84-1.35],0.5860588698716509
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRLB,Fc receptor-like B,27634,122,1.16 [0.90-1.50],0.2556811146069321
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FDX1,"Adrenodoxin, mitochondrial",23828,115,0.91 [0.67-1.24],0.5579647124613937
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FDX2,"Ferredoxin-2, mitochondrial",23828,115,1.21 [0.92-1.60],0.1685191253718974
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FEN1,Flap endonuclease 1,27634,122,0.84 [0.64-1.12],0.2425042327270032
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FES,Tyrosine-protein kinase Fes/Fps,27634,122,1.00 [0.71-1.40],0.9993629405153178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FETUB,Fetuin-B,28372,127,0.86 [0.56-1.35],0.5201881676928051
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGA,Fibrinogen alpha chain,24057,115,1.08 [0.60-1.92],0.803213071367332
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24574,116,0.98 [0.79-1.21],0.8216822081173801
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF12,Fibroblast growth factor 12,23910,115,0.98 [0.66-1.46],0.915231856729916
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF16,Fibroblast growth factor 16,23910,115,0.66 [0.42-1.03],0.0648109729713951
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF19,Fibroblast growth factor 19,28450,126,1.01 [0.82-1.23],0.9528518626902368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF2,Fibroblast growth factor 2,28308,124,1.18 [0.94-1.48],0.1476870076911215
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF20,Fibroblast growth factor 20,23910,115,1.17 [0.81-1.69],0.3984717572355342
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF21,Fibroblast growth factor 21,28542,126,0.98 [0.86-1.12],0.780557842713421
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF23,Fibroblast growth factor 23,28528,125,1.21 [0.96-1.53],0.1028736043088647
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF3,Fibroblast growth factor 3,23910,115,1.22 [0.74-2.03],0.4319924022658525
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF5,Fibroblast growth factor 5,27801,122,1.20 [0.76-1.92],0.4313023471444519
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF6,Fibroblast growth factor 6,23910,115,1.06 [0.71-1.59],0.7745164297007296
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF7,Fibroblast growth factor 7,23740,114,1.01 [0.81-1.27],0.900071895066084
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF9,Fibroblast growth factor 9,23692,114,1.09 [0.70-1.70],0.6986124921429755
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFBP1,Fibroblast growth factor-binding protein 1,28391,125,0.87 [0.54-1.40],0.5552607013633697
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFBP2,Fibroblast growth factor-binding protein 2,24601,117,1.06 [0.75-1.50],0.7393002171670358
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFBP3,Fibroblast growth factor-binding protein 3,24539,118,0.81 [0.50-1.30],0.3822947309481259
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFR2,Fibroblast growth factor receptor 2,28391,125,0.90 [0.44-1.85],0.7822378537020969
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFR4,Fibroblast growth factor receptor 4,24061,114,1.09 [0.78-1.53],0.6139741199063846
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGL1,Fibrinogen-like protein 1,24634,116,1.23 [0.93-1.62],0.155178376782897
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGR,Tyrosine-protein kinase Fgr,27654,122,1.07 [0.84-1.37],0.5792129370422983
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FH,"Fumarate hydratase, mitochondrial",23828,117,0.95 [0.76-1.20],0.6826101412420214
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FHIP2A,FHF complex subunit HOOK interacting protein 2A,23828,115,0.84 [0.57-1.26],0.4083491733220346
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FHIT,Bis(5'-adenosyl)-triphosphatase,27654,122,1.00 [0.80-1.24],0.9977769781858932
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FIS1,Mitochondrial fission 1 protein,28295,125,1.06 [0.87-1.29],0.5819710723176093
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24574,116,1.05 [0.88-1.25],0.5895438547435252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,28435,122,1.00 [0.87-1.15],0.9680835495529252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,28132,127,1.08 [0.75-1.54],0.684700818024305
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,28132,127,1.09 [0.92-1.29],0.3107777828720028
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,27604,122,1.30 [1.00-1.70],0.0541416265407193
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBPL,FK506-binding protein-like,24515,118,1.04 [0.77-1.39],0.8134193308988755
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLI1,Friend leukemia integration 1 transcription factor,27634,122,1.04 [0.90-1.20],0.5689116457492256
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,28132,127,1.10 [0.63-1.90],0.7434774333980352
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLT1,Vascular endothelial growth factor receptor 1,28154,126,0.79 [0.37-1.68],0.5462233578464302
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLT3,Receptor-type tyrosine-protein kinase FLT3,27634,122,0.83 [0.48-1.43],0.4958264417331038
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLT3LG,Fms-related tyrosine kinase 3 ligand,28663,125,1.01 [0.63-1.61],0.9757860436431572
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLT4,Vascular endothelial growth factor receptor 3,28391,125,1.08 [0.68-1.71],0.7467006370983655
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FMNL1,Formin-like protein 1,27654,122,0.94 [0.73-1.22],0.6486954185266716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FMR1,Synaptic functional regulator FMR1,27634,122,1.14 [0.73-1.78],0.5788027758248803
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FN1,Fibronectin,24647,118,0.45 [0.23-0.86],0.015862192579769
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FNDC1,Fibronectin type III domain-containing protein 1,24539,118,1.20 [0.82-1.75],0.3405468630071029
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24494,116,1.44 [0.97-2.15],0.0730197181105112
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOLH1,Glutamate carboxypeptidase 2,23910,115,0.96 [0.81-1.15],0.6779157645007909
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOLR1,Folate receptor alpha,28254,125,1.24 [0.71-2.17],0.4451602258213081
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOLR2,Folate receptor beta,28593,126,1.62 [0.96-2.73],0.0729567667575857
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOLR3,Folate receptor gamma,28300,123,0.99 [0.91-1.07],0.7484013590625671
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOS,Proto-oncogene c-Fos,23692,114,0.91 [0.55-1.51],0.7271813106974272
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOSB,Protein fosB,27654,122,1.03 [0.69-1.54],0.8803792058291835
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOXJ3,Forkhead box protein J3,23910,115,0.97 [0.65-1.43],0.8595281397576945
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOXO1,Forkhead box protein O1,28308,124,1.03 [0.86-1.24],0.7582674954340678
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOXO3,Forkhead box protein O3,27634,122,0.96 [0.81-1.13],0.6093377041578965
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FRMD4B,FERM domain-containing protein 4B,23828,115,0.94 [0.72-1.22],0.6241278429203295
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FRMD7,FERM domain-containing protein 7,23924,115,0.88 [0.51-1.52],0.6495203035877024
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FRZB,Secreted frizzled-related protein 3,28035,127,1.37 [0.75-2.53],0.3066628166823756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FSHB,Follitropin subunit beta,23928,116,1.18 [0.89-1.56],0.2507101975883246
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FST,Follistatin,28407,126,0.97 [0.71-1.33],0.8606029183857183
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FSTL1,Follistatin-related protein 1,23928,116,0.67 [0.31-1.45],0.311086984884296
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FSTL3,Follistatin-related protein 3,28263,126,0.92 [0.55-1.56],0.7610359650846006
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FTCD,Formimidoyltransferase-cyclodeaminase,24499,118,0.90 [0.73-1.11],0.3352700149805134
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUCA1,Tissue alpha-L-fucosidase,28478,126,0.99 [0.82-1.19],0.8928839459530814
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUOM,Fucose mutarotase,24061,114,0.84 [0.64-1.12],0.2418228911973029
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FURIN,Furin,28391,125,0.85 [0.54-1.34],0.4930288822781946
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUS,RNA-binding protein FUS,27583,121,1.15 [0.78-1.69],0.4828869849787232
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24115,114,1.10 [0.85-1.42],0.4777665844045455
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,28593,126,1.00 [0.70-1.41],0.9813257774333126
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUT8,"Alpha-(1,6)-fucosyltransferase",28132,127,1.10 [0.84-1.43],0.5001230031976689
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FXN,"Frataxin, mitochondrial",28579,126,1.09 [0.88-1.34],0.4304644178096056
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FXYD5,FXYD domain-containing ion transport regulator 5,27801,122,1.07 [0.84-1.36],0.5636608665578648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FYB1,FYN-binding protein 1,28272,126,1.00 [0.84-1.18],0.9998614866400234
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FZD10,Frizzled-10,23924,115,0.94 [0.68-1.29],0.6877818521488346
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FZD8,Frizzled-8,23828,117,0.82 [0.52-1.31],0.4081670693971772
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24494,116,1.29 [0.95-1.75],0.0973899160730592
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24157,114,0.95 [0.72-1.26],0.7401747838569246
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,23828,117,1.12 [0.88-1.42],0.3519027378994912
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAD1,Glutamate decarboxylase 1,23740,114,0.95 [0.48-1.90],0.8903659267070944
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAD2,Glutamate decarboxylase 2,23910,115,0.83 [0.54-1.29],0.4137764254176542
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24157,114,0.83 [0.54-1.28],0.3948039881615801
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,23928,116,1.16 [0.84-1.60],0.35856832326241
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAGE2A,G antigen 2A,23740,114,0.97 [0.71-1.31],0.8310032562712079
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAL,Galanin peptides,28450,126,1.06 [0.84-1.35],0.6172495214441922
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,28200,126,1.00 [0.57-1.74],0.9979893682028724
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,28579,126,0.67 [0.37-1.22],0.1920118296747048
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,27801,122,1.34 [0.93-1.95],0.1172079211244897
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24611,115,1.49 [0.79-2.79],0.2180647762198381
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT7,N-acetylgalactosaminyltransferase 7,28200,126,0.93 [0.44-1.99],0.8596991029081154
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAMT,Guanidinoacetate N-methyltransferase,23828,115,1.01 [0.62-1.64],0.9570424763284566
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23550,110,1.36 [0.74-2.50],0.3248996304256907
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GART,Trifunctional purine biosynthetic protein adenosine-3,24574,116,0.67 [0.31-1.44],0.3061831288635483
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAS2,Growth arrest-specific protein 2,24157,114,0.87 [0.59-1.26],0.4534488656599059
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAS6,Growth arrest-specific protein 6,28472,126,0.89 [0.48-1.64],0.7012183048519938
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GASK1A,Golgi-associated kinase 1A,23828,115,1.03 [0.68-1.55],0.8851208184062171
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAST,Gastrin,24539,118,1.05 [0.91-1.21],0.5095506659921953
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,23740,114,1.01 [0.51-2.00],0.9748492046841316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",23928,116,0.97 [0.77-1.22],0.7855305169812435
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBA,Lysosomal acid glucosylceramidase,23924,115,1.03 [0.74-1.42],0.8809791005077079
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBP1,Guanylate-binding protein 1,24493,117,0.91 [0.70-1.20],0.513141921552454
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBP2,Guanylate-binding protein 2,27801,122,1.15 [0.89-1.49],0.2697317581103846
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBP4,Guanylate-binding protein 4,27654,122,0.99 [0.71-1.38],0.9423261053380164
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBP6,Guanylate-binding protein 6,23828,115,0.96 [0.63-1.45],0.8345806811552337
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GC,Vitamin D-binding protein,24647,118,1.16 [0.59-2.25],0.6678128040763157
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCC1,GRIP and coiled-coil domain-containing protein 1,24539,118,1.01 [0.86-1.19],0.8779999387298824
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCG,Pro-glucagon,27634,122,1.06 [0.93-1.21],0.3585035006605059
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23468,112,0.92 [0.64-1.33],0.6528689539348743
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCLM,Glutamate--cysteine ligase regulatory subunit,23828,115,1.16 [0.82-1.65],0.3983519711848003
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",28200,126,0.98 [0.62-1.55],0.9376909370160448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GDF15,Growth/differentiation factor 15,28675,127,1.27 [0.92-1.76],0.1436329564817315
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GDF2,Growth/differentiation factor 2,28326,123,0.76 [0.49-1.20],0.2417966104160378
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GDNF,Glial cell line-derived neurotrophic factor,27654,122,1.01 [0.66-1.54],0.955183482810716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GET3,ATPase GET3,24611,115,1.17 [0.88-1.56],0.2838473622768701
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFAP,Glial fibrillary acidic protein,27592,122,1.25 [0.88-1.77],0.2207673457107116
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFER,FAD-linked sulfhydryl oxidase ALR,27634,122,1.07 [0.84-1.36],0.6009770192783856
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,27634,122,0.93 [0.80-1.07],0.2973878407640437
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFRA1,GDNF family receptor alpha-1,28542,126,1.62 [0.93-2.81],0.0873794383861322
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFRA2,GDNF family receptor alpha-2,28200,126,1.02 [0.48-2.19],0.953420102279814
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFRA3,GDNF family receptor alpha-3,28039,127,0.59 [0.33-1.04],0.0698961066089418
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFRAL,GDNF family receptor alpha-like,23823,117,0.89 [0.67-1.19],0.4468590112832847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGA1,ADP-ribosylation factor-binding protein GGA1,27654,122,1.05 [0.84-1.30],0.6918824901593557
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGACT,Gamma-glutamylaminecyclotransferase,24611,115,0.95 [0.74-1.23],0.7154653210249482
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGCT,Gamma-glutamylcyclotransferase,24569,115,0.95 [0.66-1.37],0.7912926618105196
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGH,Gamma-glutamyl hydrolase,27801,124,1.17 [0.74-1.84],0.5081375718100157
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGT1,Glutathione hydrolase 1 proenzyme,28262,124,1.13 [0.84-1.53],0.4136429765022912
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGT5,Glutathione hydrolase 5 proenzyme,28132,127,1.44 [0.76-2.73],0.2689572796865798
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GH1,Somatotropin,28293,123,1.09 [1.00-1.18],0.0518008898705112
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GH2,Growth hormone variant,27634,122,0.97 [0.88-1.07],0.5639814336855143
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GHR,Growth hormone receptor,24061,114,1.00 [0.54-1.87],0.99653655881693
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GHRHR,Growth hormone-releasing hormone receptor,27654,122,0.98 [0.73-1.32],0.9104967892501048
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GHRL,Appetite-regulating hormone,28326,123,0.95 [0.78-1.16],0.6073158464391168
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GID8,Glucose-induced degradation protein 8 homolog,24574,116,1.21 [0.76-1.90],0.4199981099430911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIGYF2,GRB10-interacting GYF protein 2,24574,116,0.98 [0.78-1.23],0.8591788635517456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIMAP7,GTPase IMAP family member 7,24061,114,0.91 [0.52-1.61],0.7551950097297264
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIMAP8,GTPase IMAP family member 8,23740,114,0.98 [0.68-1.41],0.9080335748412126
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIP,Gastric inhibitory polypeptide,23928,116,1.49 [1.03-2.16],0.0329867513534607
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIPC2,PDZ domain-containing protein GIPC2,24539,118,1.10 [0.61-1.98],0.7440539084893604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIPC3,PDZ domain-containing protein GIPC3,24515,118,0.99 [0.83-1.18],0.9431313025490808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIPR,Gastric inhibitory polypeptide receptor,23910,115,0.93 [0.62-1.39],0.7314299628129843
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIT1,ARF GTPase-activating protein GIT1,23910,115,1.06 [0.88-1.27],0.5458473914188084
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GJA8,Gap junction alpha-8 protein,23740,114,1.17 [0.91-1.50],0.2244443415637194
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GKN1,Gastrokine-1,27117,121,1.22 [0.68-2.18],0.5046437494102599
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLA,Alpha-galactosidase A,24009,114,0.80 [0.50-1.29],0.3574221653955582
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLB1,Beta-galactosidase,28132,127,0.81 [0.56-1.19],0.2830823330936114
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLI2,Zinc finger protein GLI2,23910,115,0.73 [0.40-1.33],0.3027749823735552
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLO1,Lactoylglutathione lyase,27821,121,1.23 [0.94-1.61],0.134809096126116
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLOD4,Glyoxalase domain-containing protein 4,28252,125,1.03 [0.67-1.60],0.8881756631845991
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLP1R,Glucagon-like peptide 1 receptor,23828,117,0.92 [0.56-1.50],0.7268221525086246
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLRX,Glutaredoxin-1,28151,121,1.04 [0.79-1.37],0.769537657450553
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24061,114,1.09 [0.90-1.33],0.367182609535909
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,27654,122,0.96 [0.67-1.37],0.8176076785552364
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLYR1,Putative oxidoreductase GLYR1,24494,116,0.86 [0.62-1.19],0.364671600323176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GM2A,Ganglioside GM2 activator,24026,115,1.37 [0.95-1.96],0.0879444670053042
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GMFG,Glia maturation factor gamma,24611,115,1.10 [0.86-1.41],0.4313115948954976
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GMPR,GMP reductase 1,28663,125,0.89 [0.65-1.21],0.4428106199434718
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GMPR2,GMP reductase 2,24061,114,1.10 [0.85-1.44],0.4703201647949852
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNAS,Neuroendocrine secretory protein 55,24574,116,1.01 [0.83-1.23],0.9138226586111436
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,27634,122,1.17 [0.93-1.48],0.1883642344205204
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,23924,115,1.12 [0.82-1.52],0.4806776663415564
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNLY,Granulysin,28313,126,0.88 [0.66-1.19],0.409291342229797
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNPDA1,Glucosamine-6-phosphate isomerase 1,23928,116,1.04 [0.62-1.74],0.8956381195508556
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNPDA2,Glucosamine-6-phosphate isomerase 2,24061,114,1.05 [0.65-1.70],0.8272160997344299
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GOLGA3,Golgin subfamily A member 3,24574,116,1.15 [0.93-1.44],0.195516964078606
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GOLM2,Protein GOLM2,28593,126,1.05 [0.52-2.11],0.8981630067505548
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,28308,124,1.04 [0.89-1.22],0.6071532698915105
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GORASP2,Golgi reassembly-stacking protein 2,24515,118,1.08 [0.75-1.55],0.6841668107502756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GOT1,"Aspartate aminotransferase, cytoplasmic",24601,117,0.73 [0.48-1.11],0.1430180070855977
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP1BA,Platelet glycoprotein Ib alpha chain,28188,127,1.07 [0.66-1.72],0.7827745453308917
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP1BB,Platelet glycoprotein Ib beta chain,23828,115,0.93 [0.71-1.21],0.5903705486142166
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,27459,119,0.83 [0.67-1.02],0.080277652125537
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP5,Platelet glycoprotein V,24061,114,1.47 [0.88-2.47],0.1449036564922298
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP6,Platelet glycoprotein VI,28272,126,1.06 [0.89-1.27],0.5146967316347381
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPA33,Cell surface A33 antigen,28200,126,0.88 [0.79-1.00],0.0430321461131121
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPC1,Glypican-1,28579,126,1.33 [0.78-2.27],0.2984994135474531
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPC5,Glypican-5,28132,127,0.99 [0.75-1.30],0.9316282612829938
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPD1,Glycerol-3-phosphate dehydrogenase,24494,116,1.05 [0.76-1.45],0.757481280891994
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPHA2,Glycoprotein hormone alpha-2,24515,118,1.09 [0.78-1.54],0.6063262691950901
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPI,Glucose-6-phosphate isomerase,24634,116,1.05 [0.73-1.51],0.780125289850941
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24515,118,1.04 [0.81-1.33],0.7768667773128628
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPKOW,G-patch domain and KOW motifs-containing protein,27654,122,1.09 [0.65-1.84],0.7307905369203793
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPNMB,Transmembrane glycoprotein NMB,27560,120,1.37 [0.77-2.43],0.2854491971274631
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPR101,Probable G-protein coupled receptor 101,23828,117,1.18 [0.94-1.49],0.1567641420566278
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPR158,Probable G-protein coupled receptor 158,24574,116,0.88 [0.52-1.50],0.647459229776648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPR15L,Protein GPR15L,24515,118,1.24 [0.95-1.63],0.1155146168074259
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPR37,Prosaposin receptor GPR37,27821,121,1.05 [0.82-1.35],0.6989969900904935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPRC5C,G-protein coupled receptor family C group 5 member C,24494,116,0.98 [0.72-1.34],0.9070011380621812
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRAP2,GRB2-related adapter protein 2,28326,123,1.07 [0.94-1.21],0.2931246771961031
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24611,115,1.02 [0.78-1.35],0.8722043418983207
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRIK2,"Glutamate receptor ionotropic, kainate 2",24574,116,1.06 [0.69-1.64],0.7813702777964062
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",23828,117,0.91 [0.64-1.28],0.5741943602014361
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRK5,G protein-coupled receptor kinase 5,27821,121,0.85 [0.60-1.19],0.3399183965064621
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRN,Progranulin,28171,124,0.80 [0.41-1.53],0.4973587017417801
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRP,Gastrin-releasing peptide,23928,116,0.81 [0.59-1.13],0.2249452115151496
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRPEL1,"GrpE protein homolog 1, mitochondrial",28200,126,1.10 [0.86-1.40],0.4588489105190148
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRSF1,G-rich sequence factor 1,23605,114,1.05 [0.84-1.30],0.6890471056647645
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSAP,Gamma-secretase-activating protein,27634,122,1.01 [0.84-1.21],0.9424846956327612
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSN,Gelsolin,24532,116,0.51 [0.20-1.27],0.1477023159333847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSR,"Glutathione reductase, mitochondrial",24500,115,0.92 [0.41-2.05],0.8367171424672679
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTA1,Glutathione S-transferase A1,28287,123,0.85 [0.70-1.03],0.1038589943517006
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTA3,Glutathione S-transferase A3,27634,122,0.99 [0.80-1.22],0.9046367245538868
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTM4,Glutathione S-transferase Mu 4,23828,115,1.22 [1.00-1.49],0.0532554140117372
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTP1,Glutathione S-transferase P,27476,120,1.15 [0.93-1.44],0.2017801347295602
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTT2B,Glutathione S-transferase theta-2B,24539,118,1.00 [0.93-1.07],0.9281519257697304
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24157,114,1.04 [0.81-1.32],0.7732128202262574
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GTPBP2,GTP-binding protein 2,23924,115,0.99 [0.79-1.23],0.9097116410830232
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GUCA2A,Guanylin,28179,126,1.05 [0.65-1.71],0.8290969561318364
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GUCY2C,Heat-stable enterotoxin receptor,24157,114,1.19 [1.00-1.42],0.0468879289274703
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GUK1,Guanylate kinase,23828,115,1.33 [0.97-1.81],0.0744780795608655
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GUSB,Beta-glucuronidase,28428,126,1.03 [0.80-1.34],0.8012860444444759
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GYS1,"Glycogen [starch] synthase, muscle",27821,121,1.03 [0.87-1.22],0.737337839994084
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GZMA,Granzyme A,28663,125,1.24 [0.79-1.94],0.3449220553375739
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GZMB,Granzyme B,28308,124,0.90 [0.70-1.16],0.4065959750533011
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GZMH,Granzyme H,27821,121,0.92 [0.73-1.15],0.4436486117638706
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,H2AP,Huntingtin-interacting protein M,23740,114,1.19 [0.89-1.58],0.2473394556760171
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",23828,115,0.70 [0.47-1.04],0.0781257721544829
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",28505,126,0.99 [0.80-1.23],0.9306643757144945
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HAO1,Hydroxyacid oxidase 1,28579,126,0.95 [0.84-1.07],0.3809363741735597
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HARS1,"Histidine--tRNA ligase, cytoplasmic",28313,126,1.07 [0.87-1.31],0.5097030981585657
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HAVCR1,Hepatitis A virus cellular receptor 1,28542,126,1.02 [0.79-1.32],0.8724692918448028
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HAVCR2,Hepatitis A virus cellular receptor 2,28313,126,1.23 [0.78-1.93],0.3720974303637486
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HBEGF,Proheparin-binding EGF-like growth factor,28505,126,0.91 [0.74-1.13],0.4053903016725062
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HBQ1,Hemoglobin subunit theta-1,28579,126,0.94 [0.73-1.22],0.6450831288765256
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HBZ,Hemoglobin subunit zeta,24611,115,1.05 [0.89-1.23],0.5896161476423472
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HCG22,Protein PBMUCL2,23828,115,1.17 [0.90-1.51],0.2379290068138083
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HCLS1,Hematopoietic lineage cell-specific protein,28663,125,1.28 [0.97-1.70],0.0837647402229249
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDAC8,Histone deacetylase 8,23910,115,0.99 [0.74-1.32],0.9454204622031124
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDAC9,Histone deacetylase 9,23828,117,1.01 [0.77-1.33],0.946621869285746
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDDC2,5'-deoxynucleotidase HDDC2,24515,118,1.31 [0.91-1.89],0.1441771054809047
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDGF,Hepatoma-derived growth factor,28547,126,0.97 [0.82-1.15],0.7150996096147101
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDGFL2,Hepatoma-derived growth factor-related protein 2,24539,118,1.05 [0.80-1.36],0.7433615669451338
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEBP1,Heme-binding protein 1,27821,121,0.97 [0.71-1.31],0.8293415255314766
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEG1,Protein HEG homolog 1,24061,114,0.75 [0.39-1.46],0.3987857633848363
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEPACAM2,HEPACAM family member 2,24539,118,0.88 [0.58-1.33],0.5359770270365445
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEPH,Hephaestin,24611,115,0.75 [0.42-1.32],0.3146836288721729
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEXIM1,Protein HEXIM1,28308,124,1.04 [0.86-1.26],0.7088973167536596
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HGF,Hepatocyte growth factor,28663,125,1.44 [0.94-2.23],0.0953385283855101
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HGFAC,Hepatocyte growth factor activator,24402,113,0.83 [0.44-1.56],0.5586302446350639
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,27634,122,1.10 [0.90-1.34],0.3533300200608237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HHEX,Hematopoietically-expressed homeobox protein HHEX,24539,118,1.05 [0.84-1.31],0.672357770986199
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HIF1A,Hypoxia-inducible factor 1-alpha,23910,115,0.71 [0.49-1.01],0.0582083179620835
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HIP1,Huntingtin-interacting protein 1,23828,115,0.56 [0.30-1.07],0.0800730030583952
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HIP1R,Huntingtin-interacting protein 1-related protein,24501,118,0.83 [0.53-1.28],0.3895456359906112
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HJV,Hemojuvelin,24574,116,0.85 [0.55-1.31],0.4659116058113692
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HK2,Hexokinase-2,27821,121,0.83 [0.46-1.49],0.524932796782967
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",24574,116,0.77 [0.45-1.32],0.3511530426748844
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",28216,124,1.07 [0.69-1.65],0.7685204934521901
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",28308,124,0.75 [0.41-1.35],0.3346372839310398
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMBS,Porphobilinogen deaminase,28579,126,0.85 [0.60-1.22],0.373306221586316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMCN2,Hemicentin-2,24014,113,0.77 [0.57-1.05],0.0939358975291272
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",23928,116,1.06 [0.76-1.50],0.7205433544305462
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",23828,115,1.15 [0.79-1.67],0.4696028953469242
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMMR,Hyaluronan mediated motility receptor,23700,114,1.30 [0.97-1.75],0.0796198605335464
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMOX1,Heme oxygenase 1,28005,121,0.98 [0.70-1.38],0.9254757582175532
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMOX2,Heme oxygenase 2,27654,122,0.98 [0.70-1.38],0.9128156340052088
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HNF1A,Hepatocyte nuclear factor 1-alpha,23924,115,0.96 [0.74-1.24],0.7511057070431004
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HNMT,Histamine N-methyltransferase,27996,127,0.96 [0.69-1.34],0.8156425069244574
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,27721,120,1.04 [0.85-1.27],0.7104844798244141
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24574,116,1.10 [0.78-1.53],0.5956058543357982
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HPCAL1,Hippocalcin-like protein 1,28663,125,1.07 [0.86-1.32],0.5537687700419246
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HPGDS,Hematopoietic prostaglandin D synthase,27634,122,0.86 [0.56-1.33],0.4968023453164935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HPSE,Heparanase,24284,115,1.05 [0.87-1.27],0.5985913984754514
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HRAS,GTPase Hras,24123,114,0.88 [0.71-1.10],0.2698495745574675
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,23928,116,1.47 [0.98-2.19],0.0617639610717916
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HRG,Histidine-rich glycoprotein,24515,118,0.77 [0.45-1.34],0.3571706066777148
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HS1BP3,HCLS1-binding protein 3,23928,116,1.03 [0.85-1.25],0.7549612435007859
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,28200,126,1.28 [0.85-1.92],0.2463551866457861
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,28579,126,0.71 [0.45-1.14],0.1552109578727332
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,23910,115,1.83 [1.15-2.93],0.0115306150345631
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSBP1,Heat shock factor-binding protein 1,23928,116,1.11 [0.93-1.34],0.2458703045234395
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,28308,124,1.07 [0.72-1.59],0.7347003941251475
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24539,118,1.03 [0.78-1.37],0.8140641001317002
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSD17B3,Testosterone 17-beta-dehydrogenase 3,23828,115,0.84 [0.57-1.26],0.4100470628074171
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,23928,116,0.94 [0.65-1.37],0.7524422559899269
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSP90B1,Endoplasmin,27523,122,1.03 [0.81-1.29],0.8230245608261392
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPA1A,Heat shock 70 kDa protein 1A,28395,126,1.03 [0.83-1.28],0.7766874615609769
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPA2,Heat shock-related 70 kDa protein 2,24494,116,1.42 [0.96-2.09],0.079365320005193
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPB1,Heat shock protein beta-1,27852,121,1.29 [1.01-1.66],0.0447347606262074
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPB6,Heat shock protein beta-6,28579,126,1.98 [1.39-2.81],0.0001409551018191
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,28091,125,1.08 [0.57-2.05],0.8034184411506055
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HTR1A,5-hydroxytryptamine receptor 1A,23828,117,0.78 [0.58-1.05],0.1064470187123963
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HTR1B,5-hydroxytryptamine receptor 1B,23828,117,0.99 [0.65-1.50],0.9535259160812642
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HTRA2,"Serine protease HTRA2, mitochondrial",28391,125,0.99 [0.77-1.28],0.9437172407123788
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HYAL1,Hyaluronidase-1,28135,127,0.78 [0.39-1.55],0.4831429164186848
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HYOU1,Hypoxia up-regulated protein 1,28675,127,1.16 [0.57-2.37],0.6821582495746104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICA1,Islet cell autoantigen 1,27801,122,1.05 [0.86-1.28],0.6283468658048162
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM1,Intercellular adhesion molecule 1,28190,126,1.47 [0.87-2.48],0.1504365398356505
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM2,Intercellular adhesion molecule 2,28675,127,1.29 [0.79-2.13],0.3082107540863601
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM3,Intercellular adhesion molecule 3,28675,127,0.68 [0.36-1.25],0.2146883428766572
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM4,Intercellular adhesion molecule 4,28308,124,0.99 [0.73-1.33],0.9385469412996824
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM5,Intercellular adhesion molecule 5,28326,123,0.95 [0.67-1.35],0.7772064388417356
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICOSLG,ICOS ligand,28200,126,0.79 [0.34-1.80],0.574221895776754
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ID4,DNA-binding protein inhibitor ID-4,24157,114,0.93 [0.60-1.42],0.725489559369632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IDI2,Isopentenyl-diphosphate delta-isomerase 2,27654,122,1.23 [0.90-1.69],0.1959763749597441
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IDO1,"Indoleamine 2,3-dioxygenase 1",23928,116,1.19 [0.92-1.55],0.1913859373324833
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IDS,Iduronate 2-sulfatase,28663,125,0.53 [0.10-2.82],0.4554479730338928
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IDUA,Alpha-L-iduronidase,28579,126,1.21 [0.86-1.70],0.2820633185546111
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,23939,115,0.90 [0.56-1.42],0.6391814332431676
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24157,114,0.89 [0.61-1.28],0.5181757821321779
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24157,114,1.24 [0.81-1.89],0.3219454176662371
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNAR1,Interferon alpha/beta receptor 1,24515,118,1.19 [0.62-2.28],0.6098282583022197
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNG,Interferon gamma,27801,122,0.99 [0.86-1.13],0.8498405227211484
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNGR1,Interferon gamma receptor 1,28450,126,0.77 [0.35-1.68],0.5048104684335483
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNGR2,Interferon gamma receptor 2,28132,127,0.89 [0.66-1.21],0.4541943268099541
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNL1,Interferon lambda-1,27654,122,0.94 [0.66-1.35],0.7459831164015067
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNL2,Interferon lambda-2,23828,117,1.02 [0.77-1.34],0.9105568723104656
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNLR1,Interferon lambda receptor 1,28308,124,0.65 [0.40-1.05],0.0764238492079424
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNW1,Interferon omega-1,23828,115,1.01 [0.61-1.66],0.9833208894548344
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFT20,Intraflagellar transport protein 20 homolog,23924,115,0.89 [0.59-1.36],0.5895171600590989
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGBP1,Immunoglobulin-binding protein 1,24574,116,1.09 [0.82-1.45],0.559996059194391
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,23828,117,0.79 [0.51-1.23],0.3020585550942039
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24601,117,2.10 [1.11-3.97],0.0221053544327606
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGF1R,Insulin-like growth factor 1 receptor,28200,126,0.67 [0.31-1.43],0.2998934630160738
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,23828,115,0.81 [0.53-1.26],0.3515392825554642
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGF2R,Cation-independent mannose-6-phosphate receptor,28313,126,0.66 [0.34-1.28],0.2219184002532404
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP1,Insulin-like growth factor-binding protein 1,28628,126,0.95 [0.84-1.08],0.4295451806262697
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP2,Insulin-like growth factor-binding protein 2,28621,127,1.22 [0.95-1.56],0.1256724121994974
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP3,Insulin-like growth factor-binding protein 3,28407,127,0.94 [0.55-1.60],0.8068278288600307
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP4,Insulin-like growth factor-binding protein 4,27952,125,1.35 [0.93-1.95],0.1104069672407782
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP6,Insulin-like growth factor-binding protein 6,28193,126,0.78 [0.44-1.39],0.4055109180035989
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP7,Insulin-like growth factor-binding protein 7,28675,127,0.99 [0.58-1.67],0.964216069188981
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBPL1,Insulin-like growth factor-binding protein-like 1,28326,123,0.85 [0.52-1.38],0.5090912266973029
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFL4,Insulin growth factor-like family member 4,23910,115,1.14 [0.94-1.38],0.1947340464293131
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGHMBP2,DNA-binding protein SMUBP-2,23828,115,0.91 [0.66-1.27],0.5928605298506775
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGLC2,Immunoglobulin lambda constant 2,24609,118,1.14 [0.60-2.15],0.6922413032961297
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGLON5,IgLON family member 5,23740,114,0.81 [0.62-1.05],0.1099548600098549
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGSF21,Immunoglobulin superfamily member 21,23928,116,1.07 [0.69-1.65],0.7653099925858255
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGSF3,Immunoglobulin superfamily member 3,28200,126,0.81 [0.51-1.30],0.384499448111274
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGSF8,Immunoglobulin superfamily member 8,28326,123,1.01 [0.60-1.71],0.961983674087634
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGSF9,Protein turtle homolog A,24611,115,0.93 [0.75-1.15],0.5021460078489068
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IKBKG,NF-kappa-B essential modulator,28308,124,0.96 [0.81-1.14],0.6622843273397583
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IKZF2,Zinc finger protein Helios,27634,122,0.95 [0.79-1.14],0.5792563950339935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL10,Interleukin-10,27801,122,0.95 [0.77-1.16],0.6113731063230927
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL10RA,Interleukin-10 receptor subunit alpha,27801,122,0.97 [0.73-1.29],0.8227520891493566
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL10RB,Interleukin-10 receptor subunit beta,28450,126,1.15 [0.66-1.98],0.6221054113106751
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL11,Interleukin-11,27801,122,1.05 [0.82-1.34],0.711460570467322
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL12A_IL12B,Interleukin-12,28200,126,0.91 [0.74-1.13],0.4097646588184831
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL12B,Interleukin-12 subunit beta,28663,125,0.93 [0.69-1.25],0.6254439232193552
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL12RB1,Interleukin-12 receptor subunit beta-1,27801,122,1.31 [0.86-2.01],0.212638054632069
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL12RB2,Interleukin-12 receptor subunit beta-2,23910,115,1.11 [0.74-1.67],0.6206077736680888
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL13,Interleukin-13,27801,122,0.76 [0.50-1.15],0.1908532857098589
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL13RA1,Interleukin-13 receptor subunit alpha-1,27946,122,0.85 [0.43-1.68],0.6377518894823506
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL13RA2,Interleukin-13 receptor subunit alpha-2,23828,117,0.71 [0.39-1.30],0.265717917857342
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL15,Interleukin-15,28308,124,1.18 [0.74-1.90],0.4838497859911079
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL15RA,Interleukin-15 receptor subunit alpha,27801,122,0.87 [0.55-1.39],0.5618087608146494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL16,Pro-interleukin-16,28663,125,0.94 [0.65-1.36],0.7453628836717402
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17A,Interleukin-17A,27757,122,1.10 [0.78-1.55],0.5906700117556216
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17C,Interleukin-17C,27801,122,1.10 [0.88-1.38],0.3896923906033989
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17D,Interleukin-17D,27801,122,0.77 [0.45-1.34],0.3581469931499822
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17F,Interleukin-17F,27801,122,1.21 [1.03-1.42],0.02242215069723
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17RA,Interleukin-17 receptor A,28313,126,1.19 [0.83-1.70],0.3343473523641418
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17RB,Interleukin-17 receptor B,27938,124,1.17 [0.87-1.57],0.2931047514569868
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL18,Interleukin-18,28205,126,0.96 [0.68-1.34],0.7946883753816296
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL18BP,Interleukin-18-binding protein,28407,127,1.28 [0.77-2.13],0.3367239778347026
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL18R1,Interleukin-18 receptor 1,28663,125,0.90 [0.56-1.44],0.6557983335448382
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL18RAP,Interleukin-18 receptor accessory protein,27951,127,1.03 [0.94-1.12],0.5769551639132664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL19,Interleukin-19,27628,117,1.13 [0.90-1.41],0.2939502842552004
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1A,Interleukin-1 alpha,27801,122,0.84 [0.60-1.17],0.3013982565617149
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1B,Interleukin-1 beta,27660,122,1.12 [0.86-1.46],0.388740160062061
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1R1,Interleukin-1 receptor type 1,28262,124,1.66 [0.84-3.26],0.1443189964459084
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1R2,Interleukin-1 receptor type 2,28258,125,0.73 [0.33-1.61],0.4335193575301462
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1RAP,Interleukin-1 receptor accessory protein,28313,126,1.34 [0.95-1.90],0.0952017111007997
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1RL1,Interleukin-1 receptor-like 1,28573,126,0.82 [0.59-1.14],0.2378291198990395
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1RL2,Interleukin-1 receptor-like 2,27801,122,0.97 [0.65-1.46],0.887270521050867
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1RN,Interleukin-1 receptor antagonist protein,28253,125,1.04 [0.79-1.38],0.7738600289356148
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL2,Interleukin-2,27801,122,1.02 [0.61-1.71],0.9306078522117528
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL20,Interleukin-20,27801,122,0.88 [0.62-1.25],0.4764980168950872
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL20RA,Interleukin-20 receptor subunit alpha,27801,122,0.91 [0.62-1.34],0.642237574159358
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL20RB,Interleukin-20 receptor subunit beta,23910,115,0.84 [0.55-1.30],0.4397622790447497
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL21R,Interleukin-21 receptor,23910,115,0.82 [0.56-1.22],0.3318941732224101
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL22,Interleukin-22,24494,116,1.20 [0.94-1.53],0.1379976562091597
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL22RA1,Interleukin-22 receptor subunit alpha-1,27801,122,0.86 [0.57-1.29],0.4550249315377764
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL24,Interleukin-24,27801,122,1.16 [0.85-1.58],0.3442642095110542
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL25,Interleukin-25,23655,114,0.69 [0.41-1.16],0.1601385963490722
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL2RA,Interleukin-2 receptor subunit alpha,28143,125,1.38 [0.95-2.01],0.0895985915050103
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL2RB,Interleukin-2 receptor subunit beta,27801,122,1.02 [0.67-1.56],0.9262695190462088
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL2RG,Cytokine receptor common subunit gamma,24494,116,1.31 [0.92-1.88],0.1363555495944838
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL3,Interleukin-3,23740,114,1.17 [0.86-1.61],0.3212508406891565
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL31,Interleukin-31,23910,115,1.07 [0.80-1.43],0.6677308682186427
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL31RA,Interleukin-31 receptor subunit alpha,23824,115,0.87 [0.56-1.37],0.5576414302474022
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL32,Interleukin-32,28308,124,1.06 [0.74-1.53],0.7515201751906138
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL33,Interleukin-33,27801,122,1.25 [0.84-1.87],0.2775844131075337
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL34,Interleukin-34,27603,122,1.46 [0.92-2.33],0.1097658056112011
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL36A,Interleukin-36 alpha,23910,115,1.06 [0.79-1.41],0.7075891467584787
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL36G,Interleukin-36 gamma,23830,115,1.21 [0.97-1.51],0.0916370120173114
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL3RA,Interleukin-3 receptor subunit alpha,27801,122,0.88 [0.53-1.47],0.6275532564718665
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL4,Interleukin-4,27801,122,1.48 [1.18-1.86],0.0008002762018022
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL4R,Interleukin-4 receptor subunit alpha,28308,124,1.21 [0.78-1.86],0.3932147502376307
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL5,Interleukin-5,27801,122,0.96 [0.85-1.08],0.492503335798201
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL5RA,Interleukin-5 receptor subunit alpha,28308,124,1.06 [0.79-1.41],0.714828661395541
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL6,Interleukin-6,28200,126,1.31 [1.12-1.52],0.0007188364048402
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL6R,Interleukin-6 receptor subunit alpha,28134,126,1.22 [0.77-1.92],0.4033348756228029
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL6ST,Interleukin-6 receptor subunit beta,28326,123,1.74 [0.73-4.15],0.2100738018694012
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL7,Interleukin-7,28308,124,0.99 [0.77-1.26],0.9124703610626984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL7R,Interleukin-7 receptor subunit alpha,28313,126,0.95 [0.71-1.28],0.7587659588547838
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL9,Interleukin-9,24157,114,1.25 [0.98-1.60],0.0738377980885517
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,27615,122,1.00 [0.76-1.31],0.9813963514826686
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IMMT,MICOS complex subunit MIC60,24494,116,1.20 [0.84-1.71],0.3267611025569956
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IMPA1,Inositol monophosphatase 1,28132,127,0.97 [0.75-1.26],0.8398433992572449
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IMPACT,Protein IMPACT,24539,118,0.99 [0.72-1.35],0.9436147797449042
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IMPG1,Interphotoreceptor matrix proteoglycan 1,23828,117,1.45 [0.92-2.30],0.1090432301076079
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ING1,Inhibitor of growth protein 1,27604,122,0.94 [0.66-1.34],0.7340827397242244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INHBB,Inhibin beta B chain,24061,114,1.03 [0.73-1.47],0.8498723040655312
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INHBC,Inhibin beta C chain,28313,126,0.89 [0.61-1.29],0.5259081772780737
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INPP1,Inositol polyphosphate 1-phosphatase,28200,126,0.96 [0.72-1.28],0.770848896441839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",23928,116,1.13 [0.83-1.52],0.439405452253085
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24574,116,1.07 [0.71-1.61],0.7607883734324482
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",28200,126,1.03 [0.88-1.21],0.7346297082823984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INSL3,Insulin-like 3,24539,118,0.78 [0.63-0.97],0.025164790946929
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INSL4,Early placenta insulin-like peptide,24494,116,1.00 [0.71-1.42],0.9863423156476278
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INSL5,Insulin-like peptide INSL5,24515,118,0.90 [0.75-1.09],0.2801367848988675
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INSR,Insulin receptor,23910,115,0.74 [0.25-2.19],0.5803469925385174
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IPCEF1,Interactor protein for cytohesin exchange factors 1,28083,127,1.06 [0.89-1.26],0.500918292179612
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IQGAP2,Ras GTPase-activating-like protein IQGAP2,28200,126,0.97 [0.73-1.29],0.8385969401485187
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",27821,121,0.94 [0.78-1.13],0.4949293599136658
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IRAK1,Interleukin-1 receptor-associated kinase 1,27801,122,1.06 [0.84-1.32],0.6364332571395678
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IRAK4,Interleukin-1 receptor-associated kinase 4,28308,124,1.07 [0.92-1.25],0.3949676088065561
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,27236,122,0.81 [0.53-1.24],0.3396340904082103
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ISM1,Isthmin-1,28308,124,0.79 [0.53-1.17],0.2323491549610257
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ISM2,Isthmin-2,24601,117,1.00 [0.67-1.49],0.997199118061142
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IST1,IST1 homolog,24338,118,1.07 [0.89-1.27],0.469214396487387
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGA11,Integrin alpha-11,28308,124,1.04 [0.65-1.64],0.8746943504962089
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGA2,Integrin alpha-2,24061,114,0.78 [0.46-1.32],0.3529749703129808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGA5,Integrin alpha-5,28313,126,0.62 [0.33-1.17],0.1414610312500153
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGA6,Integrin alpha-6,28308,124,1.05 [0.78-1.40],0.7638462891729987
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGAL,Integrin alpha-L,23910,115,1.28 [0.84-1.96],0.2523106840403502
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGAM,Integrin alpha-M,28313,126,0.73 [0.44-1.20],0.2131302237466282
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGAV,Integrin alpha-V,28579,126,0.44 [0.18-1.09],0.0767242274093276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGAX,Integrin alpha-X,24157,114,1.04 [0.74-1.46],0.816954981106983
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB1,Integrin beta-1,28267,126,0.86 [0.41-1.78],0.6754955310406187
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB1BP1,Integrin beta-1-binding protein 1,27634,122,0.99 [0.67-1.47],0.9576446760834048
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB1BP2,Integrin beta-1-binding protein 2,27821,121,1.10 [0.95-1.27],0.2112316962134853
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB2,Integrin beta-2,28153,125,0.80 [0.46-1.40],0.4424134509196054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB5,Integrin beta-5,28391,125,0.86 [0.57-1.31],0.4870131869388406
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB6,Integrin beta-6,27801,122,0.61 [0.36-1.05],0.0724386399552019
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB7,Integrin beta-7,28579,126,1.13 [0.81-1.58],0.4759488622717871
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGBL1,Integrin beta-like protein 1,24601,117,0.93 [0.57-1.51],0.7555816660692071
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24647,118,0.90 [0.36-2.26],0.8186408811020945
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,28407,127,1.07 [0.71-1.60],0.753138134393404
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24647,118,0.79 [0.39-1.59],0.5009446558573499
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24494,116,0.61 [0.39-0.96],0.0325919084498601
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITM2A,Integral membrane protein 2A,28308,124,0.96 [0.74-1.26],0.7883675377052447
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITPA,Inosine triphosphate pyrophosphatase,23828,115,0.90 [0.69-1.18],0.4453889810458151
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",23928,116,1.12 [0.89-1.42],0.3166467324036081
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",23828,117,1.09 [0.77-1.56],0.6239151236953663
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",27654,122,0.85 [0.60-1.20],0.3658757324882979
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IZUMO1,Izumo sperm-egg fusion protein 1,23740,114,0.97 [0.66-1.41],0.8671082994221869
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JAM2,Junctional adhesion molecule B,28593,126,0.85 [0.45-1.59],0.6016529141556783
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JAM3,Junctional adhesion molecule C,24061,114,0.93 [0.65-1.32],0.6706909022727927
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JCHAIN,Immunoglobulin J chain,27801,122,1.02 [0.78-1.32],0.8912523052176451
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,23740,114,1.01 [0.73-1.39],0.9515965733671689
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JPT2,Jupiter microtubule associated homolog 2,24515,118,1.06 [0.87-1.29],0.5953568815197103
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JUN,Transcription factor AP-1,27801,122,0.70 [0.46-1.04],0.0803287385502662
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,28200,126,1.23 [0.86-1.77],0.2548506702831016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KAZN,Kazrin,24515,118,1.00 [0.85-1.19],0.964493457872888
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KCNC4,Potassium voltage-gated channel subfamily C member 4,23828,117,1.18 [0.90-1.55],0.2412689512008198
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KCNH2,Potassium voltage-gated channel subfamily H member 2,23924,115,0.83 [0.62-1.11],0.2093525336571977
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KCNIP4,Kv channel-interacting protein 4,27654,122,0.88 [0.62-1.25],0.4913208604254548
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KCTD5,BTB/POZ domain-containing protein KCTD5,24063,115,0.64 [0.41-1.00],0.0487461373218806
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KDM3A,Lysine-specific demethylase 3A,23910,115,0.93 [0.76-1.15],0.5163300916927434
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KDR,Vascular endothelial growth factor receptor 2,28391,125,0.93 [0.51-1.69],0.8074054669324611
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KEL,Kell blood group glycoprotein,27654,122,0.79 [0.50-1.23],0.2939246694154853
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KHDC3L,KH domain-containing protein 3,23740,114,1.06 [0.82-1.36],0.6638031379675438
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KHK,Ketohexokinase,23928,116,0.92 [0.70-1.21],0.5627153882736466
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIAA0319,Dyslexia-associated protein KIAA0319,24539,118,0.84 [0.47-1.51],0.5585547901847365
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIAA1549,UPF0606 protein KIAA1549,24157,114,1.03 [0.80-1.33],0.827207742708606
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIAA1549L,UPF0606 protein KIAA1549L,24157,114,0.75 [0.39-1.47],0.4036536147684918
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIAA2013,Uncharacterized protein KIAA2013,24494,116,1.05 [0.77-1.41],0.7716329125077995
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIF1C,Kinesin-like protein KIF1C,23828,115,1.09 [0.69-1.72],0.7161199717212714
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIF20B,Kinesin-like protein KIF20B,23828,117,1.08 [0.87-1.35],0.4766323445665164
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIF22,Kinesin-like protein KIF22,23828,115,1.05 [0.90-1.22],0.5276895959895476
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIFBP,KIF-binding protein,28200,126,1.08 [0.89-1.31],0.4203477512160942
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24494,116,0.85 [0.69-1.05],0.1238184596456167
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,27634,122,1.01 [0.82-1.25],0.9434218501576552
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24515,118,0.98 [0.88-1.09],0.6965839525236801
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,27634,122,0.97 [0.85-1.11],0.6302754065594092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,23740,114,1.16 [0.98-1.37],0.0921842656371465
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIRREL1,Kin of IRRE-like protein 1,23828,117,1.00 [0.75-1.35],0.9827461339336968
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIRREL2,Kin of IRRE-like protein 2,27654,122,0.96 [0.64-1.44],0.8292891422826649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIT,Mast/stem cell growth factor receptor Kit,28372,127,0.82 [0.48-1.39],0.4515954673125653
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KITLG,Kit ligand,28326,123,1.07 [0.70-1.63],0.7520332524902382
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLB,Beta-klotho,27654,122,0.98 [0.79-1.22],0.8479405112868957
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLF4,Krueppel-like factor 4,23828,117,1.13 [0.75-1.70],0.5631462599104513
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLHL41,Kelch-like protein 41,24574,116,1.16 [0.85-1.58],0.355737190135473
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK1,Kallikrein-1,28036,125,1.04 [0.92-1.18],0.5251182650806969
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK10,Kallikrein-10,28303,125,0.67 [0.45-1.00],0.0512950454758599
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK11,Kallikrein-11,28115,124,1.05 [0.62-1.80],0.8471809624720078
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK12,Kallikrein-12,27634,122,1.05 [0.93-1.18],0.4435331237958316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK13,Kallikrein-13,27679,121,1.03 [0.71-1.48],0.8909975900578422
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK14,Kallikrein-14,28579,126,0.97 [0.69-1.36],0.8669241184797482
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK15,Kallikrein-15,24456,116,0.90 [0.63-1.28],0.5625273131237005
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK3,Prostate-specific antigen,24601,117,0.91 [0.74-1.13],0.413459563313425
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK4,Kallikrein-4,28579,126,1.13 [0.89-1.45],0.3149080787425229
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK6,Kallikrein-6,28351,125,1.08 [0.64-1.82],0.7858356326118379
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK7,Kallikrein-7,23436,110,1.10 [0.69-1.75],0.6911824782109581
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK8,Kallikrein-8,27363,123,1.29 [0.82-2.02],0.2691199450691364
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLKB1,Plasma kallikrein,24166,118,1.39 [0.70-2.78],0.3461308835728448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRB1,Killer cell lectin-like receptor subfamily B member 1,28663,125,1.02 [0.67-1.57],0.9167954683779644
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,23828,117,1.14 [0.88-1.46],0.324450114349078
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRD1,Natural killer cells antigen CD94,28663,125,1.03 [0.73-1.45],0.8589950771062288
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRF1,Killer cell lectin-like receptor subfamily F member 1,23910,115,1.15 [0.79-1.67],0.4770500752177665
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRK1,NKG2-D type II integral membrane protein,24539,118,1.13 [0.77-1.66],0.5403328038271995
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT14,"Keratin, type I cytoskeletal 14",26771,119,1.10 [0.64-1.87],0.7330896106787697
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT17,"Keratin, type I cytoskeletal 17",23828,115,1.15 [0.75-1.77],0.527585005120244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT18,"Keratin, type I cytoskeletal 18",28200,126,0.95 [0.78-1.15],0.6043132647453855
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT19,"Keratin, type I cytoskeletal 19",28270,124,1.26 [1.01-1.58],0.0401553274901926
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT5,"Keratin, type II cytoskeletal 5",27654,122,0.80 [0.58-1.12],0.1937668043109458
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT6C,"Keratin, type II cytoskeletal 6C",23828,115,0.99 [0.63-1.55],0.9719685781525468
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT8,"Keratin, type II cytoskeletal 8",23828,117,0.82 [0.59-1.12],0.2138683201457112
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KYAT1,Kynurenine--oxoglutarate transaminase 1,28271,123,0.93 [0.70-1.23],0.6037454077570918
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KYNU,Kynureninase,28663,125,0.82 [0.58-1.15],0.2488008713042087
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,L1CAM,Neural cell adhesion molecule L1,28391,125,0.88 [0.51-1.51],0.6447474216695137
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24611,115,1.05 [0.86-1.27],0.6399575779080622
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LACRT,Extracellular glycoprotein lacritin,24449,116,1.07 [0.75-1.53],0.7040065036461742
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LACTB2,Endoribonuclease LACTB2,28326,123,1.12 [0.89-1.41],0.348159624820112
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAG3,Lymphocyte activation gene 3 protein,28200,126,0.82 [0.55-1.22],0.3284989480449651
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,28305,126,0.92 [0.60-1.41],0.6938659058747194
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,28132,127,0.90 [0.78-1.04],0.1382362366243821
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMA1,Laminin subunit alpha-1,23828,115,0.91 [0.63-1.31],0.602911621512441
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMA4,Laminin subunit alpha-4,28450,126,1.02 [0.64-1.62],0.9252677916777176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMB1,Laminin subunit beta-1,23928,116,0.79 [0.45-1.39],0.4123786393425986
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMP1,Lysosome-associated membrane glycoprotein 1,23934,113,1.05 [0.56-1.96],0.8788332218942787
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMP2,Lysosome-associated membrane glycoprotein 2,27469,122,0.83 [0.37-1.89],0.6607699664733666
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMP3,Lysosome-associated membrane glycoprotein 3,28612,123,1.08 [0.80-1.46],0.5943620215974958
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMTOR5,Ragulator complex protein LAMTOR5,24494,116,0.70 [0.43-1.13],0.1465265997155493
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAP3,Cytosol aminopeptidase,27801,122,1.09 [0.79-1.51],0.6088201050150648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LARP1,La-related protein 1,24494,116,1.23 [0.97-1.55],0.0865841950758579
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAT,Linker for activation of T-cells family member 1,28663,125,1.04 [0.85-1.28],0.7151654726602625
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAT2,Linker for activation of T-cells family member 2,28200,126,1.05 [0.93-1.19],0.4249592017540958
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LATS1,Serine/threonine-protein kinase LATS1,23910,115,1.10 [0.90-1.36],0.3435632690652601
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAYN,Layilin,28082,127,1.51 [0.96-2.38],0.0722474537720284
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LBP,Lipopolysaccharide-binding protein,28407,127,1.08 [0.83-1.41],0.5687521678068268
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LBR,Delta(14)-sterol reductase LBR,28593,126,0.95 [0.76-1.20],0.6890103428691661
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LCAT,Phosphatidylcholine-sterol acyltransferase,24634,116,0.67 [0.30-1.48],0.321506365298244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LCN15,Lipocalin-15,24574,116,1.02 [0.77-1.35],0.9056085700739948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LCN2,Neutrophil gelatinase-associated lipocalin,27428,123,1.62 [1.12-2.35],0.0111676227316097
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LCP1,Plastin-2,24601,117,0.55 [0.37-0.82],0.0034178024977073
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LDLR,Low-density lipoprotein receptor,28400,126,0.90 [0.67-1.22],0.505935729618398
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24574,116,1.07 [0.89-1.27],0.4854936864561552
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LECT2,Leukocyte cell-derived chemotaxin-2,24611,115,0.89 [0.68-1.18],0.4309017233323348
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEFTY2,Left-right determination factor 2,28542,126,0.80 [0.60-1.08],0.1414537427208042
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEG1,Protein LEG1 homolog,23210,106,0.72 [0.54-0.95],0.0225225541947677
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LELP1,Late cornified envelope-like proline-rich protein 1,23828,117,0.98 [0.76-1.26],0.8683004568958473
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEO1,RNA polymerase-associated protein LEO1,24574,116,0.94 [0.50-1.77],0.8599871061523201
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEP,Leptin,28326,123,1.07 [0.85-1.35],0.5635714169161972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEPR,Leptin receptor,28326,123,0.78 [0.46-1.32],0.359656977806141
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LETM1,Mitochondrial proton/calcium exchanger protein,24574,116,1.28 [0.95-1.73],0.1103514394124296
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS1,Galectin-1,28326,123,1.29 [0.82-2.03],0.2647265146500593
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS3,Galectin-3,28396,126,0.94 [0.56-1.58],0.810297691842504
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS3BP,Galectin-3-binding protein,24647,118,0.63 [0.34-1.17],0.1449700887168786
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS4,Galectin-4,28305,126,0.99 [0.74-1.33],0.9647547506652786
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS7_LGALS7B,Galectin-7,28273,124,1.07 [0.73-1.56],0.7312332670938866
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS8,Galectin-8,28593,126,0.98 [0.76-1.26],0.8480509006662376
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS9,Galectin-9,28307,125,0.89 [0.54-1.47],0.6513486296263434
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGMN,Legumain,28450,126,0.91 [0.59-1.40],0.6572886030485914
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LHB,Lutropin subunit beta,27634,122,1.06 [0.90-1.26],0.4806801832969948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,28353,126,1.01 [0.77-1.31],0.97009947863193
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LIF,Leukemia inhibitory factor,27654,122,1.13 [0.85-1.49],0.4097605605373688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LIFR,Leukemia inhibitory factor receptor,28308,124,1.53 [0.82-2.83],0.1794351377617093
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,28313,126,1.04 [0.67-1.60],0.8658220927201691
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24601,117,1.12 [0.95-1.32],0.1799467330246814
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,23828,115,0.86 [0.59-1.26],0.4464480033732673
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,28293,123,0.78 [0.47-1.27],0.3156654300172741
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24611,115,1.01 [0.80-1.29],0.9124761757804551
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,28675,127,1.03 [0.59-1.82],0.9123190432837884
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,28519,126,1.58 [0.99-2.51],0.0548301854892415
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,27801,122,0.97 [0.67-1.43],0.894145480235896
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,28675,127,0.90 [0.73-1.12],0.3429555646617241
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LIPF,Gastric triacylglycerol lipase,23928,116,0.99 [0.73-1.33],0.9395296361748364
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LMNB1,Lamin-B1,24464,118,1.00 [0.76-1.32],0.9992353992490004
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LMNB2,Lamin-B2,24539,118,1.18 [0.64-2.18],0.5969919136918352
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LMOD1,Leiomodin-1,24574,116,0.95 [0.56-1.58],0.8314306583182558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LMOD2,Leiomodin-2,23828,117,0.88 [0.65-1.20],0.4271463981854707
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LONP1,"Lon protease homolog, mitochondrial",23928,116,1.10 [0.90-1.34],0.3664161963459417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPA,Apolipoprotein(a),24044,117,0.95 [0.86-1.05],0.3019184157561755
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPCAT2,Lysophosphatidylcholine acyltransferase 2,28200,126,0.90 [0.60-1.35],0.6179735381613981
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPL,Lipoprotein lipase,28326,123,1.02 [0.73-1.42],0.9124521200223992
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPO,Lactoperoxidase,27420,125,0.77 [0.59-1.00],0.0499659614162766
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPP,Lipoma-preferred partner,23828,115,0.99 [0.76-1.30],0.9533211482195836
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,23828,115,0.97 [0.75-1.26],0.833340359274688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,23924,115,0.56 [0.34-0.93],0.0244409289972672
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRG1,Leucine-rich alpha-2-glycoprotein,24647,118,1.94 [1.03-3.66],0.0410371501147493
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,28505,126,0.73 [0.46-1.15],0.169135989851562
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,23824,115,0.75 [0.37-1.50],0.4123964759821775
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRP1,Prolow-density lipoprotein receptor-related protein 1,28200,126,0.89 [0.49-1.60],0.6889546018306015
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRP11,Low-density lipoprotein receptor-related protein 11,28326,123,0.97 [0.62-1.53],0.90527379259937
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRP2,Low-density lipoprotein receptor-related protein 2,23924,115,0.72 [0.42-1.23],0.2328719041787462
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRP2BP,LRP2-binding protein,23924,115,0.97 [0.77-1.22],0.7781411208508483
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,28593,126,0.96 [0.72-1.28],0.7873417920165681
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRC25,Leucine-rich repeat-containing protein 25,28200,126,1.03 [0.69-1.54],0.8698628459241462
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24515,118,0.74 [0.49-1.11],0.1495879365065034
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRC38,Leucine-rich repeat-containing protein 38,23924,115,0.75 [0.50-1.12],0.1599376585389843
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRC59,Leucine-rich repeat-containing protein 59,24611,115,1.12 [0.79-1.60],0.5270468688012899
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24494,116,0.95 [0.66-1.37],0.7845896646210238
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRN1,Leucine-rich repeat neuronal protein 1,27801,122,0.94 [0.62-1.41],0.748851492613777
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,23924,115,0.92 [0.59-1.43],0.7038197057524762
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24574,116,0.72 [0.36-1.46],0.3633853186678157
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LSM1,U6 snRNA-associated Sm-like protein LSm1,27634,122,0.97 [0.73-1.30],0.8536749705020493
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LSM8,U6 snRNA-associated Sm-like protein LSm8,24157,114,0.89 [0.70-1.13],0.3193284122306836
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LSP1,Lymphocyte-specific protein 1,28308,124,1.20 [0.83-1.75],0.3361839117435494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTA,Lymphotoxin-alpha,28308,124,1.48 [1.03-2.14],0.0349634623139455
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTA4H,Leukotriene A-4 hydrolase,28579,126,1.07 [0.83-1.38],0.5947083100448294
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTB,Lymphotoxin-beta,24494,116,1.10 [0.68-1.79],0.6931346153279576
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTBP2,Latent-transforming growth factor beta-binding protein 2,28675,127,0.82 [0.49-1.37],0.447200934496802
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTBP3,Latent-transforming growth factor beta-binding protein 3,27634,122,1.16 [0.88-1.51],0.2881502570175478
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTBR,Tumor necrosis factor receptor superfamily member 3,28150,125,1.10 [0.62-1.95],0.752925886130297
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTO1,Protein LTO1 homolog,27801,122,1.26 [0.92-1.75],0.1537611635670336
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LUZP2,Leucine zipper protein 2,24494,116,0.83 [0.54-1.28],0.3984742576630843
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LXN,Latexin,27990,127,0.94 [0.74-1.19],0.5913726087398368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LY6D,Lymphocyte antigen 6D,28154,125,1.07 [0.70-1.64],0.7594862480661723
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LY75,Lymphocyte antigen 75,28308,124,0.92 [0.62-1.38],0.6980168274979037
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LY9,T-lymphocyte surface antigen Ly-9,28029,123,1.28 [0.74-2.21],0.3678701465672616
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LY96,Lymphocyte antigen 96,28132,127,1.07 [0.70-1.65],0.7551047242239204
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYAR,Cell growth-regulating nucleolar protein,27634,122,1.03 [0.77-1.37],0.8459816490188392
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYN,Tyrosine-protein kinase Lyn,28200,126,1.08 [0.90-1.30],0.392727850254242
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYPD1,Ly6/PLAUR domain-containing protein 1,27654,122,0.88 [0.66-1.17],0.3761250525343188
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYPD3,Ly6/PLAUR domain-containing protein 3,28176,125,1.17 [0.74-1.85],0.5065623587573373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYPD8,Ly6/PLAUR domain-containing protein 8,27634,122,0.95 [0.69-1.31],0.7502015986125214
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYPLA2,Acyl-protein thioesterase 2,23828,117,0.91 [0.76-1.10],0.3368992150271511
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,23924,115,1.10 [0.94-1.29],0.230949617964119
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24647,118,0.95 [0.39-2.36],0.918173063070706
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYZL2,Lysozyme-like protein 2,23740,114,1.04 [0.64-1.68],0.8835868895177783
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LZTFL1,Leucine zipper transcription factor-like protein 1,24061,114,1.04 [0.81-1.33],0.7432908187792358
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,M6PR,Cation-dependent mannose-6-phosphate receptor,23928,116,0.97 [0.62-1.53],0.9073880559188884
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,28043,127,0.82 [0.57-1.17],0.2757377576204617
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAEA,E3 ubiquitin-protein transferase MAEA,27634,122,1.12 [0.77-1.63],0.5600481369596204
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAG,Myelin-associated glycoprotein,23924,115,1.00 [0.68-1.47],0.9883283255349012
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAGEA3,Melanoma-associated antigen 3,24157,114,0.91 [0.75-1.11],0.3447608184825462
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAGED1,Melanoma-associated antigen D1,27634,122,1.20 [0.88-1.65],0.2450302749739336
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAMDC2,MAM domain-containing protein 2,24611,115,0.74 [0.43-1.28],0.2831990245395378
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAMDC4,Apical endosomal glycoprotein,24494,116,0.97 [0.71-1.32],0.8287033858621808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",23928,116,0.90 [0.45-1.79],0.7602729642156529
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAN2B2,Epididymis-specific alpha-mannosidase,24611,115,0.91 [0.68-1.23],0.5490519216408867
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",23740,114,0.98 [0.69-1.39],0.8987507049311602
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MANF,Mesencephalic astrocyte-derived neurotrophic factor,28450,126,1.04 [0.91-1.18],0.591468159213019
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MANSC1,MANSC domain-containing protein 1,28391,125,0.91 [0.51-1.61],0.7468782745235467
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MANSC4,MANSC domain-containing protein 4,23828,115,1.09 [0.83-1.44],0.5309215680967952
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,23828,117,1.52 [0.90-2.58],0.1193419413863523
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,23828,115,1.02 [0.78-1.34],0.866402802840617
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP2,Microtubule-associated protein 2,24539,118,1.17 [0.82-1.67],0.3843783117836434
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24515,118,1.07 [0.82-1.40],0.624897774731223
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,28308,124,1.06 [0.90-1.24],0.4733304225230791
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,27634,122,0.93 [0.78-1.09],0.3653378887286888
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,28082,127,1.03 [0.89-1.18],0.6882102565005773
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPK13,Mitogen-activated protein kinase 13,23740,114,0.81 [0.52-1.25],0.341054368296073
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPK9,Mitogen-activated protein kinase 9,28308,124,0.83 [0.58-1.19],0.3054543902765895
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPKAPK2,MAP kinase-activated protein kinase 2,24157,114,1.06 [0.83-1.35],0.6409119242012833
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPRE3,Microtubule-associated protein RP/EB family member 3,23740,114,0.98 [0.86-1.11],0.7167031240358585
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPT,Microtubule-associated protein tau,27654,122,1.12 [0.81-1.54],0.5001429844362737
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MARCO,Macrophage receptor MARCO,28326,123,1.31 [0.71-2.41],0.3830018463913126
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MARS1,"Methionine--tRNA ligase, cytoplasmic",24009,114,1.04 [0.85-1.28],0.6939531331878274
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MASP1,Mannan-binding lectin serine protease 1,28082,127,1.05 [0.54-2.04],0.8822195167945274
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MATN2,Matrilin-2,28355,126,1.36 [0.81-2.29],0.2466925559965629
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MATN3,Matrilin-3,28083,127,0.80 [0.49-1.31],0.3769867586836766
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAVS,Mitochondrial antiviral-signaling protein,27634,122,1.07 [0.90-1.27],0.4435588367104902
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAX,Protein max,27654,122,1.09 [0.93-1.26],0.2894649784196447
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MB,Myoglobin,28675,127,1.64 [1.30-2.06],2.4123407831726733e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MBL2,Mannose-binding protein C,24291,118,0.79 [0.68-0.93],0.0040385331871732
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCAM,Cell surface glycoprotein MUC18,28407,127,1.14 [0.71-1.81],0.5881335890142808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24574,116,1.32 [0.97-1.81],0.0764816063847874
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCEMP1,Mast cell-expressed membrane protein 1,23910,115,0.94 [0.77-1.15],0.5475239122069758
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCFD2,Multiple coagulation factor deficiency protein 2,28204,123,1.15 [0.81-1.63],0.429314528298567
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCTS1,Malignant T-cell-amplified sequence 1,24515,118,1.29 [0.69-2.42],0.4190920337799149
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,28132,127,1.13 [0.91-1.41],0.2759215006124628
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MDH1,"Malate dehydrogenase, cytoplasmic",24496,115,1.06 [0.69-1.62],0.8044527644156311
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MDK,Midkine,28299,125,1.15 [0.86-1.54],0.3296380263584142
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MDM1,Nuclear protein MDM1,23924,115,0.86 [0.48-1.53],0.5996893191722675
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",23928,116,1.06 [0.88-1.29],0.5296049580496818
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MED18,Mediator of RNA polymerase II transcription subunit 18,27634,122,1.12 [0.91-1.38],0.2965109818225265
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MED21,Mediator of RNA polymerase II transcription subunit 21,23828,115,1.23 [0.92-1.63],0.1592132884066852
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEGF10,Multiple epidermal growth factor-like domains protein 10,28305,126,2.23 [1.52-3.27],4.341319336142875e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEGF11,Multiple epidermal growth factor-like domains protein 11,23828,115,1.08 [0.64-1.85],0.7655365734035834
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEGF9,Multiple epidermal growth factor-like domains protein 9,28573,126,0.97 [0.46-2.05],0.9407748999415358
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MELTF,Melanotransferrin,24611,115,1.45 [0.80-2.63],0.2266275477730736
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MENT,Protein MENT,24061,114,0.87 [0.39-1.91],0.7207285732178121
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEP1A,Meprin A subunit alpha,24515,118,1.10 [0.87-1.40],0.4237578989930942
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEP1B,Meprin A subunit beta,28326,123,0.99 [0.87-1.14],0.9368525001113778
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEPE,Matrix extracellular phosphoglycoprotein,28305,126,0.64 [0.36-1.16],0.1443469234450823
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MERTK,Tyrosine-protein kinase Mer,28663,125,1.15 [0.62-2.12],0.6654151159712244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MESD,LRP chaperone MESD,28313,126,1.06 [0.94-1.21],0.3350815275705557
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MET,Hepatocyte growth factor receptor,28404,126,1.12 [0.51-2.49],0.7756236007615269
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,METAP1,Methionine aminopeptidase 1,27654,122,1.12 [0.67-1.87],0.6705333754198295
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",28308,124,1.11 [0.92-1.34],0.2823133658701635
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,METAP2,Methionine aminopeptidase 2,28542,126,1.02 [0.78-1.34],0.8718976589866376
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFAP3,Microfibril-associated glycoprotein 3,27821,121,1.07 [0.78-1.46],0.6762614603693812
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFAP3L,Microfibrillar-associated protein 3-like,23924,115,0.99 [0.76-1.30],0.9598631944204012
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFAP4,Microfibril-associated glycoprotein 4,24061,114,0.62 [0.35-1.10],0.1030885455815482
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFAP5,Microfibrillar-associated protein 5,28675,127,0.84 [0.57-1.23],0.3693964330154436
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFGE8,Lactadherin,28313,126,0.69 [0.49-0.99],0.0445834353462402
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MGLL,Monoglyceride lipase,28407,126,1.04 [0.87-1.24],0.702506523413397
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MGMT,Methylated-DNA--protein-cysteine methyltransferase,28308,124,1.13 [0.99-1.29],0.0783475718412586
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MIA,Melanoma-derived growth regulatory protein,28391,125,0.60 [0.40-0.89],0.0113967592578534
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MICALL2,MICAL-like protein 2,23924,115,0.99 [0.76-1.28],0.9185515260817838
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,28308,124,1.13 [0.99-1.29],0.0609213349436174
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MIF,Macrophage migration inhibitory factor,28264,126,1.06 [0.85-1.34],0.5932069332514234
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MILR1,Allergin-1,27801,122,1.54 [1.15-2.07],0.0034925030188088
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24494,116,0.98 [0.84-1.16],0.8396687828232268
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MINK1,Misshapen-like kinase 1,24539,118,1.04 [0.86-1.25],0.7144975199524158
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MITD1,MIT domain-containing protein 1,28132,127,1.04 [0.89-1.22],0.6144823426769532
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MKI67,Proliferation marker protein Ki-67,23910,115,0.56 [0.32-1.01],0.0521785352479307
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MLLT1,Protein ENL,23740,114,0.90 [0.68-1.18],0.4434770025383839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MLN,Promotilin,28308,124,1.18 [0.99-1.41],0.0651513666548751
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MME,Neprilysin,28200,126,0.99 [0.82-1.21],0.9388933515013136
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP1,Interstitial collagenase,27324,117,1.16 [0.96-1.40],0.1138479389383168
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP10,Stromelysin-2,28277,126,0.89 [0.68-1.17],0.417540617249619
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP12,Macrophage metalloelastase,28368,124,1.06 [0.78-1.44],0.7011442853734067
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP13,Collagenase 3,27654,122,1.41 [0.85-2.33],0.1827092569126917
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP15,Matrix metalloproteinase-15,24611,115,0.93 [0.63-1.37],0.722448688730339
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP3,Stromelysin-1,28313,126,0.93 [0.67-1.30],0.6758256087564521
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP7,Matrilysin,27778,121,0.88 [0.64-1.21],0.4284517485679177
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP8,Neutrophil collagenase,28551,125,1.33 [1.10-1.62],0.0035798617325364
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP9,Matrix metalloproteinase-9,28274,126,1.40 [1.08-1.81],0.0103139652695352
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",23828,115,1.01 [0.70-1.44],0.9724698613934156
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MN1,Transcriptional activator MN1,23924,115,1.19 [0.91-1.54],0.2014347940715231
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MNAT1,CDK-activating kinase assembly factor MAT1,24157,114,0.98 [0.65-1.46],0.9070456900350108
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MNDA,Myeloid cell nuclear differentiation antigen,28287,123,0.95 [0.81-1.12],0.5602078380598682
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MOCS2,Molybdopterin synthase catalytic subunit,24061,114,0.95 [0.73-1.24],0.7069611775158842
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MOG,Myelin-oligodendrocyte glycoprotein,28579,126,1.18 [0.73-1.90],0.5088616437473372
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MORC3,MORC family CW-type zinc finger protein 3,24539,118,1.13 [0.64-2.01],0.6737510986441044
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MORF4L1,Mortality factor 4-like protein 1,24157,114,1.14 [0.76-1.69],0.5278163417662605
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MORF4L2,Mortality factor 4-like protein 2,23740,114,0.94 [0.57-1.54],0.8010417338791926
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MORN4,MORN repeat-containing protein 4,23740,114,1.09 [0.89-1.32],0.4049668227319347
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPHOSPH8,M-phase phosphoprotein 8,27821,121,1.04 [0.84-1.28],0.7093487852652192
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPI,Mannose-6-phosphate isomerase,28200,126,1.10 [0.92-1.31],0.2938971157016435
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,28407,126,1.04 [0.84-1.28],0.7322191396217557
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPO,Myeloperoxidase,28313,126,1.17 [0.85-1.61],0.3371199494817191
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPRIP,Myosin phosphatase Rho-interacting protein,24452,116,1.10 [0.75-1.61],0.6235041094234837
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRC1,Macrophage mannose receptor 1,24634,116,0.86 [0.46-1.63],0.6460999236845226
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRI1,Methylthioribose-1-phosphate isomerase,23924,115,1.00 [0.77-1.31],0.975202971451806
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL24,"39S ribosomal protein L24, mitochondrial",23828,115,0.89 [0.54-1.45],0.6342123090756484
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL28,"39S ribosomal protein L28, mitochondrial",24574,116,0.81 [0.45-1.47],0.4875401649560291
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL46,"39S ribosomal protein L46, mitochondrial",27654,122,1.06 [0.59-1.88],0.8526667792016545
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL52,"39S ribosomal protein L52, mitochondrial",23700,114,1.01 [0.50-2.06],0.9756619537002066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24574,116,0.98 [0.77-1.26],0.8844135785730016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPS16,"28S ribosomal protein S16, mitochondrial",23910,115,1.12 [0.64-1.94],0.6978321896167502
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSLN,Mesothelin,28161,126,1.13 [0.86-1.48],0.3833990065734498
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSLNL,Mesothelin-like protein,23924,115,1.08 [0.67-1.74],0.7624645211455113
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSMB,Beta-microseminoprotein,28253,124,0.78 [0.62-0.97],0.0285822731830319
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSR1,Macrophage scavenger receptor types I and II,28593,126,1.29 [0.92-1.80],0.1467345987140622
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSRA,Mitochondrial peptide methionine sulfoxide reductase,28391,125,1.04 [0.84-1.29],0.714161548351433
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MST1,Hepatocyte growth factor-like protein,24270,113,0.86 [0.69-1.06],0.1527062757954549
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSTN,Growth/differentiation factor 8,27821,121,0.78 [0.57-1.06],0.1109557084092619
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTDH,Protein LYRIC,23910,115,1.07 [0.89-1.30],0.4666694200809049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24539,118,2.04 [1.35-3.08],0.0007431894771563
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24157,114,1.06 [0.91-1.24],0.4330149859655341
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTIF3,"Translation initiation factor IF-3, mitochondrial",24515,118,1.04 [0.85-1.26],0.7237183462894289
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTPN,Myotrophin,27821,121,0.65 [0.38-1.14],0.1336361620979212
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTR,Methionine synthase,23828,115,0.89 [0.66-1.21],0.4672162760208448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTSS1,Protein MTSS 1,24515,118,0.98 [0.84-1.15],0.8114558988065342
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTSS2,Protein MTSS 2,24494,116,1.05 [0.88-1.25],0.6044965556222368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTUS1,Microtubule-associated tumor suppressor 1,24157,114,1.06 [0.78-1.44],0.7183220441216058
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MUC13,Mucin-13,27654,122,0.80 [0.58-1.11],0.1811224854180559
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MUC16,Mucin-16,28200,126,0.97 [0.90-1.06],0.5407712150157624
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MUC2,Mucin-2,24601,117,0.77 [0.63-0.94],0.0118819789981073
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MUCL3,Mucin-like protein 3,23740,114,0.80 [0.49-1.29],0.357657218047707
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MVK,Mevalonate kinase,27801,122,1.01 [0.83-1.23],0.9335227606659048
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MXRA8,Matrix remodeling-associated protein 8,24061,114,0.86 [0.48-1.55],0.6218975578057631
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYBPC1,"Myosin-binding protein C, slow-type",24611,115,1.56 [1.28-1.90],8.61294414962151e-06
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYBPC2,"Myosin-binding protein C, fast-type",23928,116,1.27 [1.08-1.49],0.0037186513924307
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24574,116,1.12 [0.87-1.43],0.3800223571515305
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYDGF,Myeloid-derived growth factor,24611,115,1.09 [0.92-1.30],0.3251967663512551
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYH4,Myosin-4,23828,115,0.78 [0.49-1.22],0.2777253297295081
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYH7B,Myosin-7B,23740,114,1.02 [0.69-1.53],0.9052018973241
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYH9,Myosin-9,24601,117,0.99 [0.85-1.16],0.9484851739473308
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",23828,115,1.20 [0.83-1.74],0.3411559223556957
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYL3,Myosin light chain 3,23928,116,1.53 [1.23-1.90],0.0001084868153882
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYL4,Myosin light chain 4,23928,116,1.21 [0.90-1.64],0.2087986027786547
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYL6B,Myosin light chain 6B,23924,115,1.01 [0.84-1.23],0.8830222558037303
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",23924,115,1.43 [1.11-1.85],0.0061782662062901
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYO6,Unconventional myosin-VI,24574,116,1.02 [0.65-1.61],0.9224009887058736
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYO9B,Unconventional myosin-IXb,27801,122,1.01 [0.79-1.28],0.9387642209376748
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYOC,Myocilin,28313,126,0.78 [0.56-1.10],0.1546439092592167
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYOM1,Myomesin-1,23828,117,1.33 [1.01-1.76],0.0444193690407631
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYOM2,Myomesin-2,23828,115,1.43 [1.11-1.85],0.0062471629396411
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYOM3,Myomesin-3,24061,114,1.46 [1.22-1.74],2.9274465248587632e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MZB1,Marginal zone B- and B1-cell-specific protein,28398,126,1.17 [0.86-1.59],0.307200525552602
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MZT1,Mitotic-spindle organizing protein 1,27634,122,0.91 [0.67-1.25],0.5740851312506209
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAA10,N-alpha-acetyltransferase 10,23828,115,1.21 [0.85-1.72],0.2858361121969293
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAA80,N-alpha-acetyltransferase 80,23924,115,0.96 [0.83-1.12],0.6261532472372808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAAA,N-acylethanolamine-hydrolyzing acid amidase,27994,127,0.83 [0.63-1.09],0.1828887634957464
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NACC1,Nucleus accumbens-associated protein 1,24494,116,0.88 [0.63-1.22],0.4455975219619056
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NADK,NAD kinase,28326,123,1.03 [0.79-1.36],0.8115888676683958
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAGA,Alpha-N-acetylgalactosaminidase,23873,115,0.85 [0.61-1.20],0.3592433861085452
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAGK,N-acetyl-D-glucosamine kinase,23884,116,0.97 [0.71-1.31],0.8230853456874052
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24061,114,1.63 [0.71-3.77],0.2510435374245818
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAMPT,Nicotinamide phosphoribosyltransferase,27634,122,1.12 [0.86-1.46],0.387508438341153
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAP1L4,Nucleosome assembly protein 1-like 4,24475,118,1.11 [0.72-1.71],0.6309962382648437
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAPRT,Nicotinate phosphoribosyltransferase,24539,118,1.17 [0.71-1.94],0.5413588614625465
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24574,116,1.21 [0.83-1.77],0.319320467728595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NBL1,Neuroblastoma suppressor of tumorigenicity 1,28391,125,1.26 [0.69-2.30],0.4521369163975065
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NBN,Nibrin,27801,122,1.15 [0.89-1.48],0.2792392566033004
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCAM1,Neural cell adhesion molecule 1,28407,127,0.89 [0.53-1.48],0.6443169994470281
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCAM2,Neural cell adhesion molecule 2,28313,126,1.51 [0.85-2.71],0.1626116349172266
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCAN,Neurocan core protein,28593,126,0.43 [0.29-0.64],2.989251385372768e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCF2,Neutrophil cytosol factor 2,28256,124,1.04 [0.87-1.24],0.6948970873602751
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCK2,Cytoplasmic protein NCK2,28450,126,1.06 [0.91-1.22],0.4467882854207471
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCLN,Nicalin,27801,122,0.75 [0.50-1.12],0.1559647817407835
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCR1,Natural cytotoxicity triggering receptor 1,28270,124,1.10 [0.71-1.71],0.6701277824333196
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24515,118,1.12 [0.66-1.87],0.6794343525941895
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCS1,Neuronal calcium sensor 1,28579,126,1.08 [0.62-1.88],0.7852319742600762
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDRG1,Protein NDRG1,27654,122,1.08 [0.88-1.33],0.4536051090859837
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24494,116,0.96 [0.71-1.29],0.7916262336583584
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,23861,115,1.50 [0.94-2.37],0.0858146214045386
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24515,118,0.95 [0.78-1.15],0.5885967968666297
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",27634,122,1.16 [0.98-1.37],0.0772533441075956
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEB,Nebulin,23828,115,1.51 [1.06-2.14],0.0215688286306824
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NECAP2,Adaptin ear-binding coat-associated protein 2,23828,115,1.08 [0.83-1.41],0.5542078041776682
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NECTIN1,Nectin-1,23910,115,1.26 [0.79-2.03],0.3302074177757446
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NECTIN2,Nectin-2,28293,123,1.15 [0.66-2.00],0.619357542789069
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NECTIN4,Nectin-4,28391,125,0.89 [0.52-1.53],0.680280849038172
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,23910,115,1.00 [0.69-1.46],0.997650458318294
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEDD9,Enhancer of filamentation 1,23910,115,0.97 [0.58-1.63],0.9134253189116194
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEFL,Neurofilament light polypeptide,27564,122,3.16 [2.66-3.76],1.294717387456869e-38
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEK7,Serine/threonine-protein kinase Nek7,24157,114,0.92 [0.71-1.20],0.5447061002318166
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NELL1,Protein kinase C-binding protein NELL1,28391,125,0.98 [0.67-1.44],0.9333226710417823
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NELL2,Protein kinase C-binding protein NELL2,28450,126,0.40 [0.22-0.70],0.0014655622287931
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NENF,Neudesin,24494,116,0.94 [0.79-1.12],0.4764879459068957
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEO1,Neogenin,24574,116,0.89 [0.40-1.98],0.7666905862885066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEXN,Nexilin,24634,116,1.02 [0.79-1.32],0.8537878467496436
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFASC,Neurofascin,28663,125,0.53 [0.30-0.94],0.0311159998574595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFAT5,Nuclear factor of activated T-cells 5,23910,115,0.90 [0.72-1.12],0.3481019844956473
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",28308,124,0.99 [0.84-1.16],0.864854880741331
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",27801,122,0.93 [0.71-1.23],0.6251809474209071
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFE2,Transcription factor NF-E2 45 kDa subunit,23928,116,1.00 [0.79-1.27],0.9973396300140736
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFIC,Nuclear factor 1 C-type,24574,116,1.09 [0.75-1.60],0.6505393900076453
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFKB1,Nuclear factor NF-kappa-B p105 subunit,23828,115,0.91 [0.72-1.16],0.4634654484844186
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24157,114,1.15 [0.89-1.47],0.2813333508283137
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFKBIE,NF-kappa-B inhibitor epsilon,27634,122,0.99 [0.72-1.38],0.96703428529452
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24515,118,1.06 [0.90-1.26],0.4785552021896603
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFX1,Transcriptional repressor NF-X1,23828,115,0.97 [0.74-1.27],0.8022778390051739
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFYA,Nuclear transcription factor Y subunit alpha,23828,115,0.80 [0.48-1.34],0.402179414739261
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NGF,Beta-nerve growth factor,28132,127,1.16 [0.34-4.00],0.8138243584081505
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NGFR,Tumor necrosis factor receptor superfamily member 16,24611,115,1.18 [0.69-2.02],0.5554617928522407
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NGRN,Neugrin,24539,118,0.78 [0.34-1.83],0.5739531233637762
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NHLRC3,NHL repeat-containing protein 3,23505,109,0.97 [0.54-1.74],0.9209993438578606
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NID1,Nidogen-1,28326,127,0.83 [0.55-1.26],0.3862017265568862
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NID2,Nidogen-2,28313,126,1.00 [0.81-1.24],0.9876966458336665
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NINJ1,Ninjurin-1,27634,122,1.01 [0.76-1.34],0.9635437675056522
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NIT1,Deaminated glutathione amidase,23928,116,1.03 [0.70-1.51],0.8925555470058838
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NIT2,Omega-amidase NIT2,24517,115,1.09 [0.86-1.38],0.4793169386535227
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NLGN1,Neuroligin-1,23924,115,0.88 [0.65-1.18],0.3866681503087595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NLGN2,Neuroligin-2,23828,117,0.95 [0.64-1.40],0.7918304474389173
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NME1,Nucleoside diphosphate kinase A,23910,115,1.33 [0.61-2.93],0.4753120521291141
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NME3,Nucleoside diphosphate kinase 3,28355,126,0.72 [0.36-1.45],0.3556840968008279
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NMI,N-myc-interactor,24390,116,0.99 [0.78-1.26],0.9321129984369108
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,28132,127,0.94 [0.76-1.17],0.5806587258006417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NMRK2,Nicotinamide riboside kinase 2,23740,114,0.82 [0.49-1.36],0.4421578862482477
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24574,116,1.12 [0.88-1.43],0.359939787571956
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOMO1,Nodal modulator 1,28313,126,0.63 [0.32-1.22],0.1684318937156814
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOP56,Nucleolar protein 56,23828,115,0.99 [0.84-1.16],0.8678182844713092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOS1,"Nitric oxide synthase, brain",27654,122,1.27 [0.96-1.67],0.089146058932318
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOS2,"Nitric oxide synthase, inducible",23828,115,1.01 [0.65-1.58],0.959590016918532
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOS3,"Nitric oxide synthase, endothelial",27654,122,1.07 [0.79-1.45],0.6660801505390127
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOTCH1,Neurogenic locus notch homolog protein 1,28675,127,0.95 [0.35-2.57],0.9263937544318054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOTCH2,Neurogenic locus notch homolog protein 2,24601,117,1.18 [0.53-2.61],0.6825007223426303
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOTCH3,Neurogenic locus notch homolog protein 3,28675,127,0.98 [0.62-1.54],0.9286424672671276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPC2,NPC intracellular cholesterol transporter 2,24197,115,1.75 [1.10-2.78],0.01867047663213
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPDC1,Neural proliferation differentiation and control protein 1,28326,123,1.27 [0.77-2.09],0.3512670032555597
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPHS1,Nephrin,23910,115,1.15 [0.70-1.89],0.5856480080911486
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPHS2,Podocin,23910,115,0.89 [0.73-1.08],0.2241990799025123
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPL,N-acetylneuraminate lyase,24611,115,0.81 [0.54-1.20],0.2934203360375879
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPPB,Natriuretic peptides B,27821,121,0.97 [0.86-1.10],0.6534245474276859
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPPC,C-type natriuretic peptide,28308,124,0.85 [0.60-1.20],0.3527096135635097
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPR1,Atrial natriuretic peptide receptor 1,23828,115,0.83 [0.52-1.34],0.4544416306136312
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPTN,Neuroplastin,27634,122,0.97 [0.79-1.19],0.7871802183378473
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPTX1,Neuronal pentraxin-1,28313,126,1.14 [0.79-1.65],0.4884751937383417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPTX2,Neuronal pentraxin-2,24601,117,0.53 [0.32-0.89],0.0153427337165178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPTXR,Neuronal pentraxin receptor,28326,123,0.67 [0.41-1.09],0.102847295242896
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPY,Pro-neuropeptide Y,28579,126,0.87 [0.69-1.09],0.2330496881313869
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRCAM,Neuronal cell adhesion molecule,28326,123,1.06 [0.61-1.87],0.830676606495101
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRGN,Neurogranin,24634,116,1.06 [0.88-1.28],0.5465724046979684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRN1,Neuritin,24574,116,1.10 [0.70-1.72],0.6812127277097522
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRP1,Neuropilin-1,28463,127,1.07 [0.61-1.87],0.8120707035477998
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRP2,Neuropilin-2,28313,126,0.58 [0.33-1.02],0.0593904499039415
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRTN,Neurturin,27801,122,0.65 [0.46-0.92],0.0155589283643737
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRXN3,Neurexin-3,23924,115,0.90 [0.53-1.55],0.7166708162105038
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NSFL1C,NSFL1 cofactor p47,28593,126,0.98 [0.77-1.25],0.876912873675467
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24611,115,1.20 [0.94-1.51],0.1379604104683387
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NT5C1A,Cytosolic 5'-nucleotidase 1A,24539,118,1.11 [0.65-1.88],0.7096852180626091
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NT5C3A,Cytosolic 5'-nucleotidase 3A,28258,124,1.05 [0.88-1.26],0.5923519994126871
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NT5E,5'-nucleotidase,28391,125,1.01 [0.76-1.34],0.9510732494169692
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTF3,Neurotrophin-3,28308,124,0.63 [0.39-1.01],0.0529228289550195
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTF4,Neurotrophin-4,27634,122,0.89 [0.57-1.40],0.6137338563406276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTRK2,BDNF/NT-3 growth factors receptor,28326,123,1.23 [0.66-2.28],0.5203449890412597
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTRK3,NT-3 growth factor receptor,28593,126,1.11 [0.54-2.29],0.7756766440937587
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTproBNP,N-terminal prohormone of brain natriuretic peptide,28326,123,0.97 [0.82-1.15],0.7417830970875104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUB1,NEDD8 ultimate buster 1,28308,124,1.05 [0.87-1.26],0.6129300193827131
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24494,116,1.08 [0.91-1.28],0.3674923961917881
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUCB2,Nucleobindin-2,28540,126,1.06 [0.70-1.60],0.7852333085009677
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDC,Nuclear migration protein nudC,28663,125,1.07 [0.84-1.37],0.5752980531616749
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,23928,116,1.05 [0.54-2.03],0.8867208602454397
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,23828,115,0.86 [0.58-1.28],0.4683174008510091
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT16,U8 snoRNA-decapping enzyme,24478,117,0.97 [0.80-1.19],0.7987056313777732
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],28200,126,1.08 [0.83-1.41],0.5731324244096402
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT5,ADP-sugar pyrophosphatase,28313,126,1.16 [0.86-1.56],0.3345898885400756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUMB,Protein numb homolog,23910,115,1.07 [0.86-1.32],0.5528648354661119
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUP50,Nuclear pore complex protein Nup50,23828,115,0.72 [0.38-1.36],0.3105877666373559
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NXPE4,NXPE family member 4,23828,115,0.99 [0.59-1.66],0.971701476671374
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NXPH1,Neurexophilin-1,27654,122,1.19 [0.80-1.77],0.3954707767789062
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NXPH3,Neurexophilin-3,23910,115,0.95 [0.53-1.72],0.8720812588265667
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OBP2B,Odorant-binding protein 2b,28033,127,0.84 [0.66-1.08],0.1675087807408996
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OCLN,Occludin,24574,116,0.99 [0.66-1.49],0.965120044298741
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ODAM,Odontogenic ameloblast-associated protein,27603,122,1.12 [0.85-1.47],0.412595296185448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OFD1,Oral-facial-digital syndrome 1 protein,24157,114,0.95 [0.71-1.25],0.6997754077468076
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OGA,Protein O-GlcNAcase,24515,118,1.10 [0.86-1.40],0.4578487370868453
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OGFR,Opioid growth factor receptor,28200,126,0.83 [0.51-1.35],0.4538957750939337
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OGN,Mimecan,28313,126,1.19 [0.81-1.75],0.3855181092304678
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24157,114,0.90 [0.66-1.22],0.4904831356764575
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OLFM4,Olfactomedin-4,23169,111,1.04 [0.90-1.21],0.6062501108348688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OLR1,Oxidized low-density lipoprotein receptor 1,28053,122,1.45 [1.17-1.80],0.0007907568876584
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OMD,Osteomodulin,28450,126,0.76 [0.54-1.07],0.117701145934725
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OMG,Oligodendrocyte-myelin glycoprotein,28200,126,0.85 [0.67-1.07],0.1742081287209491
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OMP,Olfactory marker protein,23828,117,1.21 [0.88-1.65],0.235436792864046
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OPHN1,Oligophrenin-1,24539,118,1.06 [0.91-1.25],0.4501966710235713
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OPLAH,5-oxoprolinase,23928,116,0.96 [0.74-1.24],0.7350193218295398
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OPTC,Opticin,28200,126,0.99 [0.69-1.41],0.9364135708597132
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ORM1,Alpha-1-acid glycoprotein 1,24563,118,1.80 [0.78-4.19],0.1711907500599425
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSBPL2,Oxysterol-binding protein-related protein 2,24539,118,0.58 [0.32-1.06],0.0786747658893164
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSCAR,Osteoclast-associated immunoglobulin-like receptor,28355,126,1.08 [0.68-1.73],0.7425980045062235
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSM,Oncostatin-M,28164,123,1.25 [1.01-1.56],0.0436429406488688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSMR,Oncostatin-M-specific receptor subunit beta,28463,127,2.35 [1.12-4.95],0.0242090618364956
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSTN,Osteocrin,23924,115,1.43 [1.09-1.88],0.0105245356086204
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OTOA,Otoancorin,23828,117,1.12 [0.82-1.52],0.4737726319281045
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OTUD6B,Deubiquitinase OTUD6B,24515,118,1.04 [0.77-1.39],0.8181396025959723
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OTUD7B,OTU domain-containing protein 7B,24574,116,1.12 [0.86-1.47],0.4059279971592779
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",23928,116,1.24 [0.97-1.58],0.0833351997891001
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OXT,Oxytocin-neurophysin 1,28593,126,0.95 [0.85-1.06],0.3908555268221706
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,P4HB,Protein disulfide-isomerase,28170,125,0.96 [0.64-1.43],0.8321137811939625
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PACS2,Phosphofurin acidic cluster sorting protein 2,23828,115,1.17 [0.89-1.55],0.2660611066924618
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PADI2,Protein-arginine deiminase type-2,27801,122,1.22 [0.99-1.50],0.0645937981092599
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PADI4,Protein-arginine deiminase type-4,27603,122,0.99 [0.80-1.23],0.9223546465360208
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAEP,Glycodelin,28132,127,1.04 [0.93-1.16],0.5215404719361648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24574,116,0.98 [0.84-1.15],0.8186806426972139
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24157,114,1.19 [0.85-1.68],0.3114396287926316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,27821,121,0.89 [0.66-1.19],0.4365898748255395
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAGR1,PAXIP1-associated glutamate-rich protein 1,23928,116,1.10 [0.75-1.61],0.6201445518004918
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23692,114,0.97 [0.69-1.37],0.8564965090871244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAK4,Serine/threonine-protein kinase PAK 4,27654,122,0.95 [0.73-1.24],0.6958137992065632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PALLD,Palladin,23910,115,1.15 [0.76-1.72],0.5071425334296868
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PALM,Paralemmin-1,24386,118,0.82 [0.46-1.47],0.5072000920221256
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PALM2,Paralemmin-2,24539,118,1.11 [0.71-1.73],0.6419753686088938
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PALM3,Paralemmin-3,23828,115,0.96 [0.75-1.23],0.7509742914044908
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAM,Peptidyl-glycine alpha-amidating monooxygenase,28533,127,1.08 [0.61-1.89],0.8022530318976728
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAMR1,Inactive serine protease PAMR1,28313,126,0.70 [0.40-1.22],0.2036527005189145
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAPPA,Pappalysin-1,27801,122,1.19 [0.85-1.67],0.3081075337483326
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PARD3,Partitioning defective 3 homolog,24157,114,1.02 [0.80-1.29],0.8961652264890482
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PARK7,Parkinson disease protein 7,28313,126,1.14 [0.85-1.53],0.374901955785876
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PARP1,Poly [ADP-ribose] polymerase 1,28308,124,1.18 [0.94-1.47],0.1538222130174727
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAXX,Protein PAXX,24061,114,1.00 [0.68-1.47],0.9989605457620436
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PBK,Lymphokine-activated killer T-cell-originated protein kinase,23740,114,1.36 [0.77-2.41],0.2857646001250978
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PBLD,Phenazine biosynthesis-like domain-containing protein,27654,122,1.02 [0.75-1.39],0.8832834285001879
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24515,118,0.52 [0.28-1.00],0.048970750446404
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCARE,Photoreceptor cilium actin regulator,23828,117,1.05 [0.87-1.27],0.6251630460563742
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24008,113,0.96 [0.66-1.39],0.8211112045190156
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCBP2,Poly(rC)-binding protein 2,24574,116,1.09 [0.86-1.39],0.472530936889848
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH1,Protocadherin-1,28571,123,0.72 [0.32-1.60],0.4165133908969447
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH12,Protocadherin-12,24574,116,1.22 [0.61-2.41],0.5754831868143294
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH17,Protocadherin-17,28326,123,0.87 [0.55-1.37],0.557480956025477
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH7,Protocadherin-7,24515,118,0.66 [0.37-1.19],0.170306555310748
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH9,Protocadherin-9,24515,118,0.88 [0.53-1.46],0.6206793622621737
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDHB15,Protocadherin beta-15,24494,116,0.90 [0.58-1.40],0.6395656078073348
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCNA,Proliferating cell nuclear antigen,23740,114,0.79 [0.56-1.12],0.1818770267099403
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCSK7,Proprotein convertase subtilisin/kexin type 7,24494,116,1.04 [0.71-1.53],0.8290414583992858
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCSK9,Proprotein convertase subtilisin/kexin type 9,28675,127,0.71 [0.48-1.05],0.0900513665615899
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24515,118,1.03 [0.82-1.29],0.8045078615461212
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24611,115,1.08 [0.90-1.29],0.4252765934715811
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCD1,Programmed cell death protein 1,28536,125,1.02 [0.70-1.50],0.9144362456096649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCD1LG2,Programmed cell death 1 ligand 2,28200,126,1.57 [0.97-2.56],0.0665072906061828
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCD5,Programmed cell death protein 5,28593,126,1.00 [0.76-1.30],0.9707000811952928
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCD6,Programmed cell death protein 6,28326,123,1.06 [0.83-1.34],0.6507320122888152
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCL2,Phosducin-like protein 2,23740,114,1.20 [0.90-1.60],0.2139247497877497
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",23740,114,1.00 [0.72-1.39],0.9872568754285588
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",23828,115,0.90 [0.65-1.24],0.5167711268859975
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24061,114,1.03 [0.87-1.23],0.7059928633541235
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFA,Platelet-derived growth factor subunit A,28675,127,1.00 [0.80-1.23],0.9757703840720612
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFB,Platelet-derived growth factor subunit B,28450,126,1.01 [0.84-1.21],0.9350372042066442
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFC,Platelet-derived growth factor C,27634,122,1.23 [0.72-2.09],0.4558968341963594
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFRA,Platelet-derived growth factor receptor alpha,28326,123,0.70 [0.39-1.25],0.2258723599319707
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFRB,Platelet-derived growth factor receptor beta,28675,127,1.20 [0.77-1.88],0.4233355428450036
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDIA2,Protein disulfide-isomerase A2,23740,114,1.19 [0.78-1.80],0.4201918663414427
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDIA3,Protein disulfide-isomerase A3,24061,114,0.96 [0.47-1.96],0.9018005040371324
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDIA4,Protein disulfide-isomerase A4,24601,117,1.14 [0.86-1.50],0.361418517933963
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDIA5,Protein disulfide-isomerase A5,23740,114,0.96 [0.71-1.30],0.7812678745999317
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDLIM5,PDZ and LIM domain protein 5,24574,116,1.05 [0.91-1.22],0.5138862740561951
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDLIM7,PDZ and LIM domain protein 7,28450,126,1.06 [0.94-1.20],0.3119360864955917
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",27634,122,1.01 [0.74-1.38],0.9703347686796822
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDRG1,p53 and DNA damage-regulated protein 1,23924,115,1.05 [0.75-1.45],0.787504478848428
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,23740,114,0.77 [0.50-1.19],0.2359097343331417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDZD2,PDZ domain-containing protein 2,23828,115,1.04 [0.77-1.40],0.7916655651402498
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,23910,115,0.78 [0.51-1.19],0.2474501277614217
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PEAR1,Platelet endothelial aggregation receptor 1,28675,127,0.98 [0.49-1.94],0.9429842440609624
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PEBP1,Phosphatidylethanolamine-binding protein 1,28313,126,1.06 [0.81-1.38],0.6918877397172531
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PECAM1,Platelet endothelial cell adhesion molecule,28313,126,0.79 [0.47-1.34],0.3799454834880439
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PECR,Peroxisomal trans-2-enoyl-CoA reductase,23928,116,0.79 [0.41-1.52],0.4784252373652936
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PENK,Proenkephalin-A,24061,114,0.92 [0.50-1.70],0.7877066253389604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PEPD,Xaa-Pro dipeptidase,24634,116,0.90 [0.46-1.76],0.7500920949593749
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PER3,Period circadian protein homolog 3,23910,115,1.02 [0.88-1.19],0.774254014193406
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PF4,Platelet factor 4,24464,118,1.01 [0.84-1.20],0.9433649754512984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PFDN2,Prefoldin subunit 2,27654,122,1.16 [0.88-1.54],0.2877242561313075
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PFDN4,Prefoldin subunit 4,23740,114,0.98 [0.70-1.37],0.913138794865457
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PFDN6,Prefoldin subunit 6,23924,115,0.96 [0.72-1.27],0.7555890643135269
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",28160,126,1.04 [0.85-1.27],0.7252077837348192
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGA4,Pepsin A-4,24634,116,1.07 [0.81-1.41],0.6220901564955641
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24611,115,1.20 [0.88-1.65],0.2479070055574161
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGF,Placenta growth factor,28663,125,1.33 [0.74-2.38],0.3336769846218709
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGLYRP1,Peptidoglycan recognition protein 1,28519,126,1.50 [1.07-2.09],0.0188651387133244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24326,117,0.80 [0.45-1.42],0.4455608425730398
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGLYRP4,Peptidoglycan recognition protein 4,23828,115,0.98 [0.73-1.32],0.9075451191536708
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGM2,Phosphoglucomutase-2,23924,115,0.72 [0.48-1.06],0.0963371434581838
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGR,Progesterone receptor,23910,115,0.94 [0.78-1.13],0.5196224599909505
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHACTR2,Phosphatase and actin regulator 2,24574,116,1.07 [0.92-1.25],0.3860503958314347
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHLDB1,Pleckstrin homology-like domain family B member 1,24515,118,1.08 [0.78-1.50],0.6309908396389527
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHLDB2,Pleckstrin homology-like domain family B member 2,23740,114,0.94 [0.77-1.16],0.5899618397934066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,28132,127,1.30 [0.75-2.23],0.3481390105735777
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24061,114,0.89 [0.59-1.36],0.6011525307218861
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PI16,Peptidase inhibitor 16,24634,116,0.68 [0.33-1.39],0.2889967900871633
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PI3,Elafin,27932,124,1.25 [0.95-1.64],0.109830292464941
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24574,116,0.99 [0.79-1.24],0.9268983627424568
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIGR,Polymeric immunoglobulin receptor,27954,122,0.96 [0.63-1.47],0.8679793222875886
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,28308,124,1.03 [0.80-1.32],0.8416221399280296
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,28313,126,1.10 [0.60-2.01],0.7671551112530786
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,23910,115,0.96 [0.69-1.32],0.7830342168526431
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PILRA,Paired immunoglobulin-like type 2 receptor alpha,28313,126,1.06 [0.72-1.54],0.776857668960071
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PILRB,Paired immunoglobulin-like type 2 receptor beta,28326,123,1.03 [0.78-1.37],0.8129694908056091
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24061,114,0.95 [0.73-1.24],0.7126330406932603
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PITHD1,PITH domain-containing protein 1,23692,114,1.14 [0.94-1.39],0.1794563688372171
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PKD1,Polycystin-1,24611,115,0.83 [0.42-1.62],0.5749781075349898
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PKD2,Polycystin-2,23828,115,1.00 [0.74-1.35],0.9940292724405912
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PKLR,Pyruvate kinase PKLR,28352,126,0.96 [0.76-1.22],0.7579973737837208
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PKN3,Serine/threonine-protein kinase N3,24157,114,1.00 [0.79-1.27],0.9778023692276824
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G10,Group 10 secretory phospholipase A2,28132,127,1.20 [0.93-1.57],0.1662627896943672
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G15,Phospholipase A2 group XV,28391,125,1.20 [0.67-2.13],0.5407053405282406
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G1B,Phospholipase A2,28622,127,0.85 [0.58-1.23],0.3831080075520038
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G2A,"Phospholipase A2, membrane associated",28265,126,1.02 [0.77-1.35],0.90100678628535
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G4A,Cytosolic phospholipase A2,28450,126,1.05 [0.88-1.25],0.5762598276653528
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G7,Platelet-activating factor acetylhydrolase,28313,126,0.95 [0.57-1.56],0.8265147674861559
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLAT,Tissue-type plasminogen activator,28573,126,0.83 [0.61-1.12],0.22408793849485
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLAU,Urokinase-type plasminogen activator,28313,126,1.02 [0.60-1.75],0.9349609861995172
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLAUR,Urokinase plasminogen activator surface receptor,28115,125,2.17 [1.27-3.70],0.0046174540380293
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLB1,"Phospholipase B1, membrane-associated",24539,118,1.01 [0.75-1.35],0.9638265441790496
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",23910,115,0.98 [0.66-1.46],0.9269615193399054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24539,118,1.01 [0.85-1.21],0.8918743274142135
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24539,118,0.97 [0.76-1.25],0.8289861761126133
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLG,Plasminogen,24007,116,0.69 [0.31-1.52],0.3578315714240351
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLIN1,Perilipin-1,27654,122,0.85 [0.52-1.38],0.5054305171559925
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLIN3,Perilipin-3,28326,123,1.20 [0.84-1.70],0.3133246363879248
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLPBP,Pyridoxal phosphate homeostasis protein,28326,123,1.09 [0.87-1.38],0.4419372713526684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLSCR3,Phospholipid scramblase 3,24498,118,1.07 [0.80-1.44],0.6439967049608262
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLTP,Phospholipid transfer protein,28571,127,1.16 [0.76-1.79],0.4929003304798749
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXDC1,Plexin domain-containing protein 1,27634,122,0.62 [0.35-1.09],0.0981043742357373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXDC2,Plexin domain-containing protein 2,24539,118,1.20 [0.64-2.22],0.5708628148720545
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXNA4,Plexin-A4,28308,124,0.98 [0.81-1.19],0.8346375364356512
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXNB2,Plexin-B2,28540,126,1.20 [0.62-2.30],0.5869229138014741
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXNB3,Plexin-B3,28222,123,1.05 [0.75-1.46],0.7769302087783321
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,28212,123,1.01 [0.93-1.10],0.8345134066370864
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PMCH,Pro-MCH,23828,115,1.00 [0.81-1.25],0.9702202569649944
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PMM2,Phosphomannomutase 2,23828,115,1.04 [0.78-1.40],0.7697991910621367
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PMS1,PMS1 protein homolog 1,23924,115,1.08 [0.76-1.51],0.6750971059822872
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PMVK,Phosphomevalonate kinase,27612,122,1.05 [0.90-1.22],0.542377456091026
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNLIP,Pancreatic triacylglycerol lipase,24634,116,0.78 [0.58-1.04],0.0890152210292216
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24539,118,0.73 [0.58-0.91],0.0048628567416728
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNLIPRP2,Pancreatic lipase-related protein 2,28305,126,1.05 [0.99-1.11],0.1102059695955245
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNMA1,Paraneoplastic antigen Ma1,23928,116,1.05 [0.78-1.42],0.753925261041284
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNMA2,Paraneoplastic antigen Ma2,23828,117,1.30 [0.91-1.85],0.1463502628860627
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",27801,122,1.04 [0.91-1.18],0.5894111055255382
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PODXL,Podocalyxin,28200,126,0.60 [0.22-1.67],0.3285638999763316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PODXL2,Podocalyxin-like protein 2,28391,125,0.75 [0.43-1.32],0.323538045586233
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POF1B,Protein POF1B,23910,115,1.46 [1.07-2.00],0.018188484529514
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POLR2A,DNA-directed RNA polymerase II subunit RPB1,23910,115,0.89 [0.48-1.64],0.7044871013385434
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",28200,126,0.99 [0.63-1.55],0.9668571188892152
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POMC,Pro-opiomelanocortin,23928,116,0.97 [0.75-1.24],0.8013998871377015
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PON1,Serum paraoxonase/arylesterase 1,24634,116,0.81 [0.42-1.55],0.5169573894087316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PON2,Serum paraoxonase/arylesterase 2,27821,121,0.83 [0.52-1.31],0.4193182887943879
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PON3,Serum paraoxonase/lactonase 3,28450,126,0.90 [0.54-1.49],0.6794129255219621
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POSTN,Periostin,24601,117,0.70 [0.44-1.13],0.145131446308297
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPBP,Platelet basic protein,24453,118,0.99 [0.81-1.22],0.9383067055635442
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPCDC,Phosphopantothenoylcysteine decarboxylase,28593,126,0.95 [0.68-1.32],0.752615606772483
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPIB,Peptidyl-prolyl cis-trans isomerase B,28323,125,1.04 [0.88-1.22],0.6479472026215873
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPIE,Peptidyl-prolyl cis-trans isomerase E,24157,114,0.86 [0.62-1.21],0.3901191082683679
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24601,117,1.13 [0.87-1.46],0.3712546795704461
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPL,Periplakin,23910,115,1.15 [0.69-1.95],0.5887761324632165
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPM1A,Protein phosphatase 1A,27634,122,1.16 [0.72-1.87],0.547459080687474
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPM1B,Protein phosphatase 1B,23910,115,0.91 [0.67-1.24],0.5409238052021097
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPM1F,Protein phosphatase 1F,24611,115,1.08 [0.78-1.51],0.6270167868874523
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPME1,Protein phosphatase methylesterase 1,28200,126,1.07 [0.82-1.38],0.6310099819923027
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24494,116,1.05 [0.85-1.30],0.6321991178275037
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,28391,125,1.07 [0.91-1.25],0.4359281771940972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24157,114,1.04 [0.81-1.32],0.771340475656203
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24574,116,1.00 [0.80-1.25],0.9848785677292868
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24574,116,1.15 [0.73-1.79],0.5506196656714155
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R2,Protein phosphatase inhibitor 2,28326,123,1.14 [0.94-1.38],0.1870805141129214
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R9B,Neurabin-2,28663,125,1.01 [0.86-1.19],0.8719539912785661
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24515,118,1.01 [0.87-1.16],0.941672427893716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP3R1,Calcineurin subunit B type 1,28132,127,1.06 [0.73-1.54],0.7667912072236879
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPT1,Palmitoyl-protein thioesterase 1,23924,115,1.07 [0.87-1.32],0.5189608211262279
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPY,Pancreatic prohormone,28249,125,0.95 [0.81-1.11],0.4807654931387394
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PQBP1,Polyglutamine-binding protein 1,27634,122,0.92 [0.68-1.25],0.5900059758866959
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRAME,Melanoma antigen preferentially expressed in tumors,23740,114,0.78 [0.38-1.61],0.5023117781698487
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRAP1,Proline-rich acidic protein 1,24601,117,1.29 [0.83-2.01],0.2631723064935021
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRC1,Protein regulator of cytokinesis 1,24494,116,1.13 [0.83-1.55],0.4349489417996578
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRCP,Lysosomal Pro-X carboxypeptidase,28477,127,0.81 [0.49-1.34],0.4115732148272893
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX1,Peroxiredoxin-1,27545,122,0.96 [0.80-1.15],0.6622447038717799
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX2,Peroxiredoxin-2,24234,115,0.81 [0.60-1.08],0.1541935092835731
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",27801,122,1.05 [0.84-1.30],0.676703843491533
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX5,"Peroxiredoxin-5, mitochondrial",28663,125,1.07 [0.85-1.35],0.5759567537473291
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX6,Peroxiredoxin-6,28579,126,0.88 [0.67-1.14],0.3357895214320038
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PREB,Prolactin regulatory element-binding protein,27801,122,1.22 [0.73-2.02],0.4437360157782503
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRELP,Prolargin,28305,126,0.89 [0.45-1.76],0.7371626249954544
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRG2,Bone marrow proteoglycan,24601,117,1.21 [0.87-1.69],0.2615754467419913
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRG3,Proteoglycan 3,24601,117,0.84 [0.60-1.20],0.3439566041438506
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,27801,122,1.01 [0.76-1.35],0.9468904101141314
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,23924,115,1.26 [0.75-2.14],0.3810213401139134
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,28326,123,1.10 [0.91-1.33],0.3307174959279408
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24491,118,1.00 [0.81-1.24],0.9858112609837792
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKCQ,Protein kinase C theta type,27801,122,1.03 [0.71-1.49],0.8792937679935374
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKD2,Serine/threonine-protein kinase D2,23828,115,0.87 [0.56-1.35],0.5365536425889614
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKG1,cGMP-dependent protein kinase 1,24061,114,1.04 [0.91-1.20],0.5640946725193625
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,27634,122,1.13 [0.89-1.42],0.3199687764880295
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRL,Prolactin,28593,126,1.01 [0.82-1.24],0.9235931169147747
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRND,Prion-like protein doppel,24539,118,1.25 [0.90-1.73],0.1805790709841948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PROC,Vitamin K-dependent protein C,28372,127,0.97 [0.53-1.78],0.9219654862862374
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PROCR,Endothelial protein C receptor,23828,115,1.04 [0.64-1.69],0.8717631111934366
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PROK1,Prokineticin-1,28308,124,0.93 [0.71-1.21],0.5785306038159421
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PROS1,Vitamin K-dependent protein S,24647,118,0.72 [0.35-1.48],0.3750214180203259
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRR4,Proline-rich protein 4,23901,114,0.92 [0.71-1.20],0.5517262999354962
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRR5,Proline-rich protein 5,23910,115,0.98 [0.67-1.44],0.9203247790890152
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRRT3,Proline-rich transmembrane protein 3,23928,116,0.58 [0.36-0.94],0.0287305684063617
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS2,Trypsin-2,28407,127,0.80 [0.59-1.09],0.1525349170228386
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS22,Brain-specific serine protease 4,23910,115,0.87 [0.50-1.50],0.6059825260912575
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS27,Serine protease 27,28224,122,1.08 [0.73-1.60],0.7075126823711124
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS53,Serine protease 53,24539,118,1.11 [0.71-1.74],0.6390870260082191
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS8,Prostasin,28213,125,1.13 [0.78-1.65],0.5154905368233311
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,27654,122,1.02 [0.89-1.18],0.7451708017824397
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRTG,Protogenin,28579,126,0.92 [0.49-1.71],0.7822669524238288
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRTN3,Myeloblastin,27620,123,1.09 [0.80-1.50],0.5786072797763087
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRUNE2,Protein prune homolog 2,24157,114,1.01 [0.54-1.88],0.9793665361381564
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSAP,Prosaposin,24378,116,1.37 [0.77-2.43],0.2881121077855417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSAPL1,Proactivator polypeptide-like 1,24515,118,0.99 [0.70-1.40],0.9485891299342124
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSCA,Prostate stem cell antigen,24515,118,0.97 [0.91-1.04],0.4485480664011952
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSG1,Pregnancy-specific beta-1-glycoprotein 1,28132,127,1.13 [0.97-1.32],0.1056863507021179
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSIP1,PC4 and SFRS1-interacting protein,28308,124,1.05 [0.83-1.32],0.6864198127888408
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMA1,Proteasome subunit alpha type-1,27634,122,0.93 [0.65-1.33],0.6950102882355952
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMC3,26S proteasome regulatory subunit 6A,23740,114,1.14 [0.63-2.05],0.6645005376172196
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24574,116,1.00 [0.71-1.43],0.9786050879025264
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMD5,26S proteasome non-ATPase regulatory subunit 5,23924,115,0.97 [0.68-1.36],0.8426804100204249
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMD9,26S proteasome non-ATPase regulatory subunit 9,28200,126,0.97 [0.73-1.29],0.8561962144502959
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSME1,Proteasome activator complex subunit 1,28099,126,0.99 [0.65-1.50],0.948001003679478
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSME2,Proteasome activator complex subunit 2,28009,127,0.89 [0.58-1.36],0.5835819843418266
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMG3,Proteasome assembly chaperone 3,28308,124,0.88 [0.65-1.21],0.4399129947361885
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMG4,Proteasome assembly chaperone 4,23910,115,1.10 [0.81-1.49],0.5325739159355254
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSPN,Persephin,28308,124,0.95 [0.80-1.12],0.5190121987943512
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSRC1,Proline/serine-rich coiled-coil protein 1,27634,122,1.07 [0.83-1.39],0.5954821485073323
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23177,111,1.05 [0.89-1.25],0.5543729333322369
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",27654,122,1.09 [0.65-1.86],0.7362717659274153
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTGDS,Prostaglandin-H2 D-isomerase,28101,126,1.36 [0.82-2.27],0.2339800914295079
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTGES2,Prostaglandin E synthase 2,23723,115,1.29 [0.94-1.76],0.1098697111083922
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTGR1,Prostaglandin reductase 1,24611,115,0.90 [0.72-1.12],0.3306750455945212
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTH,Parathyroid hormone,23924,115,1.00 [0.81-1.25],0.9672848596038603
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,28308,124,0.96 [0.62-1.48],0.8431040431409248
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTK7,Inactive tyrosine-protein kinase 7,27654,122,1.30 [0.86-1.96],0.2146690690463811
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTN,Pleiotrophin,27821,121,0.99 [0.72-1.37],0.9528258830849584
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTP4A3,Protein tyrosine phosphatase type IVA 3,23910,115,0.77 [0.52-1.12],0.1729027633179981
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,28132,127,1.04 [0.85-1.27],0.7015966625534277
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,28407,126,1.09 [0.91-1.31],0.3306384378648848
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,23861,115,0.87 [0.53-1.41],0.5701977939124514
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24611,115,0.57 [0.31-1.02],0.0600099552204171
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRC,Receptor-type tyrosine-protein phosphatase C,24601,117,1.11 [0.51-2.41],0.7930187733904822
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRF,Receptor-type tyrosine-protein phosphatase F,28675,127,1.00 [0.58-1.73],0.992066829804574
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRH,Receptor-type tyrosine-protein phosphatase H,24515,118,1.23 [0.87-1.73],0.2434992201300987
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24515,118,0.48 [0.19-1.20],0.1152472659795144
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRM,Receptor-type tyrosine-protein phosphatase mu,28255,124,0.65 [0.34-1.24],0.1872921033249941
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,28031,127,0.92 [0.56-1.51],0.7349307095518396
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRR,Receptor-type tyrosine-protein phosphatase R,24539,118,0.84 [0.52-1.37],0.4920175722740232
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRS,Receptor-type tyrosine-protein phosphatase S,28675,127,0.90 [0.48-1.69],0.7432161697832453
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24611,115,0.65 [0.37-1.14],0.1358022890569458
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24061,114,1.11 [0.82-1.49],0.5026519197375797
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTS,6-pyruvoyl tetrahydrobiopterin synthase,27529,122,0.87 [0.65-1.17],0.36166495373134
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTTG1,Securin,24157,114,1.03 [0.68-1.56],0.8895248996819224
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTX3,Pentraxin-related protein PTX3,28308,124,0.98 [0.72-1.34],0.8861612163851649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PVALB,Parvalbumin alpha,28468,126,1.06 [0.93-1.22],0.3916830280460275
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PVR,Poliovirus receptor,28593,126,1.06 [0.70-1.59],0.7977440300784671
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PXDNL,Peroxidasin-like protein,24494,116,0.89 [0.64-1.25],0.4958215486018906
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PXN,Paxillin,27654,122,1.17 [0.89-1.54],0.2589240507783159
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PYDC1,Pyrin domain-containing protein 1,23928,116,1.33 [0.93-1.91],0.1205275174661843
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PYY,Peptide YY,23828,115,1.12 [0.93-1.35],0.2271803311442168
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PZP,Pregnancy zone protein,24647,118,1.22 [0.89-1.68],0.2167615923754415
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,QDPR,Dihydropteridine reductase,28188,121,1.09 [0.76-1.57],0.6416392269061857
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,QPCT,Glutaminyl-peptide cyclotransferase,28327,126,1.21 [0.67-2.19],0.5345820865467734
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,QSOX1,Sulfhydryl oxidase 1,24134,115,0.92 [0.57-1.49],0.7435273764583384
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB10,Ras-related protein Rab-10,24611,115,1.08 [0.78-1.49],0.6485984544713709
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB11FIP3,Rab11 family-interacting protein 3,24611,115,1.01 [0.85-1.18],0.9496801885269688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB27B,Ras-related protein Rab-27B,24611,115,1.02 [0.82-1.26],0.8888165338303408
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB2B,Ras-related protein Rab-2B,24494,116,1.08 [0.82-1.43],0.5818736360291233
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB33A,Ras-related protein Rab-33A,23828,115,0.94 [0.72-1.23],0.6717821778872602
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB37,Ras-related protein Rab-37,27801,122,1.02 [0.85-1.23],0.8085453888550995
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB39B,Ras-related protein Rab-39B,23828,115,1.09 [0.92-1.30],0.2987214326945567
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,23828,117,1.08 [0.82-1.42],0.6075195003325393
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB44,Ras-related protein Rab-44,24494,116,0.99 [0.68-1.43],0.9501404670670466
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB6A,Ras-related protein Rab-6A,28308,124,1.03 [0.74-1.43],0.8742719791455553
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB6B,Ras-related protein Rab-6B,27654,122,1.02 [0.73-1.43],0.8991453825383523
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RABEP1,Rab GTPase-binding effector protein 1,24061,114,1.03 [0.82-1.30],0.7864450405524586
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RABEPK,Rab9 effector protein with kelch motifs,27634,122,0.98 [0.75-1.28],0.8716032162785472
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RABGAP1L,Rab GTPase-activating protein 1-like,27801,122,1.08 [0.84-1.41],0.5395091292470079
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAC3,Ras-related C3 botulinum toxin substrate 3,23924,115,0.63 [0.43-0.93],0.0209167260343839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAD23B,UV excision repair protein RAD23 homolog B,27634,122,1.13 [0.81-1.57],0.4766425635807535
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAD51,DNA repair protein RAD51 homolog 1,24157,114,0.83 [0.57-1.23],0.3568203266124103
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RALB,Ras-related protein Ral-B,23910,115,0.93 [0.51-1.70],0.817989387316049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RALY,RNA-binding protein Raly,24494,116,1.05 [0.75-1.46],0.790857328302606
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RANBP1,Ran-specific GTPase-activating protein,23928,116,0.96 [0.68-1.35],0.8092125968907816
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RANBP2,E3 SUMO-protein ligase RanBP2,23828,117,0.90 [0.53-1.54],0.7032862549587076
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RANGAP1,Ran GTPase-activating protein 1,27634,122,0.95 [0.68-1.33],0.7687775455815127
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAP1A,Ras-related protein Rap-1A,23910,115,0.77 [0.55-1.07],0.120277443356475
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAPGEF2,Rap guanine nucleotide exchange factor 2,24157,114,0.99 [0.70-1.38],0.9322246113074476
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RARRES1,Retinoic acid receptor responder protein 1,27634,122,1.09 [0.70-1.71],0.7069346658211066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RARRES2,Retinoic acid receptor responder protein 2,28463,127,1.32 [0.98-1.77],0.0660880949579485
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RASA1,Ras GTPase-activating protein 1,27654,122,0.87 [0.53-1.44],0.5984438274747352
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,23740,114,1.16 [0.78-1.73],0.4578478065873247
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RASSF2,Ras association domain-containing protein 2,27634,122,1.03 [0.79-1.34],0.8122320092396802
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBFOX3,RNA binding protein fox-1 homolog 3,24574,116,1.70 [1.23-2.35],0.001175844180282
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBKS,Ribokinase,27677,127,0.90 [0.66-1.23],0.5051782590098086
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBM17,Splicing factor 45,24574,116,1.10 [0.88-1.37],0.4260045902606798
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBM19,Probable RNA-binding protein 19,23828,115,1.12 [0.80-1.57],0.5187305067205255
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBM25,RNA-binding protein 25,23740,114,1.07 [0.73-1.58],0.7216974170105275
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBP1,Retinol-binding protein 1,23924,115,1.10 [0.88-1.38],0.3828998772730199
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBP2,Retinol-binding protein 2,28200,126,0.75 [0.60-0.93],0.0078555286797732
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBP5,Retinol-binding protein 5,28200,126,1.07 [0.82-1.41],0.614428660212992
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBP7,Retinoid-binding protein 7,24515,118,1.01 [0.77-1.33],0.945730253027201
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBPMS,RNA-binding protein with multiple splicing,23910,115,1.01 [0.78-1.32],0.9210151546844906
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBPMS2,RNA-binding protein with multiple splicing 2,23928,116,1.02 [0.86-1.22],0.7795250119810025
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RCC1,Regulator of chromosome condensation,24494,116,0.97 [0.68-1.38],0.8494458802387791
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RCOR1,REST corepressor 1,27821,121,1.22 [0.92-1.61],0.1631291472795039
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,23928,116,0.81 [0.35-1.89],0.6235289767810779
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REEP4,Receptor expression-enhancing protein 4,24574,116,0.99 [0.75-1.32],0.9637032067893204
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG1A,Lithostathine-1-alpha,28156,126,0.98 [0.70-1.37],0.9007844533703586
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG1B,Lithostathine-1-beta,28675,127,1.00 [0.75-1.32],0.9728346128971428
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG3A,Regenerating islet-derived protein 3-alpha,28675,127,1.07 [0.83-1.38],0.6108840026490654
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG3G,Regenerating islet-derived protein 3-gamma,24494,116,1.28 [0.84-1.94],0.2453903287892866
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG4,Regenerating islet-derived protein 4,28355,126,0.94 [0.67-1.31],0.7031537467246682
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RELB,Transcription factor RelB,23910,115,1.15 [0.84-1.59],0.3889515934927431
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RELT,Tumor necrosis factor receptor superfamily member 19L,28313,126,0.90 [0.50-1.62],0.7190055931394508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REN,Renin,28326,123,1.14 [0.92-1.42],0.2232984691315339
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REPS1,RalBP1-associated Eps domain-containing protein 1,23910,115,0.90 [0.56-1.46],0.6788729407529216
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REST,RE1-silencing transcription factor,23740,114,0.90 [0.53-1.53],0.706005287983648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,28200,126,0.86 [0.58-1.29],0.4685713433746805
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RETN,Resistin,28250,126,1.21 [0.84-1.74],0.298073387744782
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REXO2,"Oligoribonuclease, mitochondrial",23828,115,1.05 [0.73-1.50],0.7985369428954359
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RFC4,Replication factor C subunit 4,24494,116,0.70 [0.30-1.64],0.4090311433361931
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGCC,Regulator of cell cycle RGCC,24574,116,1.07 [0.85-1.35],0.5571220970690532
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24157,114,1.00 [0.75-1.32],0.9911552780424846
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGMA,Repulsive guidance molecule A,28593,126,0.66 [0.40-1.10],0.1085976014770556
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGMB,RGM domain family member B,28593,126,0.79 [0.43-1.46],0.4588621469604446
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGS10,Regulator of G-protein signaling 10,24574,116,1.03 [0.77-1.38],0.8255061327349077
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGS8,Regulator of G-protein signaling 8,27801,122,1.22 [1.01-1.49],0.0391221985015474
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RHOC,Rho-related GTP-binding protein RhoC,27964,127,1.07 [0.94-1.23],0.3037946998776704
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RICTOR,Rapamycin-insensitive companion of mTOR,23910,115,1.02 [0.71-1.48],0.9019978778967416
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24061,114,0.86 [0.60-1.25],0.4303968774213167
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RILP,Rab-interacting lysosomal protein,28505,126,1.00 [0.77-1.30],0.9876885140046772
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RILPL2,RILP-like protein 2,24611,115,1.08 [0.90-1.30],0.3834392259752668
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,23828,115,0.89 [0.66-1.19],0.4383056850978334
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RLN1,Prorelaxin H1,24574,116,0.93 [0.70-1.22],0.5853860755090969
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RLN2,Prorelaxin H2,24021,114,0.96 [0.82-1.13],0.6520766309011616
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE1,Ribonuclease pancreatic,24634,116,1.00 [0.47-2.14],0.9980660470905528
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE10,Inactive ribonuclease-like protein 10,23928,116,0.98 [0.67-1.43],0.915204018269615
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE3,Eosinophil cationic protein,28185,122,1.04 [0.91-1.19],0.5730423224719313
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE4,Ribonuclease 4,23842,112,0.85 [0.42-1.72],0.6474518021123246
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE6,Ribonuclease K6,24459,114,1.30 [0.75-2.25],0.355081359048511
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASEH2A,Ribonuclease H2 subunit A,24574,116,0.88 [0.60-1.28],0.4940026718445108
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASET2,Ribonuclease T2,28526,127,1.19 [0.66-2.15],0.5548378136744747
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF149,E3 ubiquitin-protein ligase RNF149,23928,116,1.48 [0.84-2.61],0.1804412479343886
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF168,E3 ubiquitin-protein ligase RNF168,23910,115,0.78 [0.48-1.26],0.3044966343943266
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF31,E3 ubiquitin-protein ligase RNF31,23910,115,0.71 [0.41-1.26],0.2427968002094754
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF4,E3 ubiquitin-protein ligase RNF4,24157,114,1.06 [0.81-1.37],0.6902285721155919
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF41,E3 ubiquitin-protein ligase NRDP1,27634,122,1.03 [0.81-1.30],0.8281399276030269
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF43,E3 ubiquitin-protein ligase RNF43,24157,114,0.99 [0.73-1.34],0.9400199549534288
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF5,E3 ubiquitin-protein ligase RNF5,23928,116,0.97 [0.76-1.24],0.8311594370572376
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ROBO1,Roundabout homolog 1,28355,126,0.76 [0.39-1.48],0.4126198156228031
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ROBO2,Roundabout homolog 2,28593,126,0.82 [0.41-1.62],0.5627700511376397
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ROBO4,Roundabout homolog 4,23928,116,1.40 [0.51-3.80],0.5119295951022131
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,28326,123,1.35 [0.81-2.23],0.2493569533247376
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RP2,Protein XRP2,28200,126,1.01 [0.70-1.46],0.9502667831473584
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPA2,Replication protein A 32 kDa subunit,23910,115,1.08 [0.62-1.87],0.7833814073428595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPE,Ribulose-phosphate 3-epimerase,24157,114,0.98 [0.76-1.27],0.8935099766939388
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPGR,X-linked retinitis pigmentosa GTPase regulator,23924,115,0.61 [0.37-1.02],0.0614005705376713
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPL14,60S ribosomal protein L14,23928,116,0.84 [0.53-1.34],0.4623211498727059
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPS10,40S ribosomal protein S10,23828,115,0.82 [0.52-1.32],0.4191231888890676
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RRAS,Ras-related protein R-Ras,23924,115,1.05 [0.92-1.20],0.5031792118207237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RRM2,Ribonucleoside-diphosphate reductase subunit M2,27634,122,1.11 [0.82-1.49],0.4940628938335849
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,27634,122,1.11 [0.88-1.39],0.3960294326886122
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RRP15,RRP15-like protein,23828,117,0.94 [0.77-1.15],0.5450490931832459
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RSPO1,R-spondin-1,28132,127,0.95 [0.61-1.49],0.8318202353102929
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RSPO3,R-spondin-3,28579,126,1.06 [0.60-1.90],0.8342386899333559
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RTBDN,Retbindin,28200,126,0.80 [0.47-1.39],0.4329734412227075
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RTKN2,Rhotekin-2,23828,115,1.11 [0.82-1.50],0.4870242054854847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24574,116,1.12 [0.92-1.35],0.2526888855764788
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RTN4R,Reticulon-4 receptor,28579,126,1.35 [0.88-2.06],0.1707145507133189
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RUVBL1,RuvB-like 1,27634,122,1.02 [0.87-1.19],0.8055384133841315
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RWDD1,RWD domain-containing protein 1,28593,126,1.02 [0.80-1.30],0.8829308777098132
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RYR1,Ryanodine receptor 1,23828,115,1.16 [0.72-1.88],0.5479799756220798
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A11,Protein S100-A11,28097,122,1.15 [0.85-1.55],0.3576474851263195
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A12,Protein S100-A12,27932,126,1.15 [0.94-1.42],0.1713339429803749
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A13,Protein S100-A13,23910,115,1.83 [1.21-2.77],0.0039162432054846
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A14,Protein S100-A14,24574,116,0.89 [0.63-1.27],0.5314120469510181
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A16,Protein S100-A16,27603,122,0.87 [0.67-1.15],0.3325049205792015
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A3,Protein S100-A3,24494,116,0.74 [0.44-1.25],0.2603935991897742
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A4,Protein S100-A4,28391,125,1.06 [0.80-1.39],0.7034576327195615
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100G,Protein S100-G,24574,116,0.89 [0.60-1.32],0.5589318520011178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100P,Protein S100-P,27821,121,1.26 [0.99-1.61],0.0651528369169595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAA4,Serum amyloid A-4 protein,24647,118,1.21 [0.80-1.83],0.3784357079936579
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAFB2,Scaffold attachment factor B2,24574,116,1.37 [0.77-2.41],0.2826262578614957
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAG,S-arrestin,23828,117,1.34 [1.03-1.74],0.0271850626019865
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAMD9L,Sterile alpha motif domain-containing protein 9-like,28308,124,1.07 [0.87-1.33],0.5113110371120817
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAP18,Histone deacetylase complex subunit SAP18,24157,114,1.00 [0.79-1.28],0.9682662926246312
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SARG,Specifically androgen-regulated gene protein,24531,114,1.01 [0.86-1.19],0.885166823972624
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SART1,U4/U6.U5 tri-snRNP-associated protein 1,23828,115,0.75 [0.43-1.32],0.3195752380072705
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAT1,Diamine acetyltransferase 1,23828,115,1.02 [0.71-1.46],0.9170620040492768
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAT2,Thialysine N-epsilon-acetyltransferase,24157,114,1.07 [0.84-1.36],0.5799621461971689
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SATB1,DNA-binding protein SATB1,24574,116,1.25 [0.75-2.09],0.3925406393200765
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SBSN,Suprabasin,24557,117,0.93 [0.55-1.55],0.7698414898302771
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCAMP3,Secretory carrier-associated membrane protein 3,28200,126,1.00 [0.83-1.20],0.9923888151246286
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARA5,Scavenger receptor class A member 5,28593,126,1.18 [0.69-2.00],0.5523348975696909
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARB1,Scavenger receptor class B member 1,27654,122,1.20 [0.95-1.51],0.1202453197894452
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARB2,Lysosome membrane protein 2,27590,123,1.33 [0.78-2.27],0.2965434378980689
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARF1,Scavenger receptor class F member 1,28675,127,1.13 [0.79-1.61],0.5163030336522567
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARF2,Scavenger receptor class F member 2,28593,126,1.15 [0.66-2.02],0.6201888728914096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCG2,Secretogranin-2,28466,126,0.88 [0.53-1.44],0.602667001147138
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCG3,Secretogranin-3,28355,126,0.63 [0.39-1.01],0.0534831266806208
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGB1A1,Uteroglobin,28372,126,0.79 [0.60-1.03],0.080999025714331
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGB2A2,Mammaglobin-A,23828,115,1.15 [0.68-1.94],0.5927271900806046
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGB3A1,Secretoglobin family 3A member 1,24061,114,0.69 [0.33-1.42],0.3121411828187536
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGB3A2,Secretoglobin family 3A member 2,28407,126,0.79 [0.64-0.98],0.0315998491778412
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGN,Secretagogin,27801,122,1.05 [0.73-1.52],0.7759255652607512
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCIN,Adseverin,23828,117,0.83 [0.64-1.09],0.1818785825289345
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCLY,Selenocysteine lyase,28505,126,0.77 [0.55-1.06],0.1037847313315142
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN2A,Sodium channel protein type 2 subunit alpha,23828,117,0.69 [0.44-1.09],0.1114131418645315
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN2B,Sodium channel subunit beta-2,23924,115,0.89 [0.46-1.70],0.7193982561697074
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN3A,Sodium channel protein type 3 subunit alpha,23924,115,0.85 [0.51-1.43],0.5492390180389044
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN3B,Sodium channel subunit beta-3,23828,117,0.93 [0.62-1.40],0.7337998333746589
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN4B,Sodium channel subunit beta-4,23928,116,0.71 [0.46-1.09],0.1145848828136927
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCP2,Non-specific lipid-transfer protein,27634,122,1.01 [0.82-1.24],0.949638574211209
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCPEP1,Retinoid-inducible serine carboxypeptidase,23845,116,0.98 [0.69-1.39],0.8885343905904048
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCRG1,Scrapie-responsive protein 1,24611,115,1.18 [0.63-2.22],0.6017692398103163
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCRIB,Protein scribble homolog,23928,116,0.83 [0.66-1.04],0.1112376573365972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCRN1,Secernin-1,28308,124,0.99 [0.75-1.31],0.9293016089016364
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCT,Secretin,23924,115,0.98 [0.66-1.47],0.933116569744754
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDC1,Syndecan-1,28326,123,0.71 [0.46-1.08],0.1109821078097143
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDC4,Syndecan-4,28326,123,0.87 [0.62-1.22],0.424168581843147
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDCCAG8,Serologically defined colon cancer antigen 8,24494,116,0.95 [0.81-1.11],0.5254010839326295
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDHB,Succinate dehydrogenase,24515,118,1.11 [0.88-1.41],0.366106363533441
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDK2,Protein sidekick-2,24061,114,1.00 [0.62-1.62],0.9851897886139231
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEC31A,Protein transport protein Sec31A,23928,116,1.03 [0.82-1.30],0.7955475332519537
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEL1L,Protein sel-1 homolog 1,23928,116,0.99 [0.56-1.75],0.9750031979820394
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELE,E-selectin,28675,127,0.74 [0.55-1.01],0.0573609737920564
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELENOP,Selenoprotein P,24647,118,0.95 [0.43-2.07],0.8958286325962832
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELL,L-selectin,24647,118,1.18 [0.55-2.53],0.6641230175159285
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELP,P-selectin,28407,127,0.93 [0.71-1.22],0.613018393790226
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELPLG,P-selectin glycoprotein ligand 1,28308,124,0.47 [0.31-0.73],0.0007588711859942
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA3F,Semaphorin-3F,28326,123,1.82 [1.00-3.31],0.0496560629158771
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA3G,Semaphorin-3G,24061,114,0.87 [0.57-1.32],0.5032939113997545
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA4C,Semaphorin-4C,28200,126,1.25 [0.76-2.07],0.3778782390885563
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA4D,Semaphorin-4D,28593,126,1.02 [0.61-1.71],0.9416270557909008
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA6C,Semaphorin-6C,23910,115,0.64 [0.30-1.35],0.2426100720520676
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA7A,Semaphorin-7A,28573,126,0.97 [0.54-1.74],0.9194762584723196
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEPTIN3,Neuronal-specific septin-3,24574,116,0.95 [0.75-1.20],0.6727390356380981
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEPTIN7,Septin-7,24157,114,1.05 [0.76-1.47],0.7555846395728388
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEPTIN8,Septin-8,24483,118,1.11 [0.66-1.87],0.7022551590622725
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEPTIN9,Septin-9,28200,126,1.06 [0.63-1.81],0.8192101952873018
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA1,Alpha-1-antitrypsin,24205,117,3.53 [0.58-21.38],0.1695492127484248
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA11,Serpin A11,28675,127,1.07 [0.73-1.56],0.724978936460247
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA12,Serpin A12,27538,119,1.01 [0.87-1.16],0.937983930154332
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA3,Alpha-1-antichymotrypsin,24569,118,2.55 [1.01-6.43],0.0480284956705849
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA4,Kallistatin,24201,116,0.88 [0.41-1.86],0.7282040816381758
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA5,Plasma serine protease inhibitor,24292,117,0.46 [0.24-0.86],0.0161442980138183
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA6,Corticosteroid-binding globulin,24647,118,1.13 [0.41-3.11],0.8062568417371576
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA7,Thyroxine-binding globulin,24647,118,0.90 [0.35-2.31],0.8311957843337654
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA9,Serpin A9,28068,125,0.89 [0.71-1.11],0.3068777573090051
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB1,Leukocyte elastase inhibitor,28225,126,1.05 [0.88-1.24],0.6005501734063364
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB5,Serpin B5,27821,121,1.32 [0.94-1.86],0.1053593025890144
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB6,Serpin B6,28497,125,1.10 [0.85-1.43],0.4548425237091213
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB8,Serpin B8,28663,125,0.95 [0.72-1.25],0.7251082078570403
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB9,Serpin B9,28132,127,1.01 [0.63-1.62],0.965169293718488
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINC1,Antithrombin-III,24596,118,1.03 [0.31-3.39],0.9578882886618444
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPIND1,Heparin cofactor 2,24596,118,1.07 [0.58-1.98],0.8326291594823843
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINE1,Plasminogen activator inhibitor 1,28675,127,0.94 [0.75-1.17],0.5687649645877124
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINE2,Glia-derived nexin,24611,115,0.89 [0.68-1.17],0.4201613300545153
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINF1,Pigment epithelium-derived factor,24282,117,0.78 [0.39-1.53],0.4675847399565618
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINF2,Alpha-2-antiplasmin,24191,117,0.86 [0.24-3.11],0.8156423613564728
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPING1,Plasma protease C1 inhibitor,24596,118,0.91 [0.36-2.31],0.8418242245406998
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINH1,Serpin H1,24157,114,1.10 [0.96-1.26],0.166489972556867
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINI1,Neuroserpin,24009,114,0.70 [0.37-1.29],0.2494202448247832
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINI2,Serpin I2,24515,118,0.70 [0.50-0.97],0.031121435713972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,27654,122,0.91 [0.71-1.18],0.4715309884073091
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SETMAR,Histone-lysine N-methyltransferase SETMAR,28043,127,0.85 [0.51-1.43],0.544352463558551
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEZ6,Seizure protein 6 homolog,23924,115,0.65 [0.35-1.20],0.1661800079114156
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEZ6L,Seizure 6-like protein,28391,125,0.52 [0.30-0.88],0.0147611298936136
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEZ6L2,Seizure 6-like protein 2,28200,126,1.21 [0.63-2.30],0.5720202472692689
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SF3B4,Splicing factor 3B subunit 4,28200,126,1.04 [0.85-1.28],0.6900349718376411
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFRP1,Secreted frizzled-related protein 1,28032,127,0.87 [0.60-1.27],0.4688931564331089
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFRP4,Secreted frizzled-related protein 4,24061,114,1.39 [0.90-2.14],0.1343480244133074
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFTPA1,Pulmonary surfactant-associated protein A1,27634,122,0.89 [0.66-1.20],0.4458950485078956
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFTPA2,Pulmonary surfactant-associated protein A2,27634,122,1.00 [0.73-1.36],0.999491063786336
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFTPD,Pulmonary surfactant-associated protein D,28326,123,1.00 [0.79-1.27],0.980930261854507
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SGSH,N-sulphoglucosamine sulphohydrolase,24228,114,0.92 [0.67-1.28],0.6288916481615343
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH2B3,SH2B adapter protein 3,27634,122,1.01 [0.86-1.19],0.9270175996611104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH2D1A,SH2 domain-containing protein 1A,28308,124,0.97 [0.74-1.29],0.8531353115529831
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,23828,117,1.27 [1.02-1.58],0.0334745437696162
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH3BP1,SH3 domain-binding protein 1,24515,118,1.15 [0.84-1.58],0.3686441007275349
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH3GL3,Endophilin-A3,24003,114,1.07 [0.87-1.33],0.523889924091129
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH3GLB2,Endophilin-B2,24539,118,1.04 [0.80-1.34],0.7930415694000217
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHBG,Sex hormone-binding globulin,24634,116,0.77 [0.55-1.08],0.1327423917346391
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHC1,SHC-transforming protein 1,23740,114,0.99 [0.85-1.16],0.9215438409833152
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHD,SH2 domain-containing adapter protein D,23790,115,0.93 [0.74-1.18],0.5696484327995379
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHH,Sonic hedgehog protein,23910,115,0.72 [0.46-1.13],0.1516220737993615
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHISA5,Protein shisa-5,24601,117,1.54 [0.81-2.94],0.1919352816377137
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHMT1,"Serine hydroxymethyltransferase, cytosolic",28407,126,0.96 [0.80-1.15],0.6369039515572172
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHPK,Sedoheptulokinase,24157,114,0.93 [0.59-1.47],0.7691818695515202
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIAE,Sialate O-acetylesterase,28343,125,1.00 [0.72-1.39],0.9993579704144414
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC1,Sialoadhesin,28450,126,1.11 [0.77-1.61],0.5762468093420474
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC10,Sialic acid-binding Ig-like lectin 10,28308,124,1.36 [0.85-2.16],0.1941948868569993
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC15,Sialic acid-binding Ig-like lectin 15,27654,122,1.02 [0.84-1.25],0.8283353464312271
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC5,Sialic acid-binding Ig-like lectin 5,28313,126,1.11 [0.95-1.29],0.1920292409216837
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC6,Sialic acid-binding Ig-like lectin 6,28579,126,1.29 [0.81-2.06],0.2860727518696435
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC7,Sialic acid-binding Ig-like lectin 7,28326,123,1.37 [0.78-2.39],0.2727579116689714
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC8,Sialic acid-binding Ig-like lectin 8,23928,116,1.39 [0.95-2.03],0.092655552995764
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC9,Sialic acid-binding Ig-like lectin 9,28542,126,1.34 [0.80-2.25],0.2665558286917244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIL1,Nucleotide exchange factor SIL1,23928,116,1.24 [0.79-1.94],0.3502003411628649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,28388,126,0.96 [0.73-1.26],0.7700714933374957
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRPB1,Signal-regulatory protein beta-1,28250,126,1.22 [0.87-1.73],0.2531624002830464
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRT1,NAD-dependent protein deacetylase sirtuin-1,23910,115,0.91 [0.72-1.14],0.4033671976165131
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRT2,NAD-dependent protein deacetylase sirtuin-2,28200,126,1.11 [0.93-1.32],0.268260860465505
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",27654,122,0.94 [0.70-1.28],0.7060588873090514
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIT1,Signaling threshold-regulating transmembrane adapter 1,27801,122,0.91 [0.68-1.21],0.5151848776318309
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SKAP1,Src kinase-associated phosphoprotein 1,28082,127,0.94 [0.76-1.16],0.5587026203198604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SKAP2,Src kinase-associated phosphoprotein 2,28450,126,1.00 [0.86-1.16],0.9759071107550116
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SKIV2L,Helicase SKI2W,23828,115,1.05 [0.68-1.60],0.836285898648295
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLA2,Src-like-adapter 2,24574,116,0.99 [0.84-1.17],0.934334574388928
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLAMF1,Signaling lymphocytic activation molecule,27801,122,1.22 [0.92-1.61],0.165359703437561
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLAMF6,SLAM family member 6,27634,122,1.31 [0.88-1.95],0.1900123231679805
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLAMF7,SLAM family member 7,28308,124,0.87 [0.66-1.15],0.3357460958488715
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLAMF8,SLAM family member 8,27634,122,1.13 [0.83-1.54],0.4386072994495503
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC12A2,Solute carrier family 12 member 2,23828,115,1.21 [0.70-2.09],0.4947990211131254
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC13A1,Solute carrier family 13 member 1,24494,116,0.83 [0.58-1.19],0.3043470098284982
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC16A1,Monocarboxylate transporter 1,27654,122,0.97 [0.73-1.28],0.8155231539960682
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC1A4,Neutral amino acid transporter A,23924,115,0.91 [0.63-1.31],0.6172075016892387
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC27A4,Long-chain fatty acid transport protein 4,27654,122,0.97 [0.76-1.24],0.8060715879703575
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC28A1,Sodium/nucleoside cotransporter 1,23740,114,0.97 [0.71-1.32],0.8488904994049674
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC34A3,Sodium-dependent phosphate transport protein 2C,23740,114,0.78 [0.51-1.20],0.2529433303934618
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC39A14,Zinc transporter ZIP14,27654,122,1.20 [0.76-1.91],0.4340810792821846
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC39A5,Zinc transporter ZIP5,28308,124,0.95 [0.70-1.28],0.7312563129543592
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC44A4,Choline transporter-like protein 4,23924,115,1.21 [0.99-1.49],0.0677009571877083
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC4A1,Band 3 anion transport protein,24601,117,1.33 [0.93-1.88],0.1156258558498902
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC51B,Organic solute transporter subunit beta,23828,115,0.82 [0.63-1.07],0.1447785941330666
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24061,114,1.07 [0.87-1.32],0.5213835216698379
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24515,118,0.98 [0.69-1.39],0.8993940182157643
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",23740,114,0.96 [0.70-1.33],0.8181820036604603
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLIT2,Slit homolog 2 protein,27654,122,0.86 [0.62-1.19],0.3526700481236071
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLITRK1,SLIT and NTRK-like protein 1,23910,115,0.56 [0.32-0.97],0.0394241091958699
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLITRK2,SLIT and NTRK-like protein 2,28579,126,1.00 [0.67-1.49],0.9909614282581728
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLITRK6,SLIT and NTRK-like protein 6,27821,121,0.98 [0.61-1.57],0.9347103513762184
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLK,STE20-like serine/threonine-protein kinase,24157,114,1.12 [0.92-1.36],0.2758787784377054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLMAP,Sarcolemmal membrane-associated protein,24515,118,1.01 [0.82-1.24],0.9582836430558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLURP1,Secreted Ly-6/uPAR-related protein 1,24421,117,1.43 [1.01-2.03],0.0467088706550307
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMAD1,Mothers against decapentaplegic homolog 1,27634,122,1.01 [0.83-1.22],0.9218998639700624
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMAD2,Mothers against decapentaplegic homolog 2,24494,116,1.02 [0.80-1.32],0.8492223310127915
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMAD3,Mothers against decapentaplegic homolog 3,24494,116,1.08 [0.77-1.51],0.6726580866759494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMAD5,Mothers against decapentaplegic homolog 5,28200,126,0.94 [0.44-2.03],0.8800662251265061
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMARCA2,Probable global transcription activator SNF2L2,27654,122,0.96 [0.76-1.20],0.7081185220897954
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMC3,Structural maintenance of chromosomes protein 3,23740,114,1.09 [0.80-1.48],0.5741864793418956
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMNDC1,Survival of motor neuron-related-splicing factor 30,24515,118,1.06 [0.82-1.37],0.6381346278652655
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMOC1,SPARC-related modular calcium-binding protein 1,28579,126,0.96 [0.60-1.54],0.86768992089715
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMOC2,SPARC-related modular calcium-binding protein 2,28450,126,1.20 [0.80-1.80],0.3809391591976506
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMPD1,Sphingomyelin phosphodiesterase,28453,126,0.87 [0.63-1.20],0.3913519664883151
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMPD3,Sphingomyelin phosphodiesterase 3,23910,115,0.92 [0.66-1.27],0.6067369808761252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,28395,126,0.91 [0.72-1.15],0.4409337760771175
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24494,116,1.10 [0.90-1.35],0.3431470883307166
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMS,Spermine synthase,23828,117,1.01 [0.77-1.33],0.9214662080829988
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMTN,Smoothelin,24483,118,0.96 [0.80-1.16],0.6920594353770999
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNAP23,Synaptosomal-associated protein 23,28326,123,1.08 [0.89-1.30],0.4337154564317756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNAP25,Synaptosomal-associated protein 25,23828,117,0.91 [0.63-1.33],0.638584422779441
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNAP29,Synaptosomal-associated protein 29,28391,125,1.05 [0.88-1.24],0.5917901635267793
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNAPIN,SNARE-associated protein Snapin,24574,116,0.96 [0.70-1.29],0.7672314941074619
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNCA,Alpha-synuclein,24061,114,1.05 [0.90-1.22],0.5598813332258652
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNCG,Gamma-synuclein,28132,127,0.96 [0.76-1.22],0.7554214332922247
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",23928,116,0.98 [0.56-1.71],0.9487160576870732
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNRPB2,U2 small nuclear ribonucleoprotein B'',24539,118,0.96 [0.65-1.42],0.8495080095797062
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNU13,NHP2-like protein 1,23828,115,0.93 [0.69-1.24],0.6069853507554663
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX15,Sorting nexin-15,24061,114,0.99 [0.71-1.37],0.9537161929496648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX18,Sorting nexin-18,24515,118,1.42 [1.04-1.93],0.029090522995619
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX2,Sorting nexin-2,24494,116,1.10 [0.90-1.35],0.3643575869131071
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX5,Sorting nexin-5,23928,116,0.79 [0.43-1.44],0.4413069051487207
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX9,Sorting nexin-9,28326,123,1.13 [0.91-1.42],0.2682923319369673
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOD1,Superoxide dismutase [Cu-Zn],27713,125,1.14 [0.83-1.57],0.4141553116177104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOD2,"Superoxide dismutase [Mn], mitochondrial",28313,126,1.05 [0.70-1.57],0.814175103829198
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOD3,Extracellular superoxide dismutase,24634,116,0.78 [0.53-1.15],0.2172137423237156
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SORBS1,Sorbin and SH3 domain-containing protein 1,24574,116,1.51 [1.12-2.03],0.00721385812299
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SORCS2,VPS10 domain-containing receptor SorCS2,27634,122,1.02 [0.64-1.63],0.9242701444489102
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SORD,Sorbitol dehydrogenase,28452,126,0.97 [0.77-1.21],0.7663611082361562
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SORT1,Sortilin,28293,123,0.96 [0.63-1.47],0.8584590991998651
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOST,Sclerostin,28293,123,0.74 [0.49-1.11],0.1487213086247691
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,23924,115,0.93 [0.62-1.38],0.7084267123310571
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOX2,Transcription factor SOX-2,24534,116,0.77 [0.35-1.67],0.503436796433273
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOX9,Transcription factor SOX-9,23924,115,1.08 [0.55-2.10],0.8302572023860362
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24574,116,1.27 [0.75-2.15],0.3647672231476924
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPAG1,Sperm-associated antigen 1,24574,116,0.94 [0.70-1.28],0.7162140144409991
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPARC,SPARC,28391,125,1.02 [0.82-1.27],0.8490650581514894
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPARCL1,SPARC-like protein 1,28315,127,0.74 [0.42-1.33],0.3163382231002341
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPART,Spartin,24061,114,1.02 [0.81-1.28],0.8579574201378903
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPESP1,Sperm equatorial segment protein 1,24611,115,1.71 [0.99-2.96],0.0527010587986342
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK1,Serine protease inhibitor Kazal-type 1,28313,126,1.02 [0.69-1.51],0.909059577785568
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK2,Serine protease inhibitor Kazal-type 2,24061,114,1.11 [0.69-1.80],0.670773942100023
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK4,Serine protease inhibitor Kazal-type 4,28308,124,0.85 [0.65-1.10],0.223063176399758
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK5,Serine protease inhibitor Kazal-type 5,28313,126,0.94 [0.59-1.51],0.8087564178741832
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK6,Serine protease inhibitor Kazal-type 6,28579,126,1.14 [0.85-1.52],0.3893890584552038
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK8,Serine protease inhibitor Kazal-type 8,23828,115,0.78 [0.45-1.36],0.3864300150393825
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINT1,Kunitz-type protease inhibitor 1,28213,124,1.07 [0.58-1.98],0.8284208802951808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINT2,Kunitz-type protease inhibitor 2,28450,126,0.90 [0.61-1.31],0.5679983500177143
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINT3,Kunitz-type protease inhibitor 3,24515,118,0.95 [0.85-1.07],0.424219078979684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPOCK1,Testican-1,28132,127,0.94 [0.51-1.74],0.8443579300182213
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPON1,Spondin-1,28355,126,0.64 [0.39-1.05],0.0773346907422914
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPON2,Spondin-2,28191,123,1.01 [0.63-1.63],0.9556862080489636
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPP1,Osteopontin,28621,127,0.87 [0.62-1.23],0.4419342218862528
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",23910,115,0.92 [0.61-1.39],0.6864385085969507
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRING1,SREBP regulating gene protein,23740,114,1.01 [0.75-1.36],0.9287152273223994
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRR1B,Cornifin-B,24157,114,1.13 [0.94-1.35],0.2020394555004777
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRR3,Small proline-rich protein 3,24539,118,1.07 [0.82-1.39],0.6258584178070958
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRY2,Protein sprouty homolog 2,27801,122,1.07 [0.90-1.27],0.4278552079738998
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",23828,117,1.02 [0.59-1.77],0.9436729947659956
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPTLC1,Serine palmitoyltransferase 1,24539,118,0.66 [0.37-1.17],0.1541115883075911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SRC,Proto-oncogene tyrosine-protein kinase Src,28347,125,1.05 [0.93-1.20],0.426873417394972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SRP14,Signal recognition particle 14 kDa protein,28200,126,1.03 [0.80-1.33],0.8044883374454539
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SRPK2,SRSF protein kinase 2,28308,124,1.07 [0.89-1.28],0.4899673289843095
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SRPX,Sushi repeat-containing protein SRPX,24611,115,0.85 [0.52-1.41],0.530437910595307
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSB,Lupus La protein,27654,122,1.01 [0.77-1.33],0.942593729576644
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",23910,115,1.02 [0.62-1.66],0.9521271084352164
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,28293,123,0.99 [0.86-1.13],0.8433990440910205
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,28407,127,0.91 [0.64-1.31],0.6272330401715132
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSH3,Protein phosphatase Slingshot homolog 3,23740,114,0.91 [0.49-1.69],0.7694722589138627
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24515,118,0.98 [0.70-1.38],0.9167613077994196
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ST13,Hsc70-interacting protein,24061,114,1.03 [0.75-1.42],0.8652972298399879
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",28200,126,0.99 [0.69-1.43],0.9670126298462428
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",28675,127,1.15 [0.68-1.95],0.6119280608542568
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",23910,115,0.77 [0.49-1.22],0.2621691733195017
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAB2,Stabilin-2,24601,117,1.63 [0.89-2.98],0.113112146994557
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAM,Signal transducing adapter molecule 1,24494,116,0.94 [0.58-1.52],0.8043458749237353
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAMBP,STAM-binding protein,28082,127,1.10 [0.86-1.40],0.4526026042552076
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAT2,Signal transducer and activator of transcription 2,23910,115,1.01 [0.80-1.27],0.9463960053495756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAT5B,Signal transducer and activator of transcription 5B,28200,126,1.04 [0.93-1.17],0.4949635739758034
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,23740,114,0.79 [0.57-1.08],0.1357051172137825
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STC1,Stanniocalcin-1,28593,126,0.88 [0.61-1.28],0.5138159114264581
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STC2,Stanniocalcin-2,28273,126,1.07 [0.58-1.96],0.8382753877987167
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STEAP4,Metalloreductase STEAP4,23828,117,0.91 [0.70-1.19],0.49315335535942
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STIP1,Stress-induced-phosphoprotein 1,28264,126,1.07 [0.85-1.36],0.5687866068978135
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STK11,Serine/threonine-protein kinase STK11,27821,121,1.04 [0.83-1.29],0.7525682344609826
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STK24,Serine/threonine-protein kinase 24,27654,122,1.18 [0.92-1.53],0.189659271747617
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STK4,Serine/threonine-protein kinase 4,28326,123,1.09 [0.91-1.31],0.3257851611477422
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STOML2,"Stomatin-like protein 2, mitochondrial",23740,114,0.97 [0.80-1.18],0.751214411604733
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX16,Syntaxin-16,27634,122,0.96 [0.72-1.27],0.7591139195510592
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX1B,Syntaxin-1B,23924,115,0.58 [0.33-1.02],0.0573335844505978
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX3,Syntaxin-3,24539,118,0.76 [0.44-1.29],0.3081888323102899
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX4,Syntaxin-4,28200,126,0.93 [0.71-1.22],0.595550813701398
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX5,Syntaxin-5,23910,115,0.98 [0.62-1.53],0.9176551695725924
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX6,Syntaxin-6,27634,122,0.89 [0.69-1.15],0.3655409308185932
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX7,Syntaxin-7,23910,115,1.25 [0.88-1.79],0.215700067221416
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX8,Syntaxin-8,28308,124,1.05 [0.77-1.44],0.7644517613389752
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STXBP1,Syntaxin-binding protein 1,24574,116,1.11 [0.89-1.40],0.3546386200307183
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STXBP3,Syntaxin-binding protein 3,27634,122,1.08 [0.76-1.54],0.667948611250297
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUGP1,SURP and G-patch domain-containing protein 1,24515,118,0.80 [0.51-1.25],0.3292108137727196
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUGT1,Protein SGT1 homolog,27634,122,1.14 [0.93-1.39],0.2127053181512883
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SULT1A1,Sulfotransferase 1A1,28593,126,1.03 [0.92-1.17],0.5811162895979051
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SULT2A1,Bile salt sulfotransferase,28308,124,0.86 [0.64-1.16],0.313450611042028
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUMF1,Formylglycine-generating enzyme,23910,115,0.71 [0.48-1.03],0.07233679878798
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,28593,126,0.91 [0.68-1.21],0.5206168224139098
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUOX,"Sulfite oxidase, mitochondrial",24574,116,0.78 [0.58-1.07],0.1195996411897709
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUSD1,Sushi domain-containing protein 1,27821,121,1.19 [0.85-1.67],0.317607210610827
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUSD2,Sushi domain-containing protein 2,28313,126,1.27 [0.76-2.12],0.3579423034692349
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUSD4,Sushi domain-containing protein 4,24494,116,1.01 [0.66-1.54],0.9581031085886008
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUSD5,Sushi domain-containing protein 5,23934,113,1.07 [0.63-1.81],0.8103618777773627
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SV2A,Synaptic vesicle glycoprotein 2A,23924,115,0.94 [0.69-1.26],0.6639918579520354
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SWAP70,Switch-associated protein 70,24515,118,0.85 [0.51-1.41],0.5283192701181054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SYAP1,Synapse-associated protein 1,24061,114,1.03 [0.75-1.40],0.8748283428084398
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,23828,117,1.25 [0.97-1.62],0.0903861078899747
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SYT1,Synaptotagmin-1,24539,118,1.03 [0.65-1.64],0.8844571007227016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SYTL4,Synaptotagmin-like protein 4,24611,115,1.01 [0.79-1.28],0.9624958942815812
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24157,114,1.00 [0.85-1.19],0.989138840490652
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TACC3,Transforming acidic coiled-coil-containing protein 3,28200,126,1.04 [0.91-1.19],0.5860618047602613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TACSTD2,Tumor-associated calcium signal transducer 2,25157,107,0.82 [0.45-1.49],0.515992917035517
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TADA3,Transcriptional adapter 3,24494,116,1.41 [0.93-2.14],0.1051573175381064
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAFA5,Chemokine-like protein TAFA-5,28200,126,0.94 [0.59-1.48],0.777132353135559
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAGLN3,Transgelin-3,23740,114,0.89 [0.65-1.21],0.4499532317278668
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TALDO1,Transaldolase,24520,117,1.07 [0.73-1.57],0.730645463204649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TANK,TRAF family member-associated NF-kappa-B activator,27801,122,1.04 [0.83-1.31],0.7165533705859624
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAP1,Antigen peptide transporter 1,24157,114,0.89 [0.63-1.26],0.5132176620050919
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TARBP2,RISC-loading complex subunit TARBP2,27654,122,1.02 [0.84-1.25],0.8130891016747708
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",23924,115,1.04 [0.83-1.30],0.7445435683337057
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24494,116,0.96 [0.59-1.55],0.8598044930535685
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAX1BP1,Tax1-binding protein 1,24539,118,0.98 [0.74-1.29],0.8614539746171842
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBC1D17,TBC1 domain family member 17,27654,122,1.05 [0.74-1.50],0.77796502901799
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBC1D23,TBC1 domain family member 23,28200,126,1.01 [0.85-1.20],0.9278991464935916
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBC1D5,TBC1 domain family member 5,28308,124,0.92 [0.75-1.13],0.4136887188250043
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBCA,Tubulin-specific chaperone A,24061,114,1.07 [0.87-1.31],0.5379279952738252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBCB,Tubulin-folding cofactor B,28132,127,1.07 [0.91-1.25],0.4085320124753649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBCC,Tubulin-specific chaperone C,28132,127,1.07 [0.88-1.30],0.4775268333976166
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBL1X,F-box-like/WD repeat-containing protein TBL1X,27634,122,0.99 [0.82-1.19],0.8951503934964935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBR1,T-box brain protein 1,23924,115,0.94 [0.63-1.40],0.7666731270521943
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCL1A,T-cell leukemia/lymphoma protein 1A,28079,127,0.98 [0.84-1.15],0.8373451328160735
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCL1B,T-cell leukemia/lymphoma protein 1B,27821,121,1.06 [0.88-1.27],0.5692451331841464
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCN1,Transcobalamin-1,24146,114,0.88 [0.51-1.51],0.6463874980890216
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCN2,Transcobalamin-2,28621,127,0.84 [0.49-1.44],0.5332970427121275
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCOF1,Treacle protein,24611,115,1.12 [0.66-1.91],0.6633666813697126
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCP11,T-complex protein 11 homolog,24157,114,0.84 [0.58-1.21],0.3465137355294181
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCTN3,Tectonic-3,24611,115,1.17 [0.65-2.10],0.6006186960203928
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TDGF1,Teratocarcinoma-derived growth factor 1,27654,122,1.02 [0.92-1.14],0.6801421850832315
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TDO2,"Tryptophan 2,3-dioxygenase",23924,115,0.71 [0.42-1.20],0.2034229443654452
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TDP1,Tyrosyl-DNA phosphodiesterase 1,24494,116,0.98 [0.77-1.26],0.8977688719947186
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TDRKH,Tudor and KH domain-containing protein,27654,122,1.00 [0.82-1.21],0.9782234765082614
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TEF,Thyrotroph embryonic factor,23828,115,0.87 [0.56-1.36],0.549235526767117
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TEK,Angiopoietin-1 receptor,28391,125,0.58 [0.30-1.13],0.1105035923078207
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TERF1,Telomeric repeat-binding factor 1,23910,115,0.89 [0.48-1.64],0.7017382184979613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TET2,Methylcytosine dioxygenase TET2,24123,114,0.98 [0.82-1.18],0.868897899424828
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TEX101,Testis-expressed protein 101,23924,115,1.10 [0.77-1.56],0.594346613581686
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TEX33,Testis-expressed protein 33,24157,114,0.93 [0.58-1.50],0.7624768636071518
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TF,Serotransferrin,24647,118,0.88 [0.39-1.96],0.7511600683125614
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFAP2A,Transcription factor AP-2-alpha,23828,117,1.02 [0.75-1.37],0.917534483058049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFF1,Trefoil factor 1,28180,125,0.92 [0.75-1.15],0.4735714538942075
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFF2,Trefoil factor 2,28407,126,1.01 [0.77-1.32],0.9708845811491298
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFF3,Trefoil factor 3,28283,126,0.95 [0.66-1.36],0.7673840869945038
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFPI,Tissue factor pathway inhibitor,28225,126,0.92 [0.56-1.52],0.7447462520060164
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFPI2,Tissue factor pathway inhibitor 2,28295,125,0.76 [0.49-1.18],0.2255277779536431
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFRC,Transferrin receptor protein 1,28421,126,1.28 [0.87-1.90],0.213606010968583
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TG,Thyroglobulin,24494,116,1.01 [0.86-1.18],0.9410722267959466
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFA,Protransforming growth factor alpha,28308,124,1.54 [1.14-2.08],0.005400598368663
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFB1,Transforming growth factor beta-1 proprotein,28612,123,1.02 [0.68-1.53],0.9233262759289664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFB2,Transforming growth factor beta-2 proprotein,24494,116,1.14 [0.83-1.56],0.4175825464531336
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFBI,Transforming growth factor-beta-induced protein ig-h3,28134,126,0.54 [0.30-0.98],0.0428713957617385
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFBR1,TGF-beta receptor type-1,23910,115,1.26 [0.62-2.57],0.5293490085283425
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFBR2,TGF-beta receptor type-2,28391,125,1.25 [0.76-2.05],0.3760676118912992
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFBR3,Transforming growth factor beta receptor type 3,28675,127,0.86 [0.53-1.39],0.5392477571438598
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGM2,Protein-glutamine gamma-glutamyltransferase 2,28272,123,0.93 [0.76-1.15],0.5304504372212232
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGOLN2,Trans-Golgi network integral membrane protein 2,24634,116,1.23 [0.61-2.46],0.5647350890848608
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23692,114,0.72 [0.55-0.94],0.017820571758047
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THBD,Thrombomodulin,28326,123,0.80 [0.44-1.44],0.4588885691043262
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THBS2,Thrombospondin-2,28313,126,0.85 [0.55-1.32],0.4673030100992152
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THBS4,Thrombospondin-4,28326,127,1.35 [0.96-1.90],0.0842057839807175
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THOP1,Thimet oligopeptidase,28206,120,1.08 [0.65-1.79],0.7698467692538912
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THPO,Thrombopoietin,27821,121,1.03 [0.68-1.57],0.8720369008412463
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THRAP3,Thyroid hormone receptor-associated protein 3,23828,115,1.17 [1.04-1.31],0.0113479049196824
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THSD1,Thrombospondin type-1 domain-containing protein 1,23730,115,0.82 [0.48-1.42],0.485190124494706
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THTPA,Thiamine-triphosphatase,24442,116,1.07 [0.88-1.31],0.4909550324126925
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THY1,Thy-1 membrane glycoprotein,28593,126,1.42 [0.81-2.51],0.2196898143693111
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIA1,Nucleolysin TIA-1 isoform p40,27516,121,1.07 [0.94-1.22],0.3041771934702877
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIE1,Tyrosine-protein kinase receptor Tie-1,28675,127,1.17 [0.78-1.74],0.4471453968068437
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",27604,122,0.93 [0.66-1.31],0.6909430378648029
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24157,114,0.93 [0.56-1.55],0.7859747067638443
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,28407,127,1.22 [0.86-1.75],0.2621720887200088
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24611,115,1.17 [0.77-1.80],0.4588656414556096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24539,118,1.02 [0.84-1.25],0.8180004443523238
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMP1,Metalloproteinase inhibitor 1,27992,125,1.29 [0.75-2.23],0.3594444993788106
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMP2,Metalloproteinase inhibitor 2,24611,115,0.45 [0.19-1.06],0.0693012900454723
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMP3,Metalloproteinase inhibitor 3,28450,126,1.02 [0.90-1.14],0.7852659569730447
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMP4,Metalloproteinase inhibitor 4,28313,126,1.19 [0.81-1.75],0.3695416014471645
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TINAGL1,Tubulointerstitial nephritis antigen-like,28242,122,1.24 [0.61-2.54],0.551714959688927
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TJAP1,Tight junction-associated protein 1,28391,125,0.99 [0.82-1.20],0.9322104668772696
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TJP3,Tight junction protein ZO-3,23828,117,0.84 [0.53-1.33],0.4574514031922856
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TK1,"Thymidine kinase, cytosolic",24157,114,1.07 [0.73-1.57],0.7255631234594493
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TLR1,Toll-like receptor 1,23910,115,1.48 [0.78-2.79],0.2296393037005318
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TLR2,Toll-like receptor 2,24157,114,1.18 [0.54-2.56],0.6739623658538627
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TLR3,Toll-like receptor 3,28663,125,0.89 [0.70-1.14],0.3557354924796108
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TLR4,Toll-like receptor 4,23910,115,0.79 [0.41-1.52],0.4856017330211688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,23924,115,1.11 [0.81-1.53],0.5185638468311692
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMED1,Transmembrane emp24 domain-containing protein 1,24157,114,0.82 [0.57-1.18],0.2956056208900043
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMED10,Transmembrane emp24 domain-containing protein 10,23828,115,1.28 [1.01-1.63],0.0404639992600341
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMED4,Transmembrane emp24 domain-containing protein 4,23828,115,0.87 [0.61-1.25],0.4615533625547819
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMED8,Protein TMED8,24515,118,1.05 [0.88-1.24],0.5864078789633254
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMEM106A,Transmembrane protein 106A,24494,116,1.07 [0.85-1.37],0.5545466088254132
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMEM132A,Transmembrane protein 132A,23928,116,0.85 [0.64-1.13],0.2649709916681407
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMEM25,Transmembrane protein 25,24574,116,1.21 [0.86-1.71],0.2840465148952331
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMOD4,Tropomodulin-4,23740,114,0.88 [0.56-1.38],0.5749340746893717
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMPRSS11B,Transmembrane protease serine 11B,23828,117,1.08 [0.87-1.34],0.4705054908510764
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMPRSS11D,Transmembrane protease serine 11D,24483,118,1.06 [0.67-1.70],0.7961826472375577
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMPRSS15,Enteropeptidase,28200,126,0.98 [0.82-1.17],0.849044307754487
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMPRSS5,Transmembrane protease serine 5,27985,126,0.70 [0.47-1.03],0.0730483810716419
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMSB10,Thymosin beta-10,28313,126,1.13 [0.93-1.38],0.2298998432384033
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNC,Tenascin,28407,127,1.41 [1.02-1.94],0.0352148453870833
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNF,Tumor necrosis factor,27772,121,0.87 [0.54-1.38],0.5448667309761392
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24515,118,0.86 [0.60-1.24],0.4183984870237236
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,27801,122,0.75 [0.47-1.17],0.204666981112989
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24061,114,1.07 [0.81-1.41],0.6287171343797533
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,28132,127,1.38 [0.88-2.18],0.164969528661738
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,28132,127,1.27 [1.02-1.58],0.0321937498727633
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,28375,127,1.11 [0.81-1.53],0.510028101325434
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,28663,125,1.06 [0.70-1.62],0.7777550250953837
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,28305,126,0.75 [0.44-1.29],0.3037383908101468
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,28391,125,1.51 [0.99-2.31],0.0563269365423709
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,28355,126,0.86 [0.51-1.42],0.5451597492013716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,27801,122,1.00 [0.68-1.46],0.9842646446157796
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,28355,126,1.12 [0.66-1.89],0.6774847625090028
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24061,114,0.78 [0.50-1.24],0.2974378412965774
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,28579,126,1.21 [0.73-2.00],0.4661885114903153
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,28313,126,1.30 [0.75-2.24],0.3534635767781211
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,28313,126,1.08 [0.70-1.66],0.7426960313580226
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,28593,126,0.89 [0.50-1.59],0.6975887860655104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,28612,123,1.04 [0.68-1.61],0.8492676279136149
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,28132,127,0.97 [0.73-1.29],0.8201664678466254
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,28593,126,0.95 [0.66-1.36],0.7671483766364071
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,28132,127,1.15 [0.77-1.70],0.4919604192721302
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF10,Tumor necrosis factor ligand superfamily member 10,28663,125,1.01 [0.56-1.84],0.9664860485684216
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF11,Tumor necrosis factor ligand superfamily member 11,28308,124,1.02 [0.79-1.31],0.8923641097767887
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF12,Tumor necrosis factor ligand superfamily member 12,28663,125,0.90 [0.53-1.54],0.7029922201516718
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF13,Tumor necrosis factor ligand superfamily member 13,28450,126,1.41 [0.79-2.53],0.2444911848326528
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,28620,127,1.26 [0.72-2.20],0.4278669003306281
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF14,Tumor necrosis factor ligand superfamily member 14,28132,127,1.16 [0.89-1.52],0.2618244535695963
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24601,117,1.24 [0.77-1.99],0.3822722596924488
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNIP1,TNFAIP3-interacting protein 1,24539,118,0.95 [0.78-1.16],0.6146351158058128
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNN,Tenascin-N,24601,117,0.95 [0.63-1.42],0.7967786217970829
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNNI3,"Troponin I, cardiac muscle",27821,121,1.00 [0.82-1.21],0.9798270724715776
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNPO1,Transportin-1,24157,114,0.79 [0.47-1.33],0.3708989476253106
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNR,Tenascin-R,28132,127,0.74 [0.51-1.08],0.1167925795801112
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNXB,Tenascin-X,28313,126,0.90 [0.49-1.66],0.7433411696212249
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24611,115,1.05 [0.84-1.32],0.6531510028998542
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOP1,DNA topoisomerase 1,24515,118,1.05 [0.90-1.22],0.5237192420343613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOP1MT,"DNA topoisomerase I, mitochondrial",23740,114,1.13 [0.81-1.59],0.4683530365494508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOP2B,DNA topoisomerase 2-beta,23910,115,0.96 [0.77-1.21],0.747893479904832
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOR1AIP1,Torsin-1A-interacting protein 1,23928,116,1.05 [0.76-1.43],0.7749171490045006
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP53,Cellular tumor antigen p53,27634,122,1.00 [0.69-1.44],0.9977075373202696
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP53BP1,TP53-binding protein 1,23910,115,0.96 [0.78-1.18],0.7134976237065245
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP53I3,Quinone oxidoreductase PIG3,23535,109,1.09 [0.78-1.54],0.6072073373621503
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP53INP1,Tumor protein p53-inducible nuclear protein 1,27821,121,0.74 [0.40-1.37],0.3388791617937391
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP73,Tumor protein p73,23924,115,0.66 [0.39-1.11],0.1190895198240237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPBGL,Trophoblast glycoprotein-like,23924,115,0.84 [0.52-1.36],0.4845038491026846
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPD52L2,Tumor protein D54,24061,114,1.07 [0.91-1.26],0.4236279570831145
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPK1,Thiamin pyrophosphokinase 1,24611,115,0.56 [0.30-1.04],0.0653415728874143
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPM3,Tropomyosin alpha-3 chain,23828,115,1.29 [0.91-1.84],0.1518537346885013
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPMT,Thiopurine S-methyltransferase,27634,122,1.06 [0.86-1.31],0.5845483931376688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPP1,Tripeptidyl-peptidase 1,28125,126,0.92 [0.65-1.30],0.6217247057084166
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPPP2,Tubulin polymerization-promoting protein family member 2,24157,114,1.07 [0.87-1.33],0.521404500986493
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPPP3,Tubulin polymerization-promoting protein family member 3,27654,122,0.86 [0.55-1.34],0.5046691498713425
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPR,Nucleoprotein TPR,23828,115,0.89 [0.61-1.31],0.5541221058304471
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPRKB,EKC/KEOPS complex subunit TPRKB,23740,114,1.03 [0.79-1.35],0.8050913967053155
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPSAB1,Tryptase alpha/beta-1,28612,125,0.85 [0.63-1.14],0.2821271818373959
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPSD1,Tryptase delta,24574,116,1.25 [0.83-1.88],0.2901207407104965
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPSG1,Tryptase gamma,23910,115,0.88 [0.45-1.72],0.7030352280386682
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPT1,Translationally-controlled tumor protein,27801,122,1.03 [0.81-1.30],0.8197989375412582
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRAF2,TNF receptor-associated factor 2,28308,124,1.04 [0.83-1.29],0.7519654844105024
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRAF3,"TNF receptor-associated factor 3, Isoform 2",23910,115,0.94 [0.58-1.52],0.7974957113129029
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,23828,115,1.29 [0.97-1.72],0.0836087688794745
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24157,114,0.98 [0.79-1.22],0.860437840849757
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TREH,Trehalase,24601,117,0.88 [0.70-1.10],0.269685589327612
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TREM2,Triggering receptor expressed on myeloid cells 2,28305,126,1.04 [0.77-1.39],0.7981166683745435
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TREML1,Trem-like transcript 1 protein,24634,116,0.96 [0.69-1.34],0.8089356304265907
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TREML2,Trem-like transcript 2 protein,28313,126,0.89 [0.55-1.43],0.6229755921522768
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIAP1,TP53-regulated inhibitor of apoptosis 1,28579,126,1.10 [0.87-1.41],0.4211946313941571
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM21,E3 ubiquitin-protein ligase TRIM21,28308,124,1.01 [0.82-1.25],0.9174145328294908
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM24,Transcription intermediary factor 1-alpha,24105,114,1.14 [0.88-1.47],0.3200648062225975
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24515,118,0.94 [0.80-1.11],0.4677351594003831
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM26,Tripartite motif-containing protein 26,23740,114,0.86 [0.61-1.22],0.4054420615525912
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM40,E3 ubiquitin ligase TRIM40,23924,115,0.95 [0.74-1.22],0.703342433710413
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM5,Tripartite motif-containing protein 5,28308,124,0.98 [0.82-1.18],0.8447673372930733
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM58,E3 ubiquitin-protein ligase TRIM58,24494,116,1.05 [0.86-1.29],0.6414823001287178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRPV3,Transient receptor potential cation channel subfamily V member 3,23828,115,0.56 [0.36-0.88],0.0122818626005871
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSC1,Hamartin,23910,115,0.87 [0.66-1.14],0.3224082252737931
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSC22D1,TSC22 domain family protein 1,24574,116,1.05 [0.81-1.35],0.7177346085639852
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSHB,Thyrotropin subunit beta,28326,123,1.10 [0.89-1.34],0.3808202676647586
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSLP,Thymic stromal lymphopoietin,27821,121,0.87 [0.65-1.17],0.3602571318010942
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSNAX,Translin-associated protein X,23828,115,0.92 [0.59-1.45],0.7294937838443307
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPAN1,Tetraspanin-1,27821,121,0.88 [0.58-1.32],0.5247124961848311
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPAN15,Tetraspanin-15,23828,115,1.33 [1.00-1.76],0.0471400606266219
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPAN7,Tetraspanin-7,23828,117,0.94 [0.77-1.15],0.5776686798879609
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPAN8,Tetraspanin-8,24515,118,0.79 [0.66-0.95],0.0109162415736836
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPYL1,Testis-specific Y-encoded-like protein 1,23910,115,0.95 [0.61-1.48],0.8312762824712197
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TST,Thiosulfate sulfurtransferase,27615,121,0.92 [0.74-1.13],0.4174005031999652
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TTF2,Transcription termination factor 2,23924,115,0.94 [0.65-1.36],0.7536743360006505
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TTN,Titin,23828,115,1.25 [1.02-1.54],0.0291368676221862
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TTR,Transthyretin,24377,118,0.59 [0.30-1.16],0.1230819341875176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TUBB3,Tubulin beta-3 chain,23828,117,1.24 [0.68-2.25],0.4867402896227722
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TWF2,Twinfilin-2,24601,117,1.02 [0.83-1.25],0.880445904016124
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXK,Tyrosine-protein kinase TXK,24157,114,1.14 [0.92-1.40],0.2262467006055623
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXLNA,Alpha-taxilin,28132,127,1.02 [0.86-1.22],0.7931720672124651
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXN,Thioredoxin,24234,114,1.04 [0.69-1.55],0.8609963571261439
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNDC15,Thioredoxin domain-containing protein 15,28391,125,0.91 [0.51-1.61],0.7474034313238065
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNDC5,Thioredoxin domain-containing protein 5,28593,126,1.03 [0.83-1.29],0.7757033400760566
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNDC9,Thioredoxin domain-containing protein 9,24539,118,0.98 [0.70-1.36],0.8913221104664688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNL1,Thioredoxin-like protein 1,23784,117,1.00 [0.83-1.20],0.990033115997141
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",28313,126,1.00 [0.72-1.40],0.9937811169619332
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TYMP,Thymidine phosphorylase,28151,123,1.06 [0.84-1.34],0.6235816813449332
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TYRO3,Tyrosine-protein kinase receptor TYRO3,28326,123,1.19 [0.68-2.08],0.5501715607347991
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",23910,115,0.89 [0.66-1.18],0.4112664683440001
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBAC1,Ubiquitin-associated domain-containing protein 1,28200,126,0.91 [0.58-1.43],0.6855449901297397
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBE2B,Ubiquitin-conjugating enzyme E2 B,24494,116,1.16 [0.64-2.09],0.6290432548916101
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24611,115,1.15 [0.87-1.52],0.3180870914903868
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,23910,115,1.01 [0.75-1.36],0.9286434858018094
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBQLN3,Ubiquilin-3,23828,115,0.98 [0.67-1.43],0.9037065166598268
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBXN1,UBX domain-containing protein 1,24061,114,1.06 [0.83-1.37],0.6287978302887123
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24515,118,1.02 [0.90-1.16],0.7309365139244707
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UGDH,UDP-glucose 6-dehydrogenase,23828,115,1.03 [0.87-1.22],0.7590015114208387
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UHRF2,E3 ubiquitin-protein ligase UHRF2,23828,115,0.79 [0.44-1.41],0.4197858425968038
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ULBP2,UL16-binding protein 2,28132,127,1.30 [0.87-1.96],0.2030471445346763
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UMOD,Uromodulin,28578,127,0.92 [0.69-1.22],0.5562930794954994
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UNC5D,Netrin receptor UNC5D,23910,115,0.60 [0.29-1.23],0.1607962527264047
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UNC79,Protein unc-79 homolog,23740,114,0.68 [0.48-0.97],0.0334303521196767
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UNG,Uracil-DNA glycosylase,24494,116,0.80 [0.47-1.37],0.4157532948928881
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UPB1,Beta-ureidopropionase,24611,115,0.84 [0.69-1.02],0.0751784508900287
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UPK3A,Uroplakin-3a,23828,117,0.95 [0.65-1.38],0.7908096167219083
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UPK3BL1,Uroplakin-3b-like protein 1,24117,114,0.81 [0.54-1.23],0.3257093999483063
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UROD,Uroporphyrinogen decarboxylase,24061,114,1.10 [0.86-1.43],0.4462839689346031
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UROS,Uroporphyrinogen-III synthase,23924,115,1.12 [0.88-1.42],0.3744883643040138
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USO1,General vesicular transport factor p115,28200,126,1.04 [0.87-1.24],0.6681197632093789
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24494,116,1.03 [0.81-1.32],0.7928201388262666
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24539,118,1.20 [0.79-1.81],0.394274918996825
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USP47,Ubiquitin carboxyl-terminal hydrolase 47,23828,115,0.97 [0.79-1.20],0.801855660475238
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USP8,Ubiquitin carboxyl-terminal hydrolase 8,27821,121,1.04 [0.89-1.23],0.6068956217424604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UXS1,UDP-glucuronic acid decarboxylase 1,27634,122,0.96 [0.70-1.31],0.7801058569578445
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VAMP5,Vesicle-associated membrane protein 5,27821,121,1.12 [0.85-1.48],0.4062939801349186
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VAMP8,Vesicle-associated membrane protein 8,23910,115,1.07 [0.87-1.30],0.5220102693627998
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VASH1,Tubulinyl-Tyr carboxypeptidase 1,28308,124,1.04 [0.86-1.26],0.665278968584728
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VASN,Vasorin,27866,125,1.04 [0.59-1.85],0.8855172849981827
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VASP,Vasodilator-stimulated phosphoprotein,24634,116,1.07 [0.85-1.36],0.5543196683869687
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,28200,126,0.83 [0.37-1.83],0.6387662311026968
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VAV3,Guanine nucleotide exchange factor VAV3,23828,117,0.98 [0.82-1.17],0.7925035860568663
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VCAM1,Vascular cell adhesion protein 1,28372,127,1.17 [0.66-2.07],0.6005076584719942
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VCAN,Versican core protein,28593,126,0.82 [0.49-1.39],0.4703013649986803
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VCPKMT,Protein-lysine methyltransferase METTL21D,23740,114,0.84 [0.66-1.08],0.1765067412692934
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VEGFA,Vascular endothelial growth factor A,28568,124,0.99 [0.75-1.30],0.9229952029486694
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VEGFB,Vascular endothelial growth factor B,23910,115,1.12 [0.60-2.08],0.7172682308312714
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VEGFC,Vascular endothelial growth factor C,28391,125,0.95 [0.72-1.25],0.6954816000071069
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VEGFD,Vascular endothelial growth factor D,28614,125,0.89 [0.59-1.36],0.6017071177288612
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VGF,Neurosecretory protein VGF,24574,116,0.81 [0.44-1.46],0.4774731565529069
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VIM,Vimentin,27821,121,0.99 [0.87-1.14],0.9157229821938384
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VIPR1,Vasoactive intestinal polypeptide receptor 1,23928,116,1.11 [0.57-2.16],0.7495780454313417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VIT,Vitrin,24611,115,0.90 [0.56-1.45],0.6716886200858248
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VMO1,Vitelline membrane outer layer protein 1 homolog,28200,126,0.96 [0.77-1.22],0.7615878995564336
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VNN1,Pantetheinase,24634,116,1.10 [0.86-1.41],0.4275611882069462
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VNN2,Vascular non-inflammatory molecule 2,28200,126,1.21 [0.86-1.71],0.2787076192909528
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24157,114,0.98 [0.75-1.28],0.8669295274713845
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VPS37A,Vacuolar protein sorting-associated protein 37A,28200,126,1.04 [0.85-1.26],0.714219838565203
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VPS4B,Vacuolar protein sorting-associated protein 4B,24494,116,1.04 [0.87-1.25],0.6770292060084935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VPS53,Vacuolar protein sorting-associated protein 53 homolog,28200,126,1.00 [0.82-1.22],0.98574051935926
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIG10,V-set and immunoglobulin domain-containing protein 10,24494,116,0.42 [0.23-0.78],0.005782249579432
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,23828,115,1.28 [0.79-2.08],0.3166774009738806
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIG2,V-set and immunoglobulin domain-containing protein 2,24494,116,0.99 [0.72-1.36],0.948821849762801
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIG4,V-set and immunoglobulin domain-containing protein 4,28273,126,1.16 [0.78-1.74],0.4566328710969278
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,28287,123,1.08 [0.85-1.39],0.5293624335145529
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSNL1,Visinin-like protein 1,24539,118,0.80 [0.50-1.28],0.3441165266434997
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSTM1,V-set and transmembrane domain-containing protein 1,27654,122,1.18 [0.86-1.63],0.3058851308491676
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSTM2B,V-set and transmembrane domain-containing protein 2B,24157,114,0.72 [0.42-1.21],0.214189372023891
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,27821,121,1.10 [0.84-1.43],0.4983411047774551
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,28593,126,1.03 [0.83-1.28],0.8147616248031064
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VTCN1,V-set domain-containing T-cell activation inhibitor 1,27634,122,1.16 [0.71-1.90],0.5474674847682142
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24061,114,1.03 [0.76-1.39],0.8519377041572331
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWA1,von Willebrand factor A domain-containing protein 1,28542,126,1.01 [0.70-1.45],0.9647241644403146
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWA5A,von Willebrand factor A domain-containing protein 5A,23740,114,0.77 [0.57-1.05],0.0956279288157417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWC2,Brorin,28033,127,0.94 [0.62-1.40],0.748593329360715
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWC2L,von Willebrand factor C domain-containing protein 2-like,24574,116,0.86 [0.56-1.31],0.4785014887635055
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWF,von Willebrand factor,28675,127,0.99 [0.81-1.23],0.9618315292741644
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WARS,"Tryptophan--tRNA ligase, cytoplasmic",28313,126,1.12 [0.74-1.71],0.5866705951382318
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WAS,Wiskott-Aldrich syndrome protein,27801,122,1.04 [0.83-1.32],0.7225389751106599
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WASF1,Wiskott-Aldrich syndrome protein family member 1,27821,121,1.03 [0.87-1.22],0.7500508790997165
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WASF3,Wiskott-Aldrich syndrome protein family member 3,27654,122,0.91 [0.76-1.10],0.3301798168540318
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WASHC3,WASH complex subunit 3,24539,118,0.87 [0.68-1.10],0.2444333825219683
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WASL,Neural Wiskott-Aldrich syndrome protein,23910,115,1.06 [0.80-1.39],0.6986393014031401
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WDR46,WD repeat-containing protein 46,24494,116,1.06 [0.67-1.67],0.8050760274742284
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFDC1,WAP four-disulfide core domain protein 1,24009,113,0.71 [0.47-1.08],0.1126902205793228
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFDC12,WAP four-disulfide core domain protein 12,28526,125,1.12 [0.88-1.43],0.352011790372946
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFDC2,WAP four-disulfide core domain protein 2,26858,119,1.37 [0.91-2.07],0.1322957853373663
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",28043,127,1.00 [0.68-1.47],0.9929491899437464
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",28355,126,0.93 [0.58-1.47],0.7412699904780676
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WIF1,Wnt inhibitory factor 1,28579,126,0.69 [0.43-1.09],0.1094648800395076
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WNT9A,Protein Wnt-9a,27801,122,1.07 [0.61-1.89],0.8047003873134629
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,28132,127,1.05 [0.79-1.40],0.7331926708158694
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XCL1,Lymphotactin,28579,126,1.00 [0.75-1.34],0.974372200951932
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XG,Glycoprotein Xg,28524,127,1.31 [0.80-2.17],0.2865182050094136
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XIAP,E3 ubiquitin-protein ligase XIAP,23910,115,1.01 [0.74-1.37],0.9613710314001762
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XPNPEP2,Xaa-Pro aminopeptidase 2,28391,125,0.91 [0.78-1.06],0.21883839803489
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XRCC4,DNA repair protein XRCC4,27654,122,0.79 [0.50-1.23],0.2954773603409784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YAP1,Transcriptional coactivator YAP1,24539,118,1.18 [0.61-2.26],0.6249458504178023
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24515,118,1.03 [0.92-1.17],0.5787418765828038
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YES1,Tyrosine-protein kinase Yes,28200,126,1.05 [0.91-1.20],0.512798593286275
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YJU2,Splicing factor YJU2,24494,116,0.84 [0.48-1.45],0.5303769628073601
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YOD1,Ubiquitin thioesterase OTU1,23828,115,0.97 [0.73-1.30],0.8570547252315572
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YTHDF3,YTH domain-containing family protein 3,27801,122,1.02 [0.84-1.23],0.8401678911952756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YWHAQ,14-3-3 protein theta,24061,114,1.09 [0.86-1.38],0.5002827975227278
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YY1,Transcriptional repressor protein YY1,23910,115,0.95 [0.50-1.79],0.8630266943234506
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZBP1,Z-DNA-binding protein 1,23910,115,0.89 [0.56-1.40],0.6055443711648358
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZBTB16,Zinc finger and BTB domain-containing protein 16,27634,122,0.99 [0.79-1.24],0.9559723901760326
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZBTB17,Zinc finger and BTB domain-containing protein 17,27821,121,0.95 [0.64-1.41],0.7935943546119407
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZCCHC8,Zinc finger CCHC domain-containing protein 8,23828,115,1.06 [0.80-1.40],0.6982282087279481
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZFYVE19,Abscission/NoCut checkpoint regulator,24515,118,1.01 [0.84-1.23],0.8840775236831542
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZHX2,Zinc fingers and homeoboxes protein 2,24539,118,1.18 [0.78-1.78],0.4421866035526224
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNF174,Zinc finger protein 174,23910,115,0.97 [0.60-1.58],0.9055476520067396
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNF75D,Zinc finger protein 75D,24157,114,0.88 [0.64-1.21],0.4326984228396071
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNF830,Zinc finger protein 830,24494,116,1.04 [0.85-1.29],0.6880791562836328
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNRD2,Protein ZNRD2,24515,118,0.74 [0.57-0.98],0.0339684006847595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24494,116,0.88 [0.62-1.24],0.4559382684807653
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZP3,Zona pellucida sperm-binding protein 3,23928,116,1.02 [0.95-1.09],0.5702331070314428
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZP4,Zona pellucida sperm-binding protein 4,23740,114,0.82 [0.44-1.53],0.5338140640104714
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZPR1,Zinc finger protein ZPR1,23828,117,0.98 [0.81-1.19],0.8660339891237419
